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Abstract 
Embryonic stem (ES) cells have the remarkable ability to differentiate into all cells 
comprising the three germ layers of the developing embryo. It is this pluripotency 
that makes them attractive for use in regenerative medicine. However, in order to 
harness this potential, we must understand the molecular mechanisms regulating the 
ability of ES cells to self-renew and thereby generate identical pluripotent daughter 
ES cells. The Welham laboratory has previously described a requirement for PI3K 
signalling in maintaining self-renewal of murine ES (mES) (Paling et al., 2004; 
Storm et al., 2007). To identify the molecular mechanisms involved in regulating 
mES cell self-renewal downstream of PI3K signalling, an Affymetrix microarray 
screen was carried out prior to the start of this PhD. For the screen, mES cells were 
grown in the presence of LIF and treated with the reversible PI3K inhibitor 
LY294002 (LY) or a DMSO control for 24, 48 and 72 hours. A total of 646 
statistically significant transcriptional changes were detected and subsequently 
divided into 12 clusters using k-means clustering.  
Experiments using pharmacological inhibitors suggest that genes within the same 
cluster are regulated by common mechanisms. To identify potential candidates 
involved in regulation of mES cell pluripotency, further analyses concentrated on 
transcription factors and genes with unknown functions. In our microarray data 
Zscan4c, a member of a SCAN-domain containing Zinc finger protein family, is one 
of the earliest down-regulated probe-sets. Loss-of-function experiments using siRNA 
approaches highlight a role for Zscan4 downstream of PI3Ks in regulation of ES cell 
self-renewal. Immunohistochemical staining of cells overexpressing Zscan4c showed 
nuclear accumulation of the protein. This, together with the fact that Zscan4c was 
mainly detectable in the nuclear protein fraction, strengthens a role of Zscan4c in 
transcriptional regulation. Potential Zscan4c protein interaction partners were 
identified by applying a combined immunoprecipitation (IP) - mass spectrometry 
strategy. Interestingly, the majority of potential Zscan4c interacting proteins 
identified are associated with functions related to transcriptional regulation and DNA 
damage response, all characteristics linked with Zscan4. Furthermore, the Class IA 
PI3K catalytic isoforms were genetically activated in mES cells, and liberation of the 
requirement for LIF was found upon over-expression of an activated p110 catalytic 
subunit.  
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1.1 Stem Cells and their characteristics 
Stem cells are unspecialised cells which have two features, self-renewal and 
differentiation potential, making them very unique and fascinating. They have the 
ability to differentiate into other more specialised cell types and, depending on the 
type of stem cell, they have different constraints in their abilities to differentiate. 
Their potency, or ability to differentiate, is dependent on stem cell origin and reflects 
their different purposes. Embryonic stem (ES) cells are pluripotent, meaning they are 
able to give rise to all cell types of the adult animal. Adult stem cells are, in contrast, 
limited in their lineage progression and are usually replenishing cells of damaged or 
aged tissue. The other defining characteristic of stem cells is their self-renewal 
capacity. Self-renewal of a stem cell is its division giving rise to two daughter cells, 
with at least one being identical to its parental cell. It can be also described as 
proliferation with the suppression of differentiation (Burdon et al., 2002; Smith, 
2001).  
 
Due to their properties, ES cells have the potential to be used in several fields 
including, regenerative medicine for cell-based therapies, drug development and 
toxicity screening and as an in vitro system to study early embryo development 
(Figure 1.1). 
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Figure 1.1 Properties and applications of ES cells. ES cells have self-renewal 
capacity (a), which is their ability to give rise to at least one daughter cell identical to 
the parental cell. ES cells are also pluripotent (b), they have the ability to give rise to 
all cell types of the adult animal.  Due to these properties, ES cells can be used in 
regenerative medicine (c), drug development and toxicity screening (d) and as an in 
vitro model to study early development (e). Image (b) from Tam and Loebel, 2007, 
(c) from www.stemcellresearchfoundation.org, (d) from 
http://yxhealth.com/nutrition/ho-to-take-medicines and (e) Modified from Advance 
Biology by Michael Kent (OUP, 2000). 
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1.2 History of embryonic stem cells 
The first evidence that supported the existence of embryonic stem cells dates back to 
1970 when it was observed that grafting of early mouse embryos into adult mice 
produced teratocarcinomas (Solter et al., 1970; Stevens, 1970). The teratocarcinomas 
formed contained a proportion of undifferentiated cells, which could be propagated 
in culture and retained a differentiation potential giving rise to derivatives of all three 
germ layers (Martin and Evans, 1975). These undifferentiated cells were named 
embryonal carcinoma cells (EC) cells. The fact that teratocarcinomas, and hence EC 
cells, could only be derived from grafts containing epiblast suggested that EC cells 
were derived from the epiblast (see section 1.3)  (Diwan and Stevens, 1976). EC 
cells resemble epiblast cells in their developmental potential and phenotype, are self-
renewing and pluripotent, and some EC cells were shown to be able to contribute to 
the developing embryo (Brinster, 1974). However, EC cells are tumourigenic and 
cytogenetically abnormal, and most of them did not have a significant differentiation 
potential. Embryonic stem cells were first derived in 1981 from blastocyst co-culture 
with mitotically inactivated fibroblast, so called feeders (Evans and Kaufman, 1981; 
Martin, 1981). ES cells were similar to EC cells in morphology and even in the 
ability to produce teratocarcinomas when injected into an adult mouse (Figure 1.2). 
However, they maintained a normal karyotype, opposite to EC cells that are 
normally aneuploid. Moreover, ES cells injected into a developing blastocyst are 
able to contribute to various tissues in chimeras including the germ line (Bradley et 
al., 1984). The first human ES cells were derived in 1998 by Thomson (Thomson et 
al., 1998). 
 
 
Figure 1.2 Immunohistochemistry stainings of teratomas. (i) endoderm (α-
fetoprotein-positive, green; FOXA2-positive, red), (ii) mesoderm (α-actinin-positive 
cardiac myocytes, green), (iii) ectoderm (TuJ1-positive neuronal cells, green; glial 
fibrillary acidic protein-positive cells, red). Adapted from (Gonzalez et al., 2009). 
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1.3 Preimplantation mouse development 
After fertilization, mitotic cell divisions in the zygote occur giving rise to 8 cells 
after two days of embryonic development (Figure 1.3). Remarkably the size of the 8 
cells is similar to the initial fertilized egg. The 8-cell stage is followed by 
compaction and polarization of the cells in the embryo. At this point cells will 
become either inner or outer cells. The morula, which consists of 16 cells, is then 
formed. After 3.5 days of fertilization the blastocyst is formed. At the blastocyst state 
two different populations of cells can be observed, the trophoblast cells, which are 
the outer cells, and will give rise to extraembyonic tissue, including the placenta, and 
cells in the inner cell mass (ICM), which will form the embryo proper and yolk sack 
(Rossant and Tam, 2004). These distinct cell populations are characterized by the 
expression of different markers; Cdx2 and Eomes (Strumpf et al., 2005) in the case 
of trophectoderm or Oct4 and Nanog in the ICM (Chambers et al., 2003; Chazaud et 
al., 2006; Mitsui et al., 2003). ES cells can be isolated from the ICM and they can 
give rise to all cells of the adult tissue. The blastocysts also have a cavity, the 
blastocoel (Figure 1.3), which originates from fluids secreted by the trophectoderm.  
 
After 4.5 days of fertilization the blastocyst implants into the uterine lining through 
the trophectoderm. At this stage the ICM of the blastocyst has transformed into the 
epiblast and the hypoblast or primitive endoderm (Gardner and Beddington, 1988). 
The primitive endoderm is formed between the epiblast and the blastocoel. Epiblast 
cells and primitive endoderm express different markers. Epiblast cells express Nanog 
and the primitive endoderm cells express Gata4 and Gata6 (Chazaud et al., 2006). 
 
Chapter 1: Introduction 
 
6 
 
 
 
 
Figure 1.3: Mouse early embryonic development. (A) illustrates spatial and 
temporal stages of embryonic development. Pre-implantation embryonic 
development proceeds from fertilisation at the beginning of the fallopian tubes to 
implantation of the late blastocyst in the uterus (Diagram taken from 
www.stemcells.nih.gov). (B) Bright field images of different stages of development. 
(a) oocyte, (b) zygote, (c) 2-cell stage, (d) 4-cell stage, (e) 8-cell stage, (f) morula, 
(g) blastocyst and (h) egg cilinder. Images in (B) from 
http://www.ramsem.com/images/clip_image002.jpg.   
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1.4 Derivation of embryonic stem cells 
ES cells are derived from the transient epiblast compartment of the blastocyst, the 
ICM (Figure 1.4). Different methods can be used to establish ES cell lines from the 
ICM. For example, the ICM can be isolated by laser dissection or immunosurgery, or 
mES cell lines can be created via blastocyst outgrowth and subsequent propagation 
of self-renewing colonies. ES cell derivation is improved by inducing diapause, 
which is achieved by injecting tamoxifen (Evans and Kaufman, 1981; Kawase et al., 
1994). Under natural circumstances, diapause is a state of arrested development 
occurring in pregnant female mice still lactating their first litter. The implantation of 
the embryos of the second litter is, therefore, delayed until the preceding litter has 
been weaned (Brook and Gardner, 1997; Smith, 2001). It has been observed that ES 
cells can be derived more easily from some strains of mouse than others. The 129 
mouse strain has the highest percentage of successful derivation, followed by 
C57BL/6, CBA and NOD. Derivation of ES cells from CBA and NOD mice has 
traditionally proved to be very difficult. However, more recently successful 
derivation of germline-competent ES cells from CBA and NOD strains has been 
achieved by culturing in 2i media plus LIF. The 2i is a basal media with 2 inhibitors, 
one is a MAPK inhibitor and the other is a GSK-3 inhibitor (Nichols et al., 2009; 
Ying et al., 2008). It is possible to keep ES cells self-renewing in 2i media without 
LIF, although addition of LIF enhances cloning efficiency. Derivation of germline-
competent ES cells from rats has also been achieved for the first time by using 2i 
media (Buehr et al., 2008; Li et al., 2008b). These successes were the result of 
intensive research, deciphering self-renewal mechanisms which will, hopefully lead 
to the establishment of further species-specific ES cell lines. Furthermore, these 
findings might contribute to the knowledge required for the optimal culture of hES 
cells. 
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Figure 1.4 ES cells derivation. ES cells can be derived by plating the Inner cell 
mass (ICM) of the blastocyst onto a feeder layer of mitotically inactivated 
fibroblasts. 
 
 
 
1.5 Murine embryonic stem cell self-renewal 
Self-renewal of a stem cell (described in section 1.1) is a very complex process 
regulated by a variety of extrinsic and intrinsic factors, some of which will be 
described in this section.  
 
1.5.1 Self-renewal markers of murine ES cells 
A wide range of different markers have been identified by stem cell researchers 
aiding in defining the undifferentiated state of ES cells. To assess a panel of these 
markers can help to determine the undifferentiated ES cell state. Markers facilitate 
the characterisation of different ES cell subpopulations but to assess their ability to 
differentiate into different lineages requires more stringent tests like teratoma or 
chimera formation.   
Alkaline phosphatase (ALP) is a hydrolase enzyme removing phosphate groups from 
a wide range of molecules, including alkaloids and proteins. The name reflects its 
optimal working conditions in an alkaline environment. ALP is expressed at a low 
level in all tissue types, but is elevated in some disease-related states such as liver 
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damage or bone growth alterations (Fernandez and Kidney, 2007). The inner cell 
mass of the blastocyst was also reported to have a high activity of ALP (Johnson et 
al., 1977). Undifferentiated, self-renewing mES cells also exhibit alkaline 
phosphatase activity, which is lost upon differentiation. Therefore, staining for 
alkaline phosphatase activity can be used to detect self-renewing ES cell colonies in 
the so called Alkaline phosphatase assay (Pease et al., 1990). 
Rex1, also known as Zfp42, encodes for an acidic zinc finger protein expressed in 
undifferentiated ESCs and identified to be downregulated following retinoic acid 
induced differentiation (Hosler et al., 1989). Rex1 is restrictedly expressed in the 
ICM and is regulated, beside other factors, via Oct4 (Ben-Shushan et al., 1998; 
Toyooka et al., 2008). In later pluripotent cell populations, for instance the epiblast 
and primitive ectoderm (PrE), Rex1 levels are reduced (Toyooka et al., 2008). ES 
cells cultured in vitro in the presence of LIF contain different subpopulations, among 
them Oct4 positive/Rex1 positive cells and Oct4 positive/Rex1 negative cells. The 
Rex1 positive cell population has a higher differentiation potential and contributes 
more efficiently to chimera formation (Toyooka et al., 2008). Despite this 
observation, Rex1 is dispensable for the maintenance of mESCs and is not absolutely 
required for normal mouse embryo development. However, it is a suitable marker of 
mESC pluripotency, as its expression is downregulated rapidly upon differentiation 
(Rogers et al., 1991), but as it has no functional significance should be regarded as a 
marker solely, like alkaline phosphatase activity (Masui et al., 2008).   
Three other well-known pluripotency markers are the transcription factors Nanog, 
Oct3/4 and Sox2. These pluripotency core factors hold key functional properties and 
are therefore discussed in more detail as part of the intrinsic factors of pluripotency 
section 1.5.3.  
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1.5.2 Extrinsic factors 
1.5.2.1 Leukaemia inhibitory factor (LIF) Signalling 
Maintenance of undifferentiated ES cells traditionally required their co-culture with 
feeder cells, secreting the soluble factor LIF.  LIF belongs to the IL6 family of 
cytokines and can support mESC growth and self-renewal in presence of serum 
without feeders (Smith et al., 1988; Williams et al., 1988). Furthermore, when feeder 
cells contain a non-functional Lif locus, they are unable to sustain ESC self-renewal 
(Stewart et al., 1992). LIF signalling is mediated either through gp130 homodimers 
or via heterodimers consisting of gp130 and the LIF receptor (Yoshida et al., 1994). 
Janus-associated tyrosine kinases (JAKs) are recruited to the intracellular domain of 
gp130, where they phosphorylate tyrosine residues, creating binding sites for signal 
transducer and activator of transcription 3 (STAT3) (Boulton et al., 1994; Burdon et 
al., 1999a). STAT3 binds with its SH2 domains, which allows in consequence the 
phosphorylation of STAT3 by JAKs. Phosphorylated STAT3 homodimerises and 
translocates to the nucleus where it modulates transcription of target genes (Figure 
1.5).  
The molecular mechanisms by which LIF signalling suppresses differentiation have 
been delineated in great detail (Boeuf et al., 1997; Burdon et al., 1999a; Niwa et al., 
1998). STAT3 activation was shown to be required, as inhibition of STAT3 
activation by mutant STAT3, unable to dimerise, failed to sustain self-renewal (Niwa 
et al., 1998). Furthermore, artificial STAT3 activation is sufficient to maintain the 
undifferentiated state of ES cells (Matsuda et al., 1999). STAT3 homodimers act as 
transcription factors activating mediators of ES cell self-renewal. The proto-
oncogene c-myc was reported to be a direct transcriptional target of STAT3 and 
overexpression of c-myc has been reported to lead to LIF-independent ES cells 
(Cartwright et al., 2005).  Another downstream target of LIF is Klf4. When Klf4 is 
overexpressed during embryoid body (EB) differentiation, Oct-4 levels were higher 
than control levels, consistent with the idea of Klf4 promoting ESC self-renewal (Li 
et al., 2005). Both, c-myc and Klf4, were part of the original four reprogramming 
factor cocktail used to create induced pluripotent stem cells (iPS) cells (Takahashi 
and Yamanaka, 2006). In the light of this finding, a role of these two transcription 
factors in regulating pluripotency is strengthened, though precise mechanisms 
remain unclear.  
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Gene inactivation studies targeting gp130 in mice indicate that the LIF signalling 
axis is not necessary for normal development of the early embryo prior to 
gastrulation (Ware et al., 1995; Yoshida et al., 1996). It is unknown how or if the 
gp130/STAT3 signalling plays an important role in vivo, analogous to the 
maintenance of mES cell self-renewal in the cell culture. A role for LIF signalling 
was discovered during diapause in embryo development. Embryos lacking gp130 are 
unable to re-enter normal development after diapause arrest and exhibit an inability 
to maintain the epiblast (Nichols et al., 2001). Therefore, LIF signalling appears to 
be essential for extending the epiblast lifespan during diapause and this function 
might relate to the in vitro function of gp130 signalling in ES cell maintenance 
(Smith, 2001). It could be reasoned that only species exhibiting diapause have the 
ability to generate ES cells and therefore hES cells are functionally unresponsive to 
LIF (Daheron et al., 2004; Thomson et al., 1998). However, more recent studies 
indicate that hES cells might reflect a later developmental stage (Najm et al., 2011; 
Tesar et al., 2007). Furthermore, hES cells which are brought closer to a more naïve 
state of pluripotency, exhibit LIF responsiveness (Buecker et al., 2010; Hanna et al., 
2010). 
Besides the Jak/STAT3 pathway, two other signalling pathways are activated by 
LIF, the Mitogen Activated Protein Kinase (MAPK) and PI3K pathway. Both 
pathways play a role in stem cell fate choice, PI3K signalling activation promotes 
self-renewal through activation of Akt and GSK-3 inhibition, while MAPK 
activation induces differentiation through activation of Erk (Figure 1.6) (Burdon et 
al., 1999b; Niwa et al., 2009; Paling et al., 2004). 
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Figure 1.5 LIF/STAT3 signalling. LIF binding to the receptor leads to recruitment 
of JAK to the gp130 receptor where it phosphorylates tyrosine residues creating 
docking sites for recruitment of STAT3 through its SH2 domain. STAT3 is then 
phosphorylated by JAK and phosphorylated STAT3 forms homodimers and 
translocates to the nucleus where it modulates transcription of target genes, for 
example c-myc. Modified from Cartwright et al., 2005.  
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Figure 1.6 Signalling pathways activated by LIF. LIF binding to the receptor 
leads to activation of JAK/STAT3, PI3K pathways, MAPK. The two first pathways 
promote self-renewal while MAPK induces differentiation. Adapted from Niwa et 
al., 2009 (Niwa et al., 2009). 
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1.5.2.2 Bone morphogenetic protein (BMP) signalling 
In feeder free culture systems, ESC maintenance requires the presence of serum in 
addition to LIF. LIF alone without serum is not sufficient to maintain ESC self-
renewal, and subsequently results in neuronal differentiation. Therefore, other serum 
containing factors are involved in regulating mES cell pluripotency. Bone 
morphogenetic proteins (BMPs), known to inhibit neuronal differentiation, were 
identified as factors able to support self-renewal under serum free conditions in the 
presence of LIF (Ying et al., 2003). 
BMPs bind to transmembrane serine/threonine kinase receptors. Cellular responses 
to BMPs are mediated by the formation of heteromeric complexes of type I and type 
II receptors (Shi and Massague, 2003) and in undifferentiated ESCs the two different 
types of BMP receptors, BmprIa (type I) and BmprII (type II) are both expressed (Qi 
et al., 2004). Ligand binding mediates signalling through SMADs to induce 
expression of Id (Inhibitor of differentiation) proteins, which are known to inhibit 
basic helix-loop-helix transcription factors needed for differentiation (Ruzinova and 
Benezra, 2003) (Figure 1.7). Constitutive expression of Id1, 2, or 3 is enough to free 
ES cells from BMP or serum dependence and allows self-renewal in LIF alone (Ying 
et al., 2003). ES cells not expressing Bmpr1a or Smad4 cannot be established from 
the blastocyst, contributing to the evidence that this pathway is important for self-
renewal (Qi et al., 2004). Serum used in the standard in vitro culture environment 
induces Id genes via multiple pathways, among them is Integrin, which is bound by 
extracellular matrix molecules for instance fibronectin (Benezra, 2001; Norton, 
2000).  
The SMAD proteins take their name from the drosophila homolog protein, mothers 
against decapentaplegic (MAD) and the Caenorhabditis Elegans protein SMA 
(Attisano and Wrana, 2002). Forced expression of SMAD3/4 or constitutively 
activated BMP receptors cause differentiation into lineages other than neuronal, 
highlighting that a careful regulation of this pathway is necessary (Ying et al., 2003). 
In ES cells BMP signalling is multifaceted as upon LIF withdrawal BMP signalling 
switches to promote differentiation to non-neural lineages (Ying et al., 2003).  
The LIF and BMP pathway act together to support mES cells self-renewal. While the 
BMP pathway seems to primary block TFs important for differentiation into 
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neuronal lineages, LIF acts through STAT3 to restrain mesoderm and endoderm 
differentiation (Ying et al., 2003) (Figure 1.8). 
 
 
 
 
Figure 1.7 BMP signalling. BMP4 binding to the receptor results in Smad1/5/8 
phosphorylation, phosphorylated Smad1/5/8 heterodimer with Smad4 and 
translocate to the nucleus where activate Inhibitor of differentiation (Id) proteins. 
(After Ying et al., 2003). 
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Figure 1.8 LIF and BMP cooperation to support self-renewal. LIF and BMP 
pathways cooperate to support self-renewal by restricting ES cell lineage 
commitment. LIF acts through STAT3 to inhibit mesoderm and endoderm 
differentiation while BMP through SMADs restrict neuronal differentiation 
(Modified from Ying et al., 2003). 
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1.5.2.3 MAPK signalling 
The MAPK/Erk pathway is activated by extracellular stimuli, usually growth factors, 
and subsequently signals through a protein phosphorylation cascade to downstream 
effectors that regulate a large number of cellular processes. When this important 
pathway is dysregulated, it can result in the development of serious diseases like 
cancer (reviewed in (Crabbe et al., 2007)). During the signalling process from the 
cell membrane to the nucleus several steps lead to phosphorylation and activation of 
Erk1/2. Briefly, after activation of a receptor tyrosine kinase, SH2 domain containing 
proteins, including Shp2 and the adapter protein Grb2, bind to phosphorylation sites 
on the receptor. The protein SOS, named after its homologue Son of Sevenless in 
Drosophila, is able to bind to the membrane-bound protein Ras. Inactive Ras is 
bound to the nucleotide Guanosine diphosphate (GDP). SOS catalyses the exchange 
of GDP for Guanosine triphosphate (GTP) activating RAS, which in turn activates a 
chain of kinases, Raf, MEK (MAPK Erk Kinase) and finally Erk1/2. Phosphorylated 
Extracellular signal-regulated protein kinases, Erk1 and Erk2, can activate 
transcription factors of the AP-1 family, translocate to the nucleus and activate its 
targets (Figure 1.9). Erk1 and Erk2 have been demonstrated to be involved in 
regulating mESC self-renewal. 
MAP kinases Erk1/2 are activated through the SH2 domain-containing tyrosine 
phosphatase-2 (Shp-2) as a consequence of LIF signalling. This is somewhat 
surprising, as Erk1/2 signalling negatively regulates self-renewal. The promotion of 
differentiation by Erk1/2 signalling was shown by creating gp130 mutant ES cells 
unable to bind Shp-2 (Burdon et al., 1999b). Extracellular signal stimulation did not 
activate the Erk pathway and low concentrations of LIF, normally unable to sustain 
self-renewal, were able to maintain mES cell pluripotency (Burdon et al., 1999b). 
The differentiation supporting effect of Erk signalling through Shp-2 is underlined 
by the enhanced self-renewal of ES cells overexpressing catalytically inactive Shp-2 
mutant forms (Burdon et al., 1999b). Moreover, Shp-2 null ESCs are able to self-
renew long-term, but are constrained in their ability to differentiate normally. They 
are impaired in their ability to differentiate into hematopoietic lineages, cardiac 
muscle cells, epithelial and fibroblast cells (Qu and Feng, 1998). Consistent with this 
observation, Grb2-null ESCs lack the ability to differentiate into endoderm as a 
consequence of a disturbed Ras/Erk signalling (Cheng et al., 1998). Signalling 
through Grb2/MEK was also claimed to be able to downregulate Nanog, shown by 
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introducing a constitutively active Mek mutant into ES cells or addition of the 
tyrosine phosphatase inhibitor, sodium vanadate, leading to Nanog repression and 
primitive endoderm differentiation (Hamazaki et al., 2006). Furthermore, treatment 
of ESC with the MEK inhibitor PD098059, inhibiting the activation of Erk1/2, did 
not block but rather enhanced self-renewal (Burdon et al., 1999b). This observation 
translates also to the embryo, where inhibition of Erk1/2 signalling promotes naïve 
pluripotency of the epiblast (Nichols et al., 2009). Epiblast cells expanded under Erk 
inhibition conditions could be expanded clonally and had high homogenous 
expression of pluripotency associated genes Nanog and Oct4 (Nichols et al., 2009).  
 
Fibroblast growth factors (FGFs) are also able to trigger MAPK signalling by 
binding to FGF receptors, resulting in the activation of its receptor tyrosine kinase. It 
is peculiar that undifferentiated ES cells secrete FGF4, as this pathway is implicated 
in differentiation. Mouse ES cells treated with FGF receptor inhibitors or lacking 
FGF4 are unable to form neural or mesodermal lineages and are intractable to neuron 
differentiation by BMP induction. In accordance with this finding is the evidence for 
a requirement for Erk1/2 signalling during neural specification downstream of the 
FGF receptor (Stavridis et al., 2007). Absence of FGF4 does not prohibit 
differentiation entirely since FGF4 null ES cells can still form complex teratomas, 
but with a lower frequency than FGF4 heterozygous ES cells, possibly due to 
upregulation of other FGFs (Kunath et al., 2007). Differentiation defects resulting 
from the lack of FGF4 could be rescued by addition of recombinant FGF4, adding 
further evidence to suggest that the effect is caused by autocrine FGF4 signalling 
(Kunath et al., 2007). It is reasoned that Erk signalling promotes ESCs to a state 
allowing them to exit self-renewal by facilitating the response to differentiation 
signals (Kunath et al., 2007; Stavridis et al., 2007). Only a relatively short time 
window of sustained Erk1/2 activity is required to pass the threshold and allow 
neuronal fate lineage specification (Stavridis et al., 2007). 
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Figure 1.9 LIF/MAPK signalling pathway. Following activation of a tyrosine 
kinase receptor, Shp2 and Grb2 are recruited to the receptor through their SH2 
domain. Subsequently, Ras is activated and in turn initiate a cascade of 
phosphorylation events resulting in activation of a chain of kinases, Raf, MEK, and 
Erk1/2. (After Burdon et al., 1999b). 
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1.5.2.4 GSK-3 in the Wnt-β-catenin signalling pathway  
Glycogen synthase kinase-3 (GSK-3), isoforms GSK-3 and GSK-3, are 
constitutively active serine/threonine protein kinases first discovered because of their 
ability to phosphorylate and inactivate the enzyme glycogen synthase (Embi et al., 
1980; Woodgett and Cohen, 1984). GSK-3 is highly conserved from yeast to 
mammals and the mammalian class expresses two GSK-3 isoforms, α and β, which 
are encoded by distinct genes. They share 97% amino acid sequence identity within 
their catalytic domains, but outside the kinase domain the identity differs 
significantly. GSK-3 is implicated in numerous signalling pathways, including the 
Wnt/-catenin pathway and plays key roles in a wide range of cellular processes 
(reviewed in (Woodgett, 2001; Wu and Pan, 2010)). 
The canonical Wnt signalling pathway leads to the stabilization of β-catenin after 
activation by Wnt proteins (Figure 1.10). In the absence of Wnt a multi-protein 
destruction complex forms, consisting of APC (adenomatous polyposis coli), AXIN, 
GSK-3, CKIα (casein kinase Iα), and β-catenin. The destruction complex targets β-
catenin for proteasomal degradation. When Wnt proteins bind the Frizzeled (FZD) 
receptors located at the cell membrane, GSK-3-dependent β-catenin phosphorylation 
is suppressed via the protein Dishevelled, resulting in β-catenin stabilisation. 
Stabilized β-catenin is able to enter the nucleus, where it interacts with 
transcriptional regulators. LEF1 (Lymphoid Enhancing Factor-1) and TCFs (T cell 
factors) are known interactors, which, in association with β-catenin, upregulate target 
gene expression. Because GSK-3-mediated phosphorylation of the destruction 
complex acts as a switch in regulating β-catenin stability, pharmacological inhibition 
of GSK-3 can mimic the activation of the Wnt pathway, leading to stabilized β-
catenin (reviewed in (Clevers, 2006; MacDonald et al., 2009)).  
Wnt signalling was implicated in the self-renewal of ES cells by inhibition of GSK-3 
with the small molecule inhibitor, BIO (Sato et al., 2004). Interestingly, this group 
claimed that both human and mouse ESCs maintain self-renewal upon BIO 
treatment. Consistent with this notion they showed expression of pluripotency 
associated transcription factors Oct3/4, Rex1 and Nanog. This was the first report of 
a self-renewal signalling pathway common to mouse and human ES cells, though it 
is conflicting with some more recent studies. A report by our group describes the 
discovery of a panel of compounds inhibiting GSK-3 selectively, leading to 
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enhanced self-renewal in mouse ESCs in presence of LIF and serum (Bone et al., 
2009). In contrast, when the same specific GSK-3 inhibitors were added to hESC 
cultures, under chemically defined feeder-free culture conditions, ES cells 
differentiated towards definitive endoderm (Bone et al., 2011). Also, other groups 
reported mixed involvement of Wnt signalling in self-renewal (Hao et al., 2006; 
Ogawa et al., 2006; Sato et al., 2004; Singla et al., 2006) and differentiation (Dravid 
et al., 2005; Gadue et al., 2006; Lindsley et al., 2006).  Wnt3a conditioned media 
was described to be able to support self-renewal and growth of mESCs in absence of 
LIF or feeder cells (Singla et al., 2006), while WNT5A and WNT6 were found to 
potently inhibit mES cell differentiation (Hao et al., 2006). However, -catenin 
knock-out ESCs are not majorly impaired in their self-renewal abilities (Anton et al., 
2007) and still express Sox2 and Nanog at levels comparable to wild type ESCs. 
This is surprisingly, as Wnt3a is suggested to support self-renewal via -catenin, 
underlined by the finding that constitutively active -catenin mimics the effect of 
Wnt3a (Ogawa et al., 2006). In the same study it was shown that other unidentified 
factors in the Wnt3a conditioned media were able to activate STAT3 at a low level 
and consequently it was demonstrated that low levels of LIF could act in synergy 
with Wnt3a to maintain self-renewal. Differences in the Wnt contribution to stem 
cell fate might arise from experimental setups, off-target effects of GSK-3 inhibitors 
and/or later developmental stages of ES cell lines used. The commonly used GSK-3 
inhibitor BIO was for instance reported to activate a STAT3 reporter assay (Ogawa 
et al., 2006) and furthermore to have off-target effects, inhibiting Erk 
phosphorylation (Bone et al., 2009). Interestingly, in recent reports GSK-3 inhibition 
helped to convert hES cells to a more naïve state of pluripotency (Hanna et al., 
2010), similar to mouse ESCs. This might indicate that the differences implicated by 
the above mentioned studies arise as a result of signalling pathway deviances 
because of developmental stage variations under in vitro cell culture conditions.  
GSK-3 can be also inhibited via the PI3K-dependent signalling pathway through 
activation of Akt. As the PI3K pathway is a focus of this study, it will be explained 
in more detail in the section 1.6. 
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Figure 1.10 The canonical Wnt pathway. In the absence of Wnt, the destruction 
complex formed by Axin, APC, CKI, GSK-3 and-catenin, targets -catenin for 
proteosomal degradation. Upon Wnt binding to the Frizzled receptor, the destruction 
complex is disrupted via Dishevelled (Dsh) and GSK-3 dependent phosphorylation 
of -catenin is suppressed leading to -catenin stabilisation. Stabilised -catenin 
translocates to the nucleus where interacts with Tcf and Lef promoting expression of 
target genes (Taken from Atwood, 2011, Inechweb.org). 
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1.5.3 Intrinsic factors of pluripotency 
1.5.3.1 Oct4 and Sox2 
Two years after the identification of LIF, Oct4 (octamer-binding transcription factor 
4), also known as Pou5f1, was discovered as a member of the POU-domain 
containing transcription factors (Scholer et al., 1989).  The POU (Pit Oct Unc) 
domain is named after the first letters of genes that share the sequence homology, 
Pit1, Oct1/2 which are mammalian genes, and the C. elegans gene Unc-86. Oct4 can 
bind via its POU domain to the octamer DNA motif, 5‟-ATGCAAAT-3‟, and alter 
target gene expression (Ryan and Rosenfeld, 1997). Oct4 is specifically expressed in 
germ cells, eggs, preimplantation embryos, the ICM, and the epiblast of post-
implantation embryos (Okamoto et al., 1990; Rosner et al., 1990; Scholer et al., 
1990). Oct4 deficient embryos develop to the blastocyst stage but die shortly after 
implantation with the inner cell mass not being pluripotent (Nichols et al., 1998). 
When Oct4 null ESCs are cultured in vitro they only develop trophectoderm-like 
cells and cannot contribute to inner cell masses (Nichols et al., 1998).  Suppression 
of Oct4 expression in mouse and human ESCs results in the differentiation toward 
the trophoblast lineage (Niwa et al., 2000).  However, artificial over-expression of 
Oct4, via inducible transgenes, is not able to maintain self-renewal and pluripotency 
in the absence of LIF (Niwa et al., 2000). Furthermore, reduced expression of Oct4, 
by less than 50% of wild-type levels, results in differentiation and the expression of 
trophectodermal markers (Figure 1.11). Expression levels above 150% of wild-type 
result in differentiation towards primitive endodermal and mesodermal lineages 
(Niwa et al., 2000). Thus, expression of Oct4 needs to be carefully balanced, as 
deviations greater than 50% from normal diploid expression levels alter both cell fate 
and lineage commitment (Niwa et al., 2000). 
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Figure 1.11 Relative expression levels of Oct-3/4 determine stem cell fate. To 
maintain mES cells undifferentiated Oct-3/4 levels must remain within plus or minus 
50% of normal diploid expression. An increase above this threshold triggers 
differentiation to primitive endoderm. If Oct-3/4 levels fall below, this causes 
dedifferentiation into the trophectoderm lineage. (Niwa et al., 2000) 
 
 
1.5.3.2 Nanog 
Nanog, named after Tír na nÓg, the land of the ever young of a Celtic mythology, 
was discovered by two groups in 2003 (Chambers et al., 2003; Mitsui et al., 2003). It 
was discovered independently by functional expression cloning (Chambers et al., 
2003) and through in silico differential expression analysis (Mitsui et al., 2003) 
around the same time. Both groups were able to show that overexpression of Nanog 
is sufficient to maintain ESC self-renewal independently of LIF/Stat. Nanog is a 
divergent homeodomain-containing transcription factor, which is commonly  
believed to be a key factor in the transcriptional network of pluripotency (Boyer et 
al., 2005; Loh et al., 2006; Wang et al., 2006). Furthermore, Nanog is essential for 
early embryonic development and plays a conserved role in pluripotency across a 
range of species including mammals, birds and fish (Chambers et al., 2003; Lavial et 
al., 2007; Mitsui et al., 2003; Wang et al., 2011). Nanog starts to be expressed at the 
morula stage and is expressed at a high level until the early blastocyst stage, 
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whereupon it declines before implantation. Still, it is detectable in primordial germ 
cells during their migration to the genital ridges, but is downregulated in later germ 
cell development (Chambers et al., 2007; Yamaguchi et al., 2005). In a second wave 
of transcription Nanog is re-expressed in the posterior region of the post-
implantation egg cylinder, which might protect the egg cylinder epiblast from 
precocious commitment during gastrulation (Chambers et al., 2007; Hart et al., 
2004).  
Subsequently, Austin Smith‟s group has published that Nanog null ES cells, 
generated by genetic deletion of the Nanog locus, can self-renew permanently in the 
absence of LIF (Chambers et al., 2007). Despite the ability to self-renew long term, 
these cells are more susceptible to differentiation compared to wild type ESCs. The 
group hypothesised that Nanog acts to safeguard self-renewal by countering the 
effects of differentiation inducers and preventing progression to lineage commitment 
(Chambers et al., 2007). When Nanog levels are low, cells might have the 
opportunity to escape self-renewal. Nanog null ES cells were able to differentiate 
into all three germ layers in vitro and in vivo, but maturation of primordial germ cells 
was disturbed in the genital ridge (Chambers et al., 2007). These results indicate that 
Nanog might be more important for the establishment of pluripotency and to a lesser 
extent for the maintenance of pluripotency. Consistent with this idea is the 
importance of Nanog during embryo development. Nanog null blastocysts are 
indistinguishable from normal embryos (Mitsui et al., 2003). However, at E5.5 
Nanog null embryos consist entirely of disorganized extraembryonic tissues with no 
discernible epiblast or extraembryonic ectoderm (Mitsui et al., 2003). ICMs of 
Nanog null blastocysts were isolated by immunosurgery but failed to proliferate 
when cultured on gelatin coated dishes and differentiated into parietal endoderm-like 
cells (Mitsui et al., 2003). 
 Surprisingly, despite its central role in establishing pluripotency, Nanog was not one 
of the four original factors necessary for the generation of iPS cells (Takahashi and 
Yamanaka, 2006). However, when reprogrammed cells were selected for 
reactivation of Nanog, instead of the first used Fbx15, the efficiency of full 
reprogramming was greatly increased (Okita et al., 2007). In a more recent paper, 
Nanog is shown to be required in the final phase of reprogramming (Silva et al., 
2009). At this stage the ectopic expression of the reprogramming factors has 
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probably already activated expression of endogenous Nanog, necessary to reach true 
pluripotency (Silva et al., 2009). 
 
1.5.3.3 The transcriptional network of pluripotency 
The previously introduced transcription factors Oct4, Sox2 and Nanog are central 
players in assembling the pluripotency network maintaining ES cell self-renewal. 
The targets of each transcription factors have been assessed using chromatin 
immunoprecipitation (ChIP) and microarray technologies. A substantial binding site 
overlap of the three transcription factors was found in mouse and human ES cells 
genes and their targets frequently encode other homeodomain transcription factors 
important during development (Boyer et al., 2005; Loh et al., 2006). Interestingly, 
Oct4, Sox2 and Nanog co-occupied promoters of both active and inactive genes, as 
well as their own promoters. Actively transcribed genes includes those genes with a 
role in maintaining pluripotency of ES cells including the transcription factors 
Nanog, Oct4, Sox2 and Stat3, as well as components of the Wnt and TGF- 
signalling pathways such as Dkk1 and Lefty2. Among the inactive genes are those 
encoding transcription factors with a developmental role. The fact that inactive genes 
were also co-occupied by Polycomb Repressive Complexes, which are related to 
transcriptional gene silencing, suggest that Oct4, Sox2 and Nanog repress expression 
of developmental genes while promoting expression of genes involved in 
maintaining ES cell identity (Boyer et al., 2005). Boyer et al proposed that Oct4, 
Sox2 and Nanog form a core transcription factor circuit with autoregulatory and 
positive feedback loops that promote pluripotency and repress developmental 
processes (Figure 1.12). Using a transcription factor network with positive and 
negative regulation can be a good mechanism for maintaining the right levels of gene 
expression that stabilize a particular cell state (von Dassow et al., 2000). 
Furthermore, it is possible to explain how small changes of network components can 
trigger transition from one state to another by using systems biology models 
(Kauffman, 2004). Extracellular signals feed into the core network and consequently 
influence the regulation of their targets (Niwa, 2007; Niwa et al., 2009).  
 
More recent studies (Chen et al., 2008; Cole et al., 2008; Heng et al., 2010; Kim et 
al., 2008) investigated the binding sites of others pluripotency-associated 
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transcription factors and observed that the regulatory regions of Oct4 are bound by 
multiple transcription factors including Sox2, Nanog, Smad1, Stat3, Tcf3, Dax1, 
Nac1, Zfp281, Esrrb, Nr5a2, Klf4, Tcfp21l1 and Oct4 itself. These transcription 
factors are thought to act as enhancers and a correlation between the number of 
transcription factors bound to a promoter and its transcriptional status have been 
observed. Genes actively transcribed have more transcription factors bound than 
silenced genes (Chen et al., 2008; Kim et al., 2008). For example, Oct4 and Nanog 
promoter regions are occupied by 14 and 9 transcription factors respectively. 
 
Several studies have shown that the transcription factor network is linked to the 
epigenetic and non-coding RNA networks (Barrero and Izpisua Belmonte, 2011; Loh 
et al., 2007; Marson et al., 2008; Zhang et al., 2011). For instance, Oct4 upregulates 
the expression of Jmjd1a and Jmjd2c that encode for histone H3 lysine 9 
demethylases, which promote maintenance of ES cell pluripotency because histone 
H3 lysine 9 demethylases prevent the increase of repressive methylation in gene 
promoters (Loh et al., 2007).  Oct4 can also upregulate expression of components of 
the Polycomb Repressive Complex 2 (PRC2) such as Jarid2 and Mtf2 that modulate 
trimethylation on the histone H3 lysine 27 residue,  promoting repression of lineage-
specific genes and thus contributing to maintenance of self-renewal (Zhang et al., 
2011). Furthermore, Oct4, Sox2 and Nanog have been shown to promote the 
expression of microRNAs (miRNAs) such as the clusters mir302 and mir290 
(Marson et al., 2008), which have been proposed to repress important cell cycle 
regulators including Cdkn1a, Rbl1 and Lats2 (reviewed in (Ng and Surani, 2011), 
resulting in the shortened G1 phase typical of ES cells. mir302 and mir290 are 
negatively regulated by Let-7 miRNA (Melton et al., 2010), which is repressed by 
the RNA-binding protein Lin28, and the core pluripotency transcription factor have 
been shown to upregulate Lin28 expression (Barrero and Izpisua Belmonte, 2011).  
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Figure 1.12 Core pluripotency transcriptional factor network. Oct4, Sox2 and 
Nanog form a core transcription factor circuit with autregulatory and positive 
feedback loops that induce expression of genes that promote self-renewal, Sox2, 
Nanog, Oct4, Stat3 and others and repress the expression of genes that promote 
differentiation such as Pax6, Otx1 and Myf5. (After Boyer et al., 2005).   
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1.6 Phosphoinositide 3-Kinases (PI3Ks)  
1.6.1 Structure and function of PI3Ks 
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases which play many 
important roles in the regulation of various cellular processes including proliferation, 
growth, cell differentiation, migration and immune function (Crabbe et al., 2007; 
Engelman et al., 2006). Members of the PI3K family of enzymes phosphorylate the 
D3 hydroxyl group of the inositol ring of phosphoinositides (Figure 1.13 A). This 
facilitates the recruitment of proteins containing pleckstrin homology domains (PH 
domains) and other phosphoinositide-binding domains to the plasma membrane, 
triggering a cascade of signalling events. The ability of phosphoinositides to act as 
important second messengers was first reported in the early 1980s (reviewed in 
(Berridge and Irvine, 1984; Berridge and Irvine, 1989)), linking extracellular 
signalling from growth factor receptors to downstream target genes. The different 
types of PI3Ks respond to diverse signals and favour specific inositol substrates over 
others. This results in a manifold of second messenger variations (Figure 1.13 B), 
with potentially multiple functional outputs. The PI3K pathway is an extremely 
complex signalling pathway, involving many activators, inhibitors, effectors, and 
second messengers. Because of its many loops and branches it is far from being 
completely understood, but it is essential for many cellular functions and associated 
with a wide range of diseases when dysregulated (Balla, 2006; Vanhaesebroeck et 
al., 2010).  
 
 
PI3Ks have been divided into three classes (I-III) (Vanhaesebroeck et al., 1997), of 
which class I is the focus in this study and therefore exemplified in more detail. 
Class I PI3Ks exhibit a higher susceptibility to the pharmacological broad spectrum 
inhibitors wortmannin and LY294002 and are the best studied class to date. Class I 
PI3Ks are further subdivided into classes IA and IB depending on their activation 
mechanism. Class IA consists of three catalytic subunits p110p110 p110and of 
five respective regulatory subunit p85 p55 p50p85or p55while class IB 
assemble the catalytic isoform p110with one of two regulatory subunits (p84/87 or 
p101) (Crabbe et al., 2007; Vanhaesebroeck et al., 2005). Interestingly, genetic 
deletion of either the p110 and p110 catalytic subunits results in embryonic 
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lethality, indicating non-redundant and essential regulatory roles of PI3Ks in early 
development (summarized in Table 1). 
 
 
 
 

Table 1: Class IA PI3Ks subunit composition and viability of mice with targeted PI3K catalytic 
sub-unit genetic deletions.  
 
 
 
Catalytic Subunits KO of Catalytic Subunit Regulatory Subunits 
Gene 
name 
p110 Embryonic lethal (E10.5) p85   
p110 
Embryonic lethal (blastocyst stage: around 
E.3.5) 
p55 
Pik3r1 
p110 Viable p50   
   p85 Pik3r2 
   p55 Pik3r3 
 
 
 
 
 
 
 
In contrast to the broadly expressed isoforms, p110 and p110, the other class I 
PI3Ks isoforms p110 and  exhibit a more restricted pattern of expression. P110is 
largely expressed in cells of the immune system, playing a major role in the 
lymphohaemopoietic system (Vanhaesebroeck et al., 1997). Transgenic mice 
expressing a catalytically inactive form of p110 show impaired B and T cell 
immune responses (Okkenhaug et al., 2002). P110 was also shown to be required 
for normal B cell function and development (Clayton et al., 2002; Jou et al., 2002). 
Expression of p110the only class IB PI3K isoform,is confined to the 
haematopoietic system, heart, endothelium and brain. Its function is associated with 
regulating inflammatory and cardiovascular processes (reviewed by (Ruckle et al., 
2006)). Knock-out of either p110 or p110 does not affect viability or fertility of 
mice, therefore it is unlikely that these isoforms play an important role during early 
embryonic development (Clayton et al., 2002; Jou et al., 2002; Ruckle et al., 2006).  
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A 
 
 
 
 
 
B 
 
 
 
Figure 1.13 Reactions catalysed by PI3Ks. (A) PI3K phosphorylates the D3 
position of the inositol ring of phosphatidyl inositols (PtdIns) by adding the -
phosphate of ATP. The PtdIns are anchored with their fatty acid side chains in the 
lipid bilayer of the cell membrane and are able to activate various signalling 
pathways once they are activated by phosphorylation. (Vanhaesebroeck and 
Waterfield, 1999). (B) Three reactions catalysed by PI3K activities in vitro and their 
structural phosphoinositide products are shown (Hawkins et al., 2006). 
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PI3Ks can be activated by multiple factors, usually involving extracellular stimuli 
such as growth factors, neurotransmitters, hormones or antigens (Wymann and 
Pirola, 1998). Class IA PI3Ks are primarily activated downstream of tyrosine kinase-
linked receptors, while Class I PI3Ks are activated by G protein-coupled receptors. 
There is also evidence that the class IA enzyme p110can be regulated by a 
heterotrimeric G protein subunit complex (Yart et al., 2002). Both, class IA and IB 
kinases can bind the small GTPase Ras, and there is evidence to suggest that Ras can 
activate PI3Ks when associated with GTP (Rodriguez-Viciana et al., 1994). After 
activation, PI3Ks preferentially phosphorylate phosphatidylinositol (4,5) 
bisphosphate (PIP2) to produce the important second messenger phosphatidylinositol 
(3,4,5) triphosphate (PIP3). In vitro PI3Ks have also been shown to phosphorylate PI 
and PI(4)P (Irvine, 1992). PIP3 is anchored with its fatty acid chains in the lipid 
membrane of the cell (Figure 1.13 A) and serves to amplify the PI3K signal 
transduction by interacting with partners of the signalling pathway. PI3K effector 
proteins contain the conserved Pleckstrin Homology (PH) domain allowing them to 
bind the second messenger products, which in turn recruits them to the inner cell 
membrane (Katan and Allen, 1999).  
 
One known effector recruited in this way is the phosphoinositide-dependent protein 
kinase 1 (PDK1). PDK1 can in turn interact and phosphorylate other proteins, for 
instance Akt (also known as Protein Kinase B, PKB) (Alessi et al., 1997; Komander 
et al., 2004) (Figure 1.14). The mutual ability of Akt and PDK1 to interact with PIP3 
is likely to be important for regulating Akt activation (Anderson et al., 1998; Currie 
et al., 1999; Filippa et al., 2000). In accordance with this is a report that ES cells 
expressing a mutant form of PDK1, which is unable to bind PIP3, could not activate 
Akt substantially (McManus et al., 2004).  Structural studies suggest that a major 
conformational change is induced by the binding of Akt to PIP3, which is likely to 
play an important role in Akt activation by PDK1 (Mora et al., 2004). Importantly, 
binding of PIP3 to the PDK1 PH domain has no direct repercussion on the activity of 
the PDK1 kinase domain, but rather acts through activation of Akt by direct 
interaction of Akt with PDK1 (Currie et al., 1999; Stephens et al., 1998).   
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After recruitment to the cell membrane Akt can be activated by phosphorylation of 
the Thr308 and Ser473 residues (Alessi et al., 1996). The phosphorylation sites lie in 
two distinct regions of the enzyme. While Ser473 is located in the “hydrophobic 
motif” on the carboxy terminal side of the catalytic domain, Thr308 lies in the so 
called „T-loop‟ of the kinase domain. In PDK1 knock-out cells activation of the 
Thr308 site is impaired and as a consequence downstream phosphorylation of GSK-
3 is abolished. Interestingly, phosphorylation at the Ser473 site was not affected after 
genetic deletion of PDK1. Preincubation of cells with the broad PI3K inhibitor 
LY294002 reduced the level of Ser473 phosphorylation to below basal levels, 
indicating the involvement of another phosphoinositide dependent protein kinase, 
PDK2 (Hresko et al., 2003; Williams et al., 2000). Another explanation could be the 
previously described function of a PDK1-interacting fragment (PIF), that in 
combination with PDK1 can phosphorylate Ser473 of Akt, as well as Thr308 
(Balendran et al., 1999). In respect of these findings, it is still unclear whether the 
activity arises from PDK1 in combination with PIF or PDK2. Activated Akt can in 
turn phosphorylate Ser21 and Ser9 of GSK-3  and leading to its inactivation. 
GSK-3 is known to regulate a number of cellular processes including glycogen 
synthesis, protein synthesis, cell cycle and apoptosis. 
 
PDK1 is also implicated in activating other members of the AGC family kinases, for 
instance p70 ribosomal S6 kinase (S6K) and p90 ribosomal S6 kinase (RSK) (Figure 
1.14) (reviewed in (Alessi et al., 1996; Belham et al., 1999; Williams et al., 2000)). 
The AGC group is named after the protein kinase A, G, and C families (PKA, PKC, 
PKG) and includes in total 16 families. These kinases have a strong preference for 
phosphorylation of Serine and Tyrosine residues located in close proximity to the 
basic amino acids Lysine and Arginine. PDK1 plays a central role in mediating 
extracellular signals downstream of PI3Ks by phosphorylating key regulatory 
proteins, orchestrating multiple cellular functions, including cell cycle, apoptosis, 
protein and glycogen synthesis (Hanada et al., 2004; Hennessy et al., 2005).  
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Figure 1.14 PI3K signalling. Following LIF binding PI3K is activated and 
phosphorylates PI(4,5)P2 in the membrane to form PI(3,4,5)P3, PDK1 is recruited to 
the membrane where it phosphorylates Akt at Thr308 and Ser473. Activated Akt in 
turn phosphorylates and inactivates GSK-3. PDK1 can also phosphorylate S6K 
promoting protein synthesis. 
 
 
1.6.2 Regulation of PI3K activity 
With the involvement of PI3Ks in a wide range of fundamental cellular functions, 
regulation mechanisms have to be accurately in place, as dysregulation is likely to 
result in serious consequences and diseases. A constitutively active class IA 
p110isoform, as a result of genetic mutations, is involved in proliferation and 
progression of various human tumours (Samuels et al., 2004; Vanhaesebroeck et al., 
2001). Furthermore, activating mutations of PI3K pathway components are found in 
40% of all human colorectal cancers (Parsons et al., 2005). Unbalanced regulation of 
p110or p110isoform activity can also lead to a disturbance of inflammatory 
responses (Crabbe et al., 2007). 
 
There are two important main negative regulators of the PI3Ks pathway, acting 
through reversing the phosphorylation of PIP3 induced by PI3Ks. One of them is the 
SH2-containing inositol 5-phosphatase (SHIP) and the other one is the phosphatase 
and tensin homolog (PTEN). While SHIP dephosphorylates the D5 position of the 
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phosphoinositol ring, PTEN mediates the removal of the phosphate group from the 
D3 position. Both dephosphorylation events reduce the availability of the second 
messenger PI(3,4,5)P3. Consequently, recruitment of effector proteins to the cell 
membrane and signalling cascade events are reduced. PTEN-null cells exhibited 
constitutively active Akt in the wake of increased PIP3 levels (Stambolic et al., 
1998). In accordance with PTEN antagonizing the effect of PI3Ks it is a well-
recognized potent tumour suppressor in a range of tissue types and is commonly 
mutated in multiple cancers (Li and Sun, 1997; Whang et al., 1998).  
 
The regulatory subunit p85, whose SH2 domains bind phosphotyrosine in specific 
recognition motifs, positively regulates activation of p110 isoforms in association 
with receptor-tyrosine kinases (Dhand et al., 1994). It has also been suggested to act 
as a negative regulator when prevalent as monomers, by binding to activated 
receptor domains averting the binding of the heterodimeric p85-p110 complex 
(Brachmann et al., 2005; Geering et al., 2007).  
 
 
1.6.3 Role of PI3Ks in ESCs 
1.6.3.1 Self-renewal 
The requirement of PI3Ks for maintaining mES cell self-renewal was shown for the 
first time by inhibition of PI3Ks using the broad spectrum inhibitor LY294002 or a 
dominant negative p85 subunit of PI3K (Paling et al., 2004). Both forms of 
inhibition lead to a loss of self-renewal of mES cells, even in the presence of LIF, 
implicating the importance of PI3Ks for the regulation of self-renewal. ESC 
differentiation could be rescued by MEK inhibition with U0126, and it was 
suggested that increased Erk activity is the cause of differentiation resulting from 
PI3Ks inhibition (Paling et al., 2004). Furthermore, Nanog RNA and protein levels 
decreased upon treatment with LY294002, and the reduction was reported to be 
reversible by GSK-3 inhibition with the small inhibitor BIO (Storm et al., 2007). 
GSK-3 inhibition also rescued the differentiation of ESCs induced by LY294002 
(Storm et al., 2007) and by expressing a myristoylated mouse p110 subunit it was 
shown that activation of PI3Ks can lead to phosphorylation and therefore inhibition 
of GSK-3 (Popkie et al., 2010). Surprisingly, inhibition of MEK/Erk signalling was 
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unable to reverse the decrease in Nanog expression, questioning increased Erk 
activity as the main reason for differentiation observed when PI3Ks were inhibited. 
 
The importance of the PI3Ks pathway in self-renewal of mESCs was further 
strengthened by the finding that expression of a myristoylated, and therefore 
constitutively active, form of Akt can sustain self-renewal in absence of LIF 
(Watanabe et al., 2006). In another study around the same time, Akt was also 
identified as being able to maintain self-renewal in the absence of LIF by using a 
combination of cDNA library screens and microarray (Pritsker et al., 2006). 
Furthermore, overexpression of suggested Akt downstream target genes, TBX3 and 
Nanog, results in LIF independency (Niwa et al., 2009). With Akt being an 
important downstream effector of PI3Ks, this might support the advocated role of 
PI3K signalling to self-renewal by inhibition of GSK-3 through Akt (Storm et al., 
2007). Other indications implicating PI3Ks in self-renewal comes from the finding 
that the small molecule pluripotin supports self-renewal by activating PI3K 
signalling, while suppressing Erk signalling (Chen et al., 2006).  
 
PI3K have also been shown to be involved in regulating self-renewal in human ES 
cells (Armstrong et al., 2006). In this study, hES cells were induced to differentiate 
by forming embryoid bodies and subsequent transcriptional and protein changes 
were analysed. Components of the PI3K/Akt signalling pathway were reported to be 
decreased upon differentiation. Furthermore, inhibition of the PI3K pathway using 
specific inhibitors resulted in loss of pluripotency, suggesting an important 
contribution of the PI3K signalling pathway in hES cell maintenance (Armstrong et 
al., 2006). In addition, a combination of GSK-3 inhibition, while stimulating the 
PI3K pathway by overexpressing the PI3K stimulator Eras, or potentially via 
overexpression of a PI3K transgene, was proposed to be sufficient for feeder free 
ESC proliferation (Smith, 2009). 
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1.6.3.2 Proliferation 
In mES cells PI3Ks have been reported to be involved in cell-cycle control, 
activation of ES cell proliferation and tumourigenicity (Jirmanova et al., 2002). A 
role for PI3Ks in control of mES cell proliferation was suggested after the finding 
that mES cells lacking the phosphatase PTEN exhibited a decrease in the time  
required to complete a cell division cycle (Sun et al., 1999). As previously 
mentioned, PTEN is a phosphatase that dephosphorylates the second messenger 
PI(3,4,5)P3 and therefore acts as a negative regulator of PI3K signalling. PTEN-null 
ES cells were able to proliferate in reduced levels of serum suggesting activation of 
PI3K activity by serum-containing factors. This group also proposed reduced levels 
of the G1 cyclin-dependent kinase inhibitor, p27
KIP1
as the mechanism of action for 
the enhanced growth rate. Reduced expression of p27
KIP1 
could originate from 
inhibition of FOXO family transcription factors via phosphorylation by Akt (Stahl et 
al., 2002). Akt is also implicated in increasing cell survival by phosphorylation of 
Bad, a member of the Bcl2 family of pro-apoptotic proteins and indeed in PTEN-null 
ESCs levels of phosphorylated Bad were elevated (Sun et al., 1999). Furthermore, 
deleting both alleles of Akt-1 in the PTEN-null background reversed the growth 
advantage of the PTEN knockout, highlighting Akt as a major effector in PTEN 
knockout cells (Stiles et al., 2002).  
 
Among the multiple downstream effectors of the PI3K pathway is mTOR 
(mammalian target of rapamycin), which appears to be a major player in regulating 
mES cell proliferation (Murakami et al., 2004; Takahashi et al., 2005). Inducible 
ablation of mTOR or inhibition by the specific mTOR inhibitor rapamycin leads to a 
decrease in mES cell proliferation. The mTOR protein kinase is 290 kDa in size and 
phosphorylates serine and threonine residues. The identified downstream substrates 
include p70 ribosomal S6 kinase (S6K) (Brown et al., 1995) and 4E-BP1 (eukaryotic 
initiation factor binding protein 1) (Gingras et al., 1999). PI3Ks can activate mTOR 
through relieving a negative regulator protein complex of tuberous sclerosis complex 
1 and 2 (reviewed in (Marygold and Leevers, 2002)) and can therefore be regarded a 
strong candidate for a downstream target of the PI3K signalling in ES cells 
(Takahashi et al., 2005). 
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The PI3K pathway can not only be activated by exogenous factors, but also 
endogenously by a constitutively active Ras form, termed ERas (ES cell-expressed 
Ras). ERas is uniquely expressed in mES cells and is a Ras-like protein identical to 
oncogenic Ras mutants. ERas was also reported to regulate proliferation as deletion 
of ERas resulted in a loss of proliferation (Takahashi et al., 2003). Importantly, over-
expression of p110 was able to rescue the proliferation defects of ERas null ES 
cells. In addition, inhibition of the p110 catalytic subunit of PI3Ks with the specific 
inhibitor PIK-75, or inhibition of PI3Ks with the broad specificity inhibitor 
LY294002, results in a reduced proliferation rate (Jirmanova et al., 2002; Kingham 
and Welham, 2009). Taking these findings together, PI3K signalling seems to play 
an important role in ES cell proliferation. Figure 1.15 shows a schematic overview of 
the signalling pathways regulated by PI3Ks in ES cells. 
 
 
 
 
 
Figure 1.15 Role of PI3K in regulating self-renewal and proliferation of mES 
cells. PI3K is implicated to be involved in maintaining mES cells pluripotent by 
inhibition of Erk phosphorylation, responsible for differentiation.  GSK-3 signalling, 
known to enhance self-renewal on inhibition, is also reduced by PI3K in mES cells. 
Furthermore, PI3K was postulated to play a role in proliferation of mES cells. 
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1.6.3.3 PI3Ks inhibitors and application opportunities 
The Phosphatidylinositol-3 kinase family of enzymes are involved in multiple 
important cellular functions such as cell growth, survival, proliferation, migration, 
differentiation and intracellular trafficking. When these basic cellular functions are 
anomalous, diseases are likely to occur, so it does not come as a surprise that PI3Ks 
are implicated in various diseases. Dysregulation can contribute to diseases including 
diabetes, inflammation, and also autoimmune diseases (Engelman et al., 2006; 
Hennessy et al., 2005; Rommel et al., 2007). Inhibition of PI3Ks with 
pharmacological inhibitors was subsequently considered as an elegant way of disease 
treatment. Despite containing several structural elements most, if not all, PI3K 
inhibitors target the ATP binding pocket of the catalytic subunit.  
 
The two infamously most studied PI3K inhibitors are Wortmannin, a metabolite of 
the plant pathogen Penicillium funiculosum (Wiesinger et al., 1974) and LY294002, 
developed by Lilly Research Laboratories (Vlahos et al., 1994). Wortmannin forms a 
covalent interaction with the catalytic lysine residue within the ATP-binding pocket 
of PI3Ks, thus inhibition is irreversible (Wymann et al., 1996). The other early 
inhibitor, LY294002, is, in contrast, a reversible ATP competitive inhibitor, but less 
potent than wortmannin (Vlahos et al., 1994). Both inhibitors are broad spectrum 
inhibitors and are therefore not selective for particular PI3Ks isoforms, making it 
impossible to unravel individual isoform contributions. In addition, a high toxicity 
when tested in vivo ruled out any potential therapeutic use, but as the earliest PI3Ks 
inhibitors available, they provided key tools to investigate PI3K signalling 
(Hennessy et al., 2005).  
 
The co-crystallisation of broad selectivity inhibitors binding to the ATP pocket of 
the catalytic p110 isoform helped to understand the steric composition of this 
process (Walker et al., 2000). Computer modelling based on the obtained structure 
revealed a conformational change as a result of inhibitor binding to the entrance to 
the ATP binding pocket (Knight et al., 2006; Walker et al., 2000). This leads to the 
formation of hydrogen bonds between inhibitor and binding site, which are similar to 
the ones formed with ATP. Furthermore, affinity increases when inhibitors access 
deeper into the hydrophobic ATP binding pocket (Knight et al., 2006). This 
knowledge helped to understand and develop novel, more specific PI3Ks inhibitors 
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with reduced toxicity. A number of PI3Ks inhibitors are at the moment in different 
stages of clinical trials to assess their therapeutic potential. For instance, ZSTK474 is 
an inhibitor of PI3K γ (IC50 at 6nM), PI3K α (IC50 of 17nM), and PI3K β (53nM) 
(Marone et al., 2008), and is currently in a phase I clinical trial study for treatment of 
Neoplasms (http://clinicaltrials.gov/ct2/show/NCT01280487). Another example is 
Perifosine, which acts as an Akt inhibitor and as a PI3K inhibitor and is in a phase 
III trial for colorectal cancer (http://www.clinicaltrial.gov/ct2/show/NCT01097018). 
Furthermore, Perifosine is in another phase III clinical trial for multiple myeloma 
(http://www.clinicaltrial.gov/ct2/show/NCT01002248).  
 
In this study selective inhibitors for the p110 alpha, beta and delta isoforms were 
used and are briefly described below. A summary of the structures of all PI3K 
inhibitors used in this study is shown in Table 2.2. Two p110inhibitors, compound 
15e and PIK-75, with distinct chemical structures have been used. The synthesis of 
compound 15e was published in 2006 (Hayakawa et al., 2006) and this study showed 
an inhibition of A375 cell proliferation with an IC50 of 580nM. Besides the original 
study, information on compound 15e is sparse and its potential effects on other 
PI3K-related kinases and mTOR are not available to date. PIK-75 in contrast was 
screened for kinase selectivity and inhibits p110 with an IC50 of 5.8nM, while other 
isoforms are only affected at higher doses; p110β (IC50=1300nM), p110γ 
(IC50=76nM), p110δ (IC50=510nM) (Knight et al., 2006). Like most 
p110inhibitors PIK-75 also inhibits DNA-dependent protein kinase (DNA-PK) 
quite potently, possibly resulting from a structural similarity in the active site, which 
is somewhat surprisingly as these kinases share limited sequence identity (Knight et 
al., 2006). The off target effect of PIK-75 on mTOR is, in this context, rather minor 
as it lingers in the M range and is therefore not in the typical applied concentration 
span of PIK-75. For the p110β isoform, inhibitory compounds of the Thrombogenix 
series have been developed, including TGX-121 (Robertson et al., 2001) and TGX-
221 (Jackson et al., 2004). TGX-221 is more potent than TGX-121, and contributed 
to deciphering the role of the beta isoform during platelet activation upon fluid sheer 
stress (Jackson et al., 2005). In 2001, the ICOS Corporation discovered IC87114, the 
earliest isoform selective inhibitor, exhibiting a 100–1000-fold selectivity for the 
p110 isoform over other class I PI3Ks (Sadhu et al., 2001). The selectivity of this 
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inhibitor is remarkable regarding the high conservation of the residues that line the 
ATP binding pocket of the class I PI3Ks and its discovery was the first lead for the 
generation of other selective inhibitors (Knight and Shokat, 2007; Marone et al., 
2008). IC87114 contributed to uncover essential roles of p110 in neutrophil 
polarisation and their attenuation in specific directional movement (Sadhu et al., 
2001), also an involvement in allergic airway inflammation and hyperresponsiveness 
in a murine asthma model was shown (Lee et al., 2006).  
PI3K isoform selective inhibitors are undoubtedly extremely valuable to determine 
the precise isoform function in the respective environment, but inhibitors targeting 
multiple known and accurately described pathways, also promise to be an interesting 
disease treatment option. Once the biological signalling cascades of a disease are 
correctly profiled, the adequate selective or multi-selective inhibitor can be chosen. 
An example for a multi-selective inhibitor would be the Piramed compound PI-103, 
that inhibits p110and mTor with equipotency. This inhibitor alone stops aggressive 
glioma cell lines, in vitro and in vivo, from proliferating (Fan et al., 2006). This 
effect is comparable to the combination of single specific p110and mTor inhibitors 
and therefore unlikely to be an off-target effect (Fan et al., 2006). The success in 
recent years to develop and validate novel PI3Ks inhibitors will hopefully soon lead 
to novel treatments of cancer and inflammatory diseases. A structural understanding 
of the inhibition mechanism is key to solving the remaining challenges of targeting 
the PI3Ks family pharmacologically (reviewed in Crabbe et al., 2007). 
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1.7 Pluripotent Cell Types 
Harvesting pluripotent cell types, able to differentiate into all three germ layers, was 
originally only possible using embryonic sources. More recently, researchers tried to 
establish stable pluripotent cell types from alternative cell sources, applying their 
acquired knowledge. Tremendous success, beyond common expectations, has been 
achieved in the recent years and has led to various pluripotent cell types being 
available for study today. Now there are pluripotent cells established from the germ 
cell lineage (Ko et al., 2009; Matsui et al., 1992), from post-implantation embryos 
(Brons et al., 2007; Tesar et al., 2007) and from reprogrammed somatic cells 
(Takahashi et al., 2007; Takahashi and Yamanaka, 2006). Interestingly, beside stable 
and fully pluripotent cell types, various metastable and partially reprogrammed states 
have been identified. Under appropriate culture conditions these states can often be 
pushed to naïve pluripotency, revealing an unexpected high plasticity (Chou et al., 
2008). 
 
 
1.7.1 Embryonic Germ Cells and Spermatogonial Stem Cells 
Pluripotent cell lines can be established from various stages of the germ lineage. In 
1992, it was reported for the first time that embryo-derived mouse unipotent 
primordial germ cells (PGCs) can be converted into embryonic ES-like cells, which 
were subsequently termed embryonic germ (EG) cells. PGCs are isolated from E8.5-
12.5 embryos and can be turned into EG cells when maintained long-term in media 
supplemented with steel factor, LIF and basic fibroblast growth factor (bFGF) on 
feeder cells (Matsui et al., 1992; Resnick et al., 1992). In vitro EG cell lines 
established under these conditions have similar differentiation capacity to ES cells 
and express genes associated with pluripotency. Furthermore, they fulfill the true 
hallmarks of pluripotency, giving rise to teratomas when injected into 
immunocompromised mice and being able to contribute to chimaeras including the 
germline (Labosky et al., 1994; Matsui et al., 1992). It is noteworthy that PGCs 
cannot contribute to chimaeras when transplanted directly from the embryo (Matsui 
et al., 1992). The authors also observed that additional growth factors were only 
required in the initial derivation of EG cells, once established cells could be 
maintained in conventional ES cell medium. This might imply that establishment of 
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EG cells is some sort of reprogramming event triggered by the specific culture  
growth factor environment, which can result in several unique stem cell ground 
states (Chou et al., 2008). 
 
In contrast to EG cells, Spermatogonial stem cells (SSCs) are harvested from 
neonatal mouse testis by dissociating and culturing testis cells in the presence of glial 
cell line-derived neurotrophic factor (GDNF), epidermal growth factor (EGF), bFGF, 
and LIF (Kanatsu-Shinohara et al., 2003). In these cultures morphological ESC-like 
colonies were observed and upon closer examination ES cell markers like Nanog and 
SSEA1 were detected. These cells were named multipotent germ-line (mGS) cells 
and are truly pluripotent, as assessed by teratoma formation and generation of 
chimeras (Kanatsu-Shinohara et al., 2004). Once more, the specific culture growth 
factor environment seems to be essential for the establishment of mGS cells, as 
direct transfer of neonatal testis cells into ES cell culture medium fails to produce 
pluripotent mGS colonies. The establishment of pluripotent cells from the testis of 
adult mice was reported by selecting for cells that showed GFP expression which 
was placed under the control of the Stra8 promoter, a marker of spermatogonia 
(Guan et al., 2006). GDNF was not necessary for ES-like colonies to appear, which 
is somewhat surprising and not fully understood yet. Another group was also able to 
generate functional multipotent adult stem cells (MASCs) from adult spermatogonial 
progenitor cells (SPCs) (Seandel et al., 2007). Orphan adhesion-type G-protein-
coupled receptor (GPR125) positive germline progenitor cells were shown to give 
rise to MASCs upon long-term culture, which are capable of differentiating into 
derivatives of the three embryonic germ lines and contribute to chimeras. In 2009, 
Ko and colleagues reported advances in obtaining germline-derived pluripotent stem 
(gPS) cells from adult germ cells (Ko et al., 2009). They developed a robust and 
reproducible protocol for establishing gPS cells by defining precise culture 
conditions and plated cell numbers. Their findings should facilitate further the 
investigation of the molecular reprogramming mechanisms underlying this 
conversion and will also allow other influences, such as genetic background or 
dynamics of the process, to be studied.  
 
To use adult cell sources for the direct generation of multipotent cell types is quite 
fascinating, as this promises to be an easily accessible autologous stem cell source 
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which does not require the destruction of embryos (Kanatsu-Shinohara and 
Shinohara, 2006). This idea was further nurtured by the generation of pluripotent 
stem cells from adult human testis (Conrad et al., 2008), though this study has so far 
not been reproduced and is, therefore, highly criticised (Ko et al., 2010). It remains 
to be seen if it will be possible to transfer the findings from mouse to human, but it is 
likely that cells of the germ lineage are more susceptible to spontaneous 
reprogramming events as they already express pluripotency-associated genes. 
 
 
1.7.2 Induced Pluripotent Stem Cells 
For a long time researchers have been seeking an easy way by which to create 
patient specific pluripotent cells, hence making it possible to use them for treatment 
without immunorejection. To produce this desired cell type, reprogramming, 
describing the process of altering the epigenetic status of a somatic cell, is required. 
Epigenetic marks have to be erased to reset the somatic cell programme and reopen 
the differentiation potential of the cell.  This type of cell was initially produced via 
cell fusion (Tada et al., 2001) or nuclear transfer (Gurdon et al., 1958), but both 
approaches have their limitations. Reprogramming somatic cells by fusing them with 
ES cells is possible, but results in hybrid cells that maintain a tetraploid DNA 
content, and are therefore not useful for applications (Cowan et al., 2005; Tada et al., 
2001). Somatic cell nuclear transfer (SCNT) is a process where the nucleus of a 
somatic cell is transferred to an enucleated unfertilized oocyte and therefore reset to 
pluripotency by factors of the egg cytoplasm. Reprogramming by SCNT in 
mammals was successful for the first time in 1997 with the generation of “Dolly” 
(Wilmut et al., 1997). Despite this achievement, SCNT is hindered by the obstacles 
of very low efficiency and the requirement of fresh oocytes, the latter raising the 
ethical issue surrounding the potential to produce cloned human embryos.  
 
In 2006, Takahashi and Yamanaka showed that somatic mouse fibroblast cells could 
be reprogrammed into induced pluripotent stem cells (iPSCs) by simply 
overexpressing four transcription factors: Oct4 (POU5F1), Sox2, Krüppel-like factor 
4 (Klf4), and cMyc (Takahashi and Yamanaka, 2006). This was a true breakthrough 
discovery changing the whole stem cell field in an instant. The use of induced 
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pluripotent stem cells holds the potential to overcome all previously mentioned 
barriers and iPSCs are therefore believed to be the future for regenerative medicine 
and other stem cell based applications. The “gold rush” was not stoppable anymore 
after two publications showed that this discovery is transferable to the human system 
(Takahashi et al., 2007; Yu et al., 2007). It came as something of a surprise that 
Nanog, an important transcription factor for ES cell self-renewal, appeared to be 
dispensable for iPS cell generation (Takahashi and Yamanaka, 2006), even though  
Thomsons‟s group managed to generate human iPS cells by replacing Klf4 and c-
Myc with Lin28 and Nanog (Yu et al., 2007). A possible explanation could be that 
Nanog is not required for the initial steps of reprogramming, but appears to be 
essential at later stages for reaching the naïve state of pluripotency (Silva et al., 
2009). In this case, four factor reprogramming in absence of Nanog activates 
endogenous Nanog expression, which in return helps to transit from intermediate 
states to the ground state of pluripotency. Transition might be achieved in a way that 
Nanog recruits core factor protein complexes or helps to reform the epigenome 
allowing regions that are required for the transition to be accessed (Silva et al. 2009).  
 
The initial studies used retroviruses to transfect somatic cells with the 
reprogramming factors, creating the problem of random integration of the factors 
into the genome and the risk of reactivation during development. This is especially a 
problem as c-myc and Klf4 are well known oncogenes and indeed the first chimeric 
mice generated with iPS cells developed tumours (Okita et al., 2007). A wide variety 
of different reprogramming techniques have been established since to tackle these 
hurdles and to develop easier platforms for studying reprogramming mechanisms. 
Integration-free reprogramming was achieved with transient and non-integrative 
plasmids (Gonzalez et al., 2009; Okita et al., 2008; Yu et al., 2009b), adenoviruses 
(Stadtfeld et al., 2008b), transgene post-reprogramming excisable systems (Kaji et 
al., 2009; Woltjen et al., 2009) and by direct delivery of reprogramming proteins into 
somatic cells (Kim et al., 2009a; Zhou et al., 2009). With the availability of this huge 
reprogramming toolbox, the molecular mechanisms underlying the change from 
differentiated to the bona fide pluripotent state began to be revealed.  
 
To reach a true pluripotent state a cell has to overcome several barriers, a process 
that requires time with current standard protocols. At least 1-2 weeks are necessary 
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for the first morphological ES-like colonies to emerge. It is tantalising that only a 
few cells expressing all four factors go on to form iPS colonies. A panoply of 
theories to explain this phenomenon have been suggested and are still under 
evaluation. Fluctuation in transgene expression can be excluded as all known 
methods to produce iPS cells, including polycistronic vectors and secondary iPS 
systems, exhibit this observation. The theory that there is only a small minority of 
cells in the total population susceptible for reprogramming is unlikely, as a wide 
range of cell types have now been used, including terminally differentiated and adult 
stem cells (Aoi et al., 2008; Stadtfeld et al., 2008a). Nevertheless, there are inter cell 
type specific differences, for instance keratinocytes exhibited a 100-fold higher 
reprogramming success rate than fibroblasts (Aasen et al., 2008). In an interesting 
experiment a donor pre‑B-cell population was transfected and single cells were 
plated in separate well and as expected a low percentage of cells were successfully 
reprogrammed after 2 weeks. In the following 16 weeks positive wells (containing at 
least a few pluripotent cells) reached more than 90%. This paper argues for a 
stochastic reprogramming event given enough time any cell might be susceptible to 
move to a pluripotent state. The kinetics of this process are argued to be accelerated 
by a faster proliferation rate, and therefore increased stochastic probability, as well 
as by cell division independent mechanisms, as for instance Nanog can increase 
reprogramming kinetics by activating intrinsic mechanisms, leaving proliferation 
rate unaltered (Hanna et al., 2009). There is accumulating evidence  that there are 
several epigenetic barriers to be overcome and it is reasoned that only a minority of 
cells are able to overcome all of them and are therefore fully reprogrammed (Plath 
and Lowry, 2011; Takahashi, 2010).  
 
The time course of the reprogramming process can be divided into different phases, 
each exhibiting typical attributes distinguishable by phenotypic, transcriptional and 
chromatin changes (Figure 1.16) (reviewed in (Plath and Lowry, 2011)). In the early 
phase of reprogramming, ectopic expression of transcription factors leads to a 
morphological change into smaller, and more rapid proliferating cells. Somatic genes 
start to be downregulated while proliferation genes are upregulated. Also the 
epigenome of the cells are changing, for instance promoter regions of pluripotency-
associated genes show increased H3K4 dimethylation (Mikkelsen et al., 2008). It is 
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noteworthy that most cells, despite expressing all necessary transgenes, drop out 
already in the first phase of reprogramming (Plath and Lowry, 2011). The 
intermediate phase of reprogramming is marked by the appearance of cells tightly 
clustering together exhibiting an epithelial character. ESC marker genes are 
upregulated, but they are still dependent on transgene expression. Partially 
reprogrammed ES-like cells often stall at this stage, not reaching a bona fide iPSC 
state. These trapped ES-like cells are termed pre-iPSCs and are a great tool for 
studying late stages of reprogramming, as it is possible to create clonal populations 
that can be propagated and driven to mature iPSCs under appropriate conditions 
(Mikkelsen et al., 2008; Silva et al., 2008).  In the late phase, proper ES-like colonies 
are obvious, key ES cell regulators are transcribed and the core transcription network 
of pluripotency forms, leading to transgene independence. Full reprogramming is 
also evident on the chromatin level, where repressive marks are lost and in mouse 
iPSCs the X chromosome is reactivated. For human iPS cells, X chromosome 
reactivation was to date not reported (Tchieu et al., 2010), even in conditions 
favouring X inactivation during hES cell derivation it seems to be not achievable, 
indicating a later time of development (reviewed in (Plath and Lowry, 2011)). 
Interestingly, some studies reported that reprogrammed cells were easier to 
differentiate back to the cell type of their derived origin and it is therefore speculated 
that they retain an „epigenetic memory‟ (reviewed in (Barrero and Izpisua Belmonte, 
2011)). Continuous culture of iPS cells seems to reduce epigenetic differences and 
some studies report that at later passage murine iPS cells are almost 
indistinguishable from mES cells. Despite these reports there are increasing numbers 
of studies that raise concerns regarding multiple differences between iPS and ES 
cells, possibly arising from incomplete reprogramming (reviewed in (Blasco et al., 
2011)). It might be misleading to directly compare these studies, as there are likely to 
be differences between the iPS cell generation and the selection of iPS cell lines 
considered as being fully reprogrammed. Furthermore, there are significant 
differences between ES cell lines themselves, so care should be taken when judging 
whether the differences between iPS cell lines fall into or are clearly distinct from 
these variations. Apparent differences should be followed and their potential 
progression to a functional level has to be assessed. Two recent manuscripts argue 
for a more general genomic instability of human pluripotent lines affecting both hiPS 
and hES cell lines, though despite both being highly plastic, general differences 
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shine through (Laurent et al., 2011; Taapken et al., 2011). The process of 
reprogramming led to deletions including tumour suppressor genes, while long-term 
culture of iPS and hESCs was accompanied by novel genomic aberrations including 
copy number variations (CV) of oncogenic genes. These worrying observations have 
to be followed-up and could result possibly from the non-ideal culture conditions of 
human pluripotent cell lines. It is of essence to solve these issues, because a common 
genomic instability would hit stem cell research at its foundation, especially as 
duplications in regions comprising pluripotency-related genes could cause serious 
issues in regard of regenerative medicine applications, where pluripotent precursors 
have to be eliminated to avoid the risk of cancer formation (Laurent et al., 2011). 
 
Remaining issues of concern are how to choose the best iPS and ES cell lines and if 
they are identical at a functional level. There is no absolute gold standard to solve 
this problem especially as the best and most stringent test, the tetraploid 
complementation assay, where pluripotent cells entirely account for the animal, is 
not ethically applicable for humans (Zhao et al., 2009). It will probably be necessary 
to decide the most appropriate pluripotent cell type for each application and assess 
their safety risk carefully. 
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Figure 1.16 The reprogramming process consists of multiple steps.  Different 
events happening during early, middle and late phases of reprogramming mouse 
embryonic fibroblasts to induced pluripotent stem cells (iPSCs) by the four 
reprogramming factors (Oct4, Sox2, Klf4, and c-myc) are shown. It is more delicate 
to separate events happening in the early and middle phase of reprogramming 
compared to those that occur at the later stage. Image obtained from (Plath and 
Lowry, 2011). 
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1.7.3 Epiblast Stem Cells 
Epiblast Stem Cells (EpiSCs) are a pluripotent cell type first derived by dissecting 
and maintaining the epiblast of post-implantation embryos (E5.5-6.5) in special 
culture conditions (Brons et al., 2007; Tesar et al., 2007). In both studies culture 
conditions similar to hES cell culture systems succeeded in maintaining the long-
term pluripotency of epiblast-derived cells. The presence of Activin A and FGF2 
seemed to be optimal for EpiSC self-renewal and similar to hES cells it was 
necessary to propagate them in clumps rather than following trypsin dissociation. 
Furthermore, like hES cells, EpiSCs grow as large flattened colonies as opposed to 
the round domed mES cell colonies.  Survival after plating at clonal density was low, 
but some cells were able to form EpiSC colonies which could again be clump 
passaged without limit. Pluripotency was proved by teratoma formation after 
injection into immunocompromised mice, in vitro differentiation assays and 
detection of pluripotency marker gene expresion. Despite being able to form all three 
germ layers, EpiSCs very poorly contributed to chimeras following morula 
aggregation or blastocyst injection. Only in one of the two studies were chimeras 
obtained (2/385) but none of them contributed to the germline (Brons et al., 2007). 
This could be due to incompatibility between the EpiSCs and the cells of the ICM 
resulting from a developmental asynchrony limiting the ability of EpiSCs to colonise 
the host embryo. As these cells apparently cannot form functional gametes they 
cannot be termed naïve or truly pluripotent, even though a functional core 
transcription factor network equivalent to ES cells is in place.  
 
The mechanisms to integrate the signals from the surface (extrinsic) to the core 
(intrinsic) differ between EpiSCs and mES cells and are in fact more similar between 
EpiSCs and hES cells. EpiSCs appear to be a distinct cell type that is confirmed by 
analysis of different markers and might reflect the later stage of development from 
which they are derived. This could become of major interest regarding the similarity 
to hES cells and raises the possibility that hES cells are also representative of a later 
developmental stage, meaning that true hES cells are not established yet, but are 
instead human EpiSCs. Two years after the initial discovery of the EpiSCs, Austin 
Smith‟s group showed that mES cells and EpiSCs are interconvertible (Guo et al., 
2009). Conversion of ES cells to EpiSCs was achieved by simply transferring mES 
cells to serum-free N2B27 medium supplemented with Activin A and Fgf2 (bFGF). 
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The reversion is possible by overexpression of Klf4 or Nanog in media containing 
inhibitors of Mek/Erk signalling plus LIF (Guo et al., 2009; Silva et al., 2009). In 
culture conditions considered to be optimal for mES cell (Ying et al., 2008), EpiSCs 
did not convert spontaneously to naïve pluripotency in the absence of transgene 
overexpression (Guo et al., 2009). In a more recent paper Najm et al. report the 
derivation of mES and EpiSCs from pre-implantation mouse embryos (Figure 1.17). 
A medium optimised for maintaining both ES and EpiSCs was able to support the 
outgrowth of preimplantation embryos, leading to two distinct morphological colony 
types (Najm et al., 2011). The round, tight ES colonies and flat EpiSC-like colonies 
were separated after 16 days and expanded in either media supporting ES or EpiSCs. 
Interestingly, the divergence appeared to be early as conversion of morphology was 
never observed (Najm et al., 2011). This raises the question of whether distinct 
pluripotent cell types relate to each other which might support the hypothesis that the 
closest in vivo counterpart of ES cells are early germ cells (Zwaka and Thomson, 
2005).  
 
A direct way of creating EpiSCs from somatic cells was achieved by reprogramming 
fibroblasts with the four factors, Oct4, Sox2, Klf4 and c-Myc and simultaneously 
applying EpiSC culture conditions (Han et al., 2011). This study demonstrated the 
importance of the culture environment being able to determine the cell fate during 
reprogramming. Cells undergoing reprogramming appear to be very plastic and 
therefore it might be possible to force cells to a new identity simply by modulating 
culture conditions. This also becomes of interest regarding transdifferentiation events 
which could possibly be triggered by forcing closely related cell fates to one or 
another in specific culture conditions, if necessary with the help of activating 
specific transcription factors.  
 
In a study performed in Rudolf Jaenisch‟s laboratory, it was demonstrated for the 
first time that human fibroblasts, as well as hESCs, can be driven to a naïve state 
very similar to mouse ESCs or mouse iPS cells (Hanna et al., 2010). This was 
achieved by overexpressing the transgenes Oct4, Klf4, and Klf2, in addition to 
culture in LIF and inhibitors of mitogen-activated protein kinase (Erk1/2) and 
glycogen synthase kinase 3β (GSK-3β) pathway. They showed that these naïve cells 
were similar to mESCs on a transcriptional level and also on an epigenetic level as 
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both X-chromosomes were inactivated, a feature that is lost in most if not all derived 
hES cells (Lengner et al., 2010). On the basis of this study it can be speculated that 
so far established hES lines are more likely to be hEpiScs or primed hES cells. 
Further work will be needed to create permanently stable naïve human pluripotent 
cells, ideally without the use of transgenes. Once this goal is reached, a powerful tool 
to be used in basic and applied research will be available to tackle human health and 
development questions, eventually opening up new opportunities for patient-speciﬁc 
treatments. 
 
 
 
 
 
Figure 1.17 Pluripotent stem cell states. Mouse embryonic stem (ES) cells and 
epiblast stem cells (EpiSCs) are distinct, pluripotent states that can be isolated from 
pre- and post-implantation embryos respectively. Furthermore, epiblast like stem 
cells could be established by reprogramming somatic cells in EpiSC culture 
conditions (Han et al., 2011). Human ES cells differ from mouse ES cells, and share 
similarities with EpiSCs, yet are derived from pre-implantation human embryos 
(Najm et al., 2011). Figure adapted from (Najm et al., 2011). 
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1.8 ZSCAN4 
Zscan4 is a novel gene family discovered in this study to be regulated downstream of 
PI3Ks. In this section the Zscan4 family is introduced, as it was a major focus of this 
study. 
 
1.8.1 Structure and composition of the Zscan4 family  
Zscan4 is a relatively novel gene family consisting of nine members that have been 
found to be specifically expressed in two-cell embryos and ES cells (Falco et al., 
2007). In their 2007 article they identified the Zscan4 family by analysing data of 
large scale EST and DNA microarray studies. Zscan4 regulation by Zfp206, a 
putative transcription factor which also regulates other genes important for ES cell 
differentiation, had previously been reported (Zhang et al., 2006b). Both, Zscan4 and 
Zfp206 are SCAN domain-containing Zinc finger proteins, which is a common 
feature in transcription factors. The SCAN domain is a leucine rich region that plays 
a role in protein-protein interactions. Its name is an artificial word derived from the 
first letters of the four proteins initially found to contain this domain (SRE-ZBP, 
CTfin-51, AW-1, Number 18 cDNA) (Williams et al., 1995) and also known as LeR 
(leucine rich region) (Pengue et al., 1994). Zinc finger domains are best known for 
their  sequence specific DNA binding function, but are also reported to be involved 
in protein-protein and RNA binding. Because of their high DNA binding specificity 
it is even possible to design Zinc finger nucleases targeting precise regions of the 
genome. Therefore, they can be used as a tool for manipulating the genome of higher 
organisms for which no species specific embryonic stem cells are available (Perez et 
al., 2008; Urnov et al., 2010). Three of the Zscan4 family members were reported to 
be pseudogenes by Falco et al. (Figure 1.18). Another third, Zscan4c,d,f are full 
length proteins consisting of 506aa and more than 94% conserved to each other. 
They contain a SCAN domain and four Zinc finger domains (Falco et al., 2007). 
Zscan4A, B and E are shorter versions and were published to encode only for the 
SCAN part of the protein, though Zscan4B and E appear to be almost full length 
(505aa) in a recent database search. This will be discussed further as part of the 
results chapter four. 
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Figure 1.18 The Zscan4 family. (A) The Zscan4 family consists of nine paralog 
members. Three of them are full length proteins, while the other two thirds are 
shorter versions or pseudo genes. (B) Predicted protein domains of the Zscan4 
family members are shown. Full length proteins contain a SCAN domain and four 
zinc fingers. (Falco et al., 2007) 
 
 
 
1.8.2 Regulation of Zscan4 
Zscan4 exhibits a very restricted pattern of expression with a strong peak in the late 
2 cell stage during mouse embryonic development. This was shown by profiling the 
expression of Zscan4 during preimplantation development stages by whole-mount in 
situ hybridization (WISH) and qRT-PCR analysis (Falco et al., 2007). Interestingly, 
Zscan4 was undetectable at the blastocyst stage where ES cells are normally derived 
from. Zscan4 transcripts were re-expressed in mES cells but only by a small fraction 
of cells within a self-renewing ES cell colony (Falco et al., 2007). This curious 
expression pattern was reconfirmed in a successive publication by the same group in 
2010 (Zalzman et al., 2010). In this study the Zscan4c promoter region was used to 
drive expression of the Cre-recombinase (CreERT2 fusion enzyme) gene which can 
translocate to the nucleus in the presence of tamoxifen. Once in the nucleus, it 
excises a neomycin resistance cassette leading to irreversible activation of LacZ 
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expression. Using these pZscan4-CreERT2 cells cultured in the presence of 
tamoxifen, they were able to estimate that every day 3% of the Zscan4 negative cells 
become Zscan4 positive, whereas 47% of the Zscan4 positive cells lost Zscan4 
expression, leading to the equilibrium of 5% positive cells at any given time 
(Zalzman et al., 2010). These data were obtained via X-gal staining and by flow 
cytometry after green fluorescent substrate CMFDG (5-chloromethylfluorescein-di-
-galactopyranoside) staining. How this expression pattern is regulated remains to be 
unravelled but seems to be extremely important for the correct physiological 
function of Zscan4. 
 
1.8.3 Function of Zscan4 
Knock-down of Zscan4 transcript by siRNA injection into the male pronucleus of 
zygotes leads to a delay in the progression from the 2-cell to the 4-cell stage of 
embryonic development by about 24h (Falco et al., 2007). This finding is 
underpinned by another set of experiments in which Zscan4 siRNA was injected into 
one of the blastomeres of early 2-cell stage embryos. About a third of the treated 
blastomeres experienced a delay in the division progression compared to the 
untreated control blastomer. Besides the developmental delay, a functional 
impairment was also observed.  Zscan4 knock down blastocysts neither implanted 
when transferred to the uterus of pseudopregnant mice nor proliferated normally in 
vitro (Falco et al., 2007). In their following publication they describe an implication 
of Zscan4 in regulating telomere elongation and genomic stability in mES cells 
(Zalzman et al., 2010). They show that knock-down of Zscan4 increases karyotype 
instability, exemplified by chromosome deletions and fusions, a phenotype that can 
be rescued by overexpression of exogenous Zscan4. Furthermore, mES cells with 
knocked-down levels of Zscan4 transcript have shorter telomeres, reduced 
proliferation and go into culture crisis with apoptosis after several passages. Their 
data also suggests that Zscan4 localizes at the telomeres leading to telomere 
extension most likely by a recombination process. An increase in telomere sister 
chromatid exchange (T-SCE) events in Zscan4-induced cells was measured by a 
telomere chromosome orientation FISH (CO-FISH) assay. The precise molecular 
recombination mechanism is unclear to date but seems to go in hand with an 
upregulation of meiosis-specific homologous recombination genes induced by 
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Zscan4 (Zalzman et al., 2010). Interestingly, sister chromatid exchange (SCE) events 
in non-telomeric regions, commonly associated with genetic instability, are 
decreased upon Zscan4 overexpression and increased after knock-down of Zscan4 
transcript. This finding further strengthens the important role of Zscan4 in guarding 
genomic stability of mESCs.  
 
In brief, Zscan4 is a key regulator for maintaining ES cell genetic stability making 
long term ES cell culture possible. Zscan4 achieves this by positive telomere 
regulation via recombination mechanisms (Zalzman et al., 2010). The described 
telomere elongation appears to be independent of telomerase activity and might be 
therefore related to a telomere elongation mechanism referred to as alternative 
lengthening of telomeres (ALTs), which is based on homologous recombination 
(Bryan et al., 1995). Beside this, Zscan4 has most likely other functions and appears 
to also act as a transcription factor activating and repressing specific target genes 
(Nishiyama et al., 2009). Furthermore, stem cells and cancer cells share many 
features in common, and as multiple types of cancers also rely on ALT mechanisms, 
it can be speculated that a similar molecular machinery underlies this common 
phenomenon. A potential role of Zscan4 in these cancer types remains to be 
investigated.  
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1.9 Aims 
The goal of current stem cell research is to increase our understanding of ES cell 
behaviour, so that one day it will be possible to use their full therapeutic potential, 
without the risk of unwanted side effects. We are far from a complete knowledge of 
ES cell behaviour and, therefore, basic studies unravelling the functional 
mechanisms controlling ES cell fate decisions are essential for reaching this ultimate 
goal. To use ES cells in future regenerative medicine applications it is necessary to 
expand them in sufficient numbers. This can be challenging as culture conditions 
have to be optimal, so that propagated cells do not lose their pluripotent phenotype, 
while also maintaining genomic stability. The PI3K signalling pathway is a focus of 
our laboratory and it has been reported by, us and others, to be important for ES cell 
self-renewal (Niwa et al., 2009; Paling et al., 2004; Storm et al., 2007). The overall 
aim of this study was to gain further knowledge of the role played by PI3K-
dependent signalling in maintaining ES cell identity. 
 
●  The first aim of this study was to identify novel regulators of ES cell identity 
downstream of PI3Ks, based on the list of transcriptional changes obtained by a 
microarray screen performed prior to the start of this study (Chapter 3). In this 
microarray screen, mES cells were cultured over a defined time-course in the 
presence or absence of the broad-spectrum pharmacological PI3K inhibitor 
LY294002.  
●  The second aim was to unravel the mechanisms of action of the novel 
regulators identified by aim 1. Zscan4 was identified as a PI3K downstream target 
important for maintaining ES cell identity. Over-expression and protein interaction 
studies were performed to gain further knowledge about its function in mES cells 
(Chapter 4).    
 
● A third aim focussed on investigating the role of Class IA PI3K catalytic 
subunit isoforms in regulation of ES cell identity. This aim was addressed by 
activation of individual Class IA PI3K catalytic subunits using a genetic approach 
(Chapter5). 
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2.1 Cell lines and tissue culture 
2.1.1 Cell lines 
2.1.1.1  E14tg2A murine embryonic stem cell line 
The E14tg2a murine embryonic stem cell line (clone R63) was a kind gift of Dr. 
Owen Witte, UCLA, California (Era and Witte, 2000).  The R63 cell line stably 
expresses the tetracycline transactivator encoded by the plasmid pCAG20-1. 
2.1.1.2 R1/ pTet-On Advanced embryonic stem cell line 
The R1/ pTet-On Advanced murine embryonic stem cell line constitutively expresses 
the tetracycline-controlled transcriptional transactivator, Tet-On Advanced (Urlinger 
et al., 2000). The R1/ pTet-On Advanced murine embryonic stem cell line was a 
kind gift of Dr. Giusi Manfredi, University of Bath, UK. 
2.1.1.3  Rex1-Gfp-BSD/Oct3/4-Ecfp-pac murine ES cells (OCRG9 cells) 
OCRG9 is a knock-in ES cell line, which contains fluorescent proteins in the Rex1 
and Oct3/4 loci to visualize expression of these genes (Toyooka et al., 2008). Cells 
contain an Oct3/4-ECFP fusion gene and IRES (internal ribosome entry site)-
puromycin resistance cassette, which allows for the selection of Oct3/4 positive cells 
with puromycin. In the Rex1 (also called Zfp42) locus an eGFP and IRES-blasticidin 
resistance cassette was inserted (Toyooka et al., 2008).  
2.1.1.4 EB5 murine embryonic stem cell line 
EB5 is a germ line-competent ES cell line derived from E14tg2a, generated by 
introducing an Oct3/4 knockout vector carrying IRESBSDpA (Niwa et al., 2002; 
Ogawa et al., 2004).  EB5 cells can be selected for Oct3/4 positive cells with 
blasticidin. 
 
2.1.1.5 Induced pluripotent stem cell line 
The induced pluripotent stem cell line used was a kind gift from Dr. Shinya 
Yamanaka. The iPS cells were established as described in (Okita et al., 2007). 
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2.1.2 Tissue culture techniques 
2.1.2.1 Embryonic stem cell culture 
Murine embryonic stem cell lines were routinely cultured on tissue culture plates 
(Nunc) coated with 0.1% (w/v) porcine gelatin (Sigma) in knock-out (KO) 
Dulbecco‟s Modified Eagle Medium (Invitrogen, Scotland) in the presence of 15% 
(v/v) knock-out serum replacement (Invitrogen), 0.1mM mercaptoethanol, 2mM 
glutamine and 0.1mM non-essential amino acids. Knockout DMEM plus 
supplements is referred to as complete KO DMEM media from here on. 
Alternatively, mES cells were cultured in Glasgow Minimal Essential Medium 
(GMEM) in presence of 10% (v/v) Hyclone serum (Perbio, Hyclone, UK). Cultures 
were supplemented with either 1000 units/ml LIF (Chemicon, UK) or 4µl/ml 
recombinant LIF conditioned media from HEK293LIFV5 cell line generated by 
stable expression of a V5 epitope-tagged LIF plasmid in HEK293 cells. To passage, 
cells were washed twice with phosphate buffered saline (PBS) then dissociated with 
Trypsin/EDTA (Invitrogen) for 5 minutes at 37°C. Dissociated cells were 
resuspended in complete KO DMEM media, centrifuged at 1000 revolutions per 
minute (rpm) for 5 minutes and supernatant was removed. After resuspending in 
complete knockout medium, the concentration of cells in the single cell suspension 
was determined using a Neubauer haemocytometer. Cells were plated at densities of 
0.5 x 10
6
 cells / 10cm dish for passage every two days or 0.2 x 10
6
 cells/dish for over 
the weekend. Cultures were maintained in humidified incubators at 37°C and 5% 
(v/v) CO2. Tissue culture consumables which were used in this study are summarised 
in Table 2.1.  
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Table 2.1 Tissue culture consumables 
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2.1.2.2 Freezing and Thawing mES cells 
Ice-cold Glasgow Minimal Essential Medium (GMEM) (Invitrogen), supplemented 
with 2mM glutamine, 50µM ß-mercaptoethanol, 0.1mM non-essential amino acids, 
1mM sodium pyruvate (Invitrogen) and 10% (v/v) Foetal Bovine Serum (FBS) was 
used for resuspending mES cell pellets, obtained using the routine culture protocol. 
Cold freezing media plus 10% (v/v) dimethylsulphoxide (DMSO) was added drop-
wise to a final concentration of 1 x 10
6 
cells/ml. Cells were aliquoted into cryovials 
(1 ml per vial) and placed at -80°C overnight before being transferred for long term 
storage in liquid nitrogen. 
 
For recovery, cells were thawed rapidly in a 37°C water bath, gently resuspended in 
KO DMEM and pelleted at 1000rpm in a Jouan CR412 centrifuge. Cell pellets were 
resuspended in complete KO DMEM media plus 1000 U/ml LIF, plated and further 
cultured in humidified incubators at 37°C with 5% CO2 (v/v) .  
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2.2 Inhibitors used in the study 
Details of pharmacological inhibitors used in this study to assess roles of PI3Ks on 
gene regulation and mES cell identity (Table 2.2). 
 
Table 2.2 Pharmacological Inhibitors 
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2.3 Biochemical and functional techniques 
Biochemical consumables used in this study are summarised in Table 2.6. 
2.3.1 Bradford protein quantification assay 
A Bradford assay (Bradford, 1976) was performed to determine protein 
concentrations of cell lysates. This assay utilises an absorption shift of the 
Coomassie brilliant blue dye at 595nm when bound to arginine and hydrophobic 
residues in a protein. To generate a standard curve, BSA was added to 1ml aliquots 
of 1:10 diluted Bradford reagent (Biorad) at a final concentration of 0, 2, 4, 6, 8, 10 
or 12g/ml. 1-5l of the protein extract samples were added to 1ml of 1 in 10 
Bradford reagent and mixed well.  100l of each sample was added to the wells of a 
96 well tray and the optical density at 595nm was determined on a Versamax 
microplate reader (Molecular Devices). A standard curve was constructed from the 
BSA standards and sample protein concentrations were extrapolated. The same 
amount of protein (10-20μg) was taken from each sample, diluted with lysis buffer, 
and boiled in SDS sample buffer (5x sample buffer; 10% SDS (w/v), 50% glycerol 
(v/v), 200mM Tris-HCl pH 6.8, 5% (v/v) 2-mercaptoethanol and 2% (w/v) 
bromophenol blue. 
 
 
2.3.2 Protein resolution and immunoblotting 
2.3.2.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
SDS-PAGE is a technique used to separate protein samples according to their 
molecular size using a gel electrophoresis system. Samples were boiled in a buffer 
containing 2-mercaptoethanol which denatures protein structure and disrupts 
(reduces) disulphide bonds. The ionic detergent SDS is another component of the 
buffer, and binds linear proteins at a rate of 1.4g SDS per 1g protein. This leads to a 
roughly equal charge to mass ratio for different proteins, allowing proteins to be 
separated by polypeptide size alone. Samples were loaded into individual wells of 
the upper stacking gel, which is a non-restrictive large pore matrix. The stacking gel 
is prepared with Tris/HCl buffer pH 6.8, at this pH glycine is only weakly ionised 
and moves slowly. NaCl, also present in the buffer, is fully ionised and moves faster. 
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The level of protein ionisation is in between those of Glycine and NaCl, hence the 
proteins move in between the boundaries of NaCl and Glycine. This leads to a 
focusing of the proteins at the small porous resolving gel, where the glycine becomes 
highly ionised because of the higher pH of 8.8. Glycine will start to migrate much 
faster, which relieves the boundary, and proteins will separate according to their size 
(Laemmli, 1970).  
 
Mini Protean III Gel Electrophoresis Apparatus (Bio-Rad) was used to prepare gels 
and perform electrophoresis according to the manufacturer‟s guidelines. The 
percentage of acrylamide used in the resolving gel was dependent upon the size of 
the target proteins (Table 2.3). 
 
 
 
 
Table 2.3 Resolving power of gels with different acrylamide percentages 
 
 
 
 
 
 
The resolving gel was prepared at the desired percentage of acrylamide (Table 2.4) 
and ~4.5ml was poured into the gel casting apparatus. The resolving gel was overlaid 
with water and allowed to polymerise, before the water was removed by aspiration. 
The stacking gel (1.67ml acrylamide, 6ml milli-Q H2O, 1.25ml 1M Tris-HCl pH6.8, 
0.15ml 10%(w/v) SDS, 50µl 10% (w/v) ammonium persulphate and 20µl TEMED) 
was poured on top and a fifteen well comb was inserted to create the wells. The 
comb was removed after solidifying of the gel and the wells were washed with 
milliQ water. The gel was placed into a gel tank filled with 1x SDS-PAGE running 
buffer (25mM Tris base, 192mM glycine, 0.1% (w/v) SDS) and samples were then 
loaded into the wells. SDS-PAGE broad range molecular weight marker (Biorad) 
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was also loaded into a separate well. Samples were run with a constant voltage of 
80mV through the stacking gel and at 180mV to resolve.  
 
Table 2.4 Acrylamide resolving gel compositions 
 
 
  
 
 
 
2.3.2.2 Immunoblotting by Semi-Dry Transfer 
Immunoblotting was used to transfer the proteins from SDS-PAGE gels onto 
nitrocellulose paper. Therefore, gels were placed onto a piece of nitrocellulose, 
sandwiched between four buffer-soaked (39mM glycine, 48mM Tris base, 0.0375% 
(w/v) SDS, 20% (v/v) methanol) 3MM Whatman paper. This stack was placed 
between the lower (positive) and the upper (negative) electrode of the transfer 
apparatus. Immunoblotting was performed with a current of 0.8mA per cm
2
 for 60 
minutes. Ponceau S was used to check protein transfer, equal loading and to mark the 
molecular weight standards. After washing in TBS (20mM Tris-HCl pH7.5, 150mM 
NaCl) blots were blocked for 1 hour in blocking solution (5% (w/v) Bovine serum 
albumen (BSA), 1% (w/v) ovalbumin, 0.05% (w/v) sodium azide in TBS) or 
Advance blocking solution (200mg ECL advance blocking agent /10ml TBS)) and 
rinsed afterwards with TBS. Blots were incubated overnight with primary antibody 
(see Table 2.5) diluted in blocking buffer before being washed once in TBS, three 
times with TBS Tween (TBST) (0.05% Tween in TBS) for 15 minutes and a final 
TBS wash. 
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Horseradish peroxidase (HRP) labelled secondary antibody were then applied and 
blots were incubated for 1 hour. Blots were washed as before with an additional final 
TBS wash. Enhanced Chemiluminescence Western blotting detection reagent 
(Amersham) was applied for 1 minute. Blots were wrapped in Clingfilm and placed 
in an autoradiography cassette. ECL signal was detected with Kodak X-AR5 film. 
 
For reprobing blots with a different antibody, the blots were stripped in stripping 
buffer (6.25% (v/v) 1M Tris-HCl pH 7.5, 2% (w/v) SDS, 0.77% (v/v) ß-
mercaptoethanol) at 55°C for 45 minutes. After stripping blots were washed 
thoroughly in TBS and blocked in blocking buffer for 1 hour. Rinsed blots were 
reprobed as mentioned. 
 
 
Table 2.5 Antibodies used for immunoblotting 
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2.3.3 Cytosolic/nuclear protein extraction 
For the separation of cytosolic and nuclear protein fraction two different methods 
were used. The NE-PER nuclear and cytoplasmic extraction reagents (PIERCE 
Biotechnology, #78833) were used according to the manufacturer‟s protocol. For the 
GFP-Nanotrap (Chromotek) the following protocol was used. ESCs were harvested 
after trypsinisation in 50ml tubes (4 x T175 flasks per tube) by centrifugation at 
1000 x g for 5 minutes at 4°C. Cytosolic extraction was performed after washing the  
cell pellet twice in cold PBS by resuspending pellets in 6ml cold cytosolic lysis 
buffer (20mM HEPES, 10mM KCl, 1mM EDTA, 10% glycerol, pH 7.9) and 
incubation on ice. Cells were then pulled 10 times through a 27G (0.4mm) needle 
and centrifuged at 16300 x g for 5 minutes at 4°C. The supernatant contained 
cytosolic proteins and was kept on ice until further use. The pellet containing the 
nuclear fraction was washed twice in 500l cytosolic extraction buffer and 
centrifuged at 16300 x g for 5 minutes at 4°C. Nuclear proteins were extracted by 
addition of 2ml of nuclear extraction buffer (20mM HEPES, 10mM KCl, 400mM 
NaCl, 1mM EDTA, 20% glycerol, pH 7.9) per nuclear pellet and incubated on a 
rotator for 1 hour at 4°C. Extracts were then centrifuged (16300 x g for 15 minutes at 
4°C) and the supernatant, containing nuclear proteins, was collected. All buffers 
contained fresh protease and phosphatase inhibitors (1mM 
phenylmethylsulfonylfluoride (PMSF), 1g/ml aprotinin, 1g/ml leupeptin, 1g/ml 
pepstatin, 5g/ml anipain, 157g/ml benzamidine, 5mM -glycerophosphate, 5mM 
NaF 1mM Na3VO4). 
 
2.3.4 Immunoprecipitation with GFP-Nanotrap (Chromotek) 
Cytosolic and nuclear cell extracts were prepared as described in 2.3.3. Cytosolic 
and nuclear fractions containing soluble protein were cleared by ultra-centrifuging 
for 30 minutes with 60,000 x g at 4°C in a Beckman Coulter ultra-centrifuge. A 
subsequent buffer exchange to IP buffer (50mM Na2HPO4, 150mM NaCl, pH 7.4) 
was performed using Amicon centrifugal filters with a 10kDa cut-off according to 
the manufacturer‟s protocol. Prior to immunoprecipitation (IP) lysates were pre-
cleared with hydrated agarose or sepharose beads for 1h at 4°C on a rolling shaker. 
IPs were performed with 500l GFP-Trap-A beads (Chromotek) for 1-3 hours on a 
rolling shaker at 4°C, followed by three washes with IP buffer. Bound protein was 
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eluted with 200mM glycine at pH 2.5 and 1M Tris-base (pH 10.4) was added for 
neutralization. The eluates were centrifuged at 1000rpm for 1 minute and the 
supernatant without beads was transferred to Amicon centrifugal filters with a 3kDa 
cut-off for concentration, according to the manufacturer‟s protocol. SDS loading 
buffer was added to samples and samples were boiled for 5 minutes before running 
on an SDS-PAGE gradient gel. 
    
2.3.5 Immunochemistry 
To obtain confocal images, ESCs were cultured on Lumox (Sarstedt) or chamber 
cover glass (NUNC) trays. Following the culture period, cells were fixed with 4% 
(w/v) paraformaldehyde (PFA) for 15 minutes at room temperature. Cells were 
permeabilised in PBST (PBS containing 0.2% Triton X-100), incubated with PBS 
containing 2%(v/v) FCS for 20 minutes to block non-specific binding and incubated 
with primary antibody overnight at 4°C. Dilution ratios of primary antibodies used 
are: 1:500/1:100 for anti-Nanog antibody, 1:500 for anti-V5 antibody, 1:200 for Oct-
4 antibody, 1:2000 for E-cadherin antibody, 1:250 for anti-pericentrin antibody. 
After washing with PBS, the cells were incubated with respective secondary Alexa-
Fluor antibodies (1:500) for 30 minutes at room temperature. Cells were then washed 
and counterstained for 10 minutes with 0.5g/ml DAPI (4',6-diamidino-2-
phenylindole) (Sigma) or 0.5g/ml Hoechst (Sigma), washed again and mounted in 
MOWIOL. Images were captured using a Leica TCS SP5 confocal microscope 
system (Leica Microsystems) or a Zeiss 10 Meta confocal microscope. 
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2.3.6 Flow cytometry 
2.3.6.1 Cell cycle analysis 
For cell cycle analysis, Zscan4c-Tet-off Clones were grown in presence and absence 
of 1g/ml tetracycline for 48h. Cells were fixed in ice-cold 70% (v/v) ethanol and 
occasionally stored at -20°C for up to 2 weeks until further use. Cells were 
rehydrated in PBS + 1% (w/v) BSA at 4°C for 10 minutes and stained with the DNA 
dye 7-AAD (25 µg/ml) at 4°C for 90 minutes. Zscan4c was labelled with 5g/ml 
anti-V5 antibody and a FITC conjugated secondary antibody. Zscan4c expression 
and 7-AAD staining was monitored by flow cytometry of 10000 events on a 
FACSCanto™ flow cytometer and analysed using FACS Diva software. 
 
 
2.3.6.2 Detection of GFP-positive ESCs 
Flow cytometry was used in this study to detect ES cells expressing GFP, on two 
different occasions. Firstly, to quantify the percentage of eGFP-Zscan4c positive 
cells after induction of expression with 1g/ml doxycycline for 72h. Secondly, 
Rex1-GFP expression was measured as a read-out for self-renewal in OCRG9 ES 
cells following treatment with  specific PI3K inhibitors. Prior to flow cytometry, 
cells were trypsinised as described in 2.1.2.1 and washed twice in cold FACS buffer 
(1% (v/v) FCS, 0.02%. (w/v) sodium azide in PBS) Approximately 0.5x10
6
 cells 
were resuspended in 500l FACS buffer supplemented with Propidium iodide 
(1:5000) and transferred to FACS tubes. Dead cells stained with propidium iodide 
were excluded from the analysis and 10000 live events were counted on a 
FACSCanto™. 
 
2.3.6.3 Gating for GFP-positive cells 
Gate for GFP-positive cells was set by using wild-type cells. Propidium iodide was 
used to analyse live cells. 
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Table 2.6 Biochemical consumables 
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2.3.7 Functional assays 
2.3.7.1 Self-renewal Assay (Alkaline Phosphatase assay) 
The undifferentiated state of ES cells can be characterized by high levels of 
expression of Alkaline Phosphatase (AP) (Pease et al., 1990; Scutt and Bertram, 
1999).  
 
ES cells were plated at 1.5x10
3
 cells per well of a 6-well NUNC tissue culture plate 
coated with 0.1% (w/v) porcine gelatin in GMEM media with 10% (v/v) serum and 
1000U/ml LIF (Chemicon). For some experiments, limited LIF concentrations were 
used, these are indicated accordingly. Cells were washed twice with PBS and fixed 
with 100% methanol for 10 minutes. Methanol was aspirated and dishes were 
allowed to air dry. Fixed colonies were incubated for 20 minutes with a solution of 
0.1M Tris-HCl pH 9.2, 200µg/ml Naphthol AS-MX and 1mg/ml Fast Red TR Salt. 
Self-renewing colonies expressing alkaline phosphatase stained red, while 
differentiated colonies remain unstained. Dishes were washed twice with dH20 and 
allowed to air dry. Colonies were counted according to their staining and 
morphology. Non-self-renewing colonies were either unstained (white) or light red 
with a flattened morphology, while self-renewing colonies were tight round and 
stained bright red or exhibited a stained red core with a white border. All colonies 
were assessed in each well and scored according to the extent of staining and 
appearance.   
 
2.3.7.2 XTT cell metabolism assay 
The XTT assay was used to measure the metabolic activity of ESCs. The assay was 
adapted from earlier studies on activated T cells and from studies investigating 
viability and proliferation of tumour cell lines (Roehm et al., 1991; Scudiero et al., 
1988). The colorimetric assay is based on the cleavage of the yellow tetrazolium salt 
XTT, sodium 3'-[1-[(phenylamino)-carbonyl]-3,4-tetrazolium]-bis(4-methoxy-6- 
nitro) benzene-sulfonic acid hydrate yielding to a highly coloured water soluble 
formazan product. The cleavage is catalysed by the dehydrogenase enzymes of 
metabolically active cells. The bioreduction of XTT is potentiated when used in 
combination with the electron coupling agent phenazine methosulfate (PMS). 
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Prior to the performance of the assay, murine Zscan4c Tet-off ES cells were plated 
in presence and absence of 1g/ml tetracycline on a NUNC flat bottomed 96-well 
plate at a density of 200 cells per well in GMEM plus 10% (v/v) Hyclone serum, or 
in complete KO DMEM medium, supplemented with 1000U/ml LIF. 50L PMS-
XTT solution was added per well after d5 or d6 of culture and incubated for 4 hours. 
The absorbance at 490nm was read on a Versamax microplate reader. 
 
 
 
Table 2.7 Functional assay consumables 
 
 
 
 
2.3.7.3  Embryoid body differentiation assay 
The embryoid body formation assay protocol is based on earlier studies on 
embryonic stem cell differentiation to hematopoietic lineages (Keller et al., 1993; 
Kennedy et al., 1997). ESCs were trypsinised and resuspended at a concentration of 
1x10
4
 cells/ml in Iscove‟s Modified Dulbecco‟s Medium (IMDM) and mixed in a 
ratio of 1:1 with 2% (v/v) methylcellulose in IMDM. The mix was supplemented 
with 450M MTG, 50g/ml L-ascorbic acid, 10g/ml recombinant human insulin, 
200g/ml transferrin and 15% (v/v) FCS. After vortexing, the mix was aliquoted into 
30mm non-adherent petri dishes and further cultured in humidified incubators at 
37°C with 5% CO2 (v/v)  for up to six days. 
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2.4 Molecular Techniques 
2.4.1 RNA extraction 
2.4.1.1 RNeasy Mini Kit (Qiagen) 
RNA was extracted using Qiagen RNeasy kits according to the manufacturer‟s 
protocol. In addition, on-column DNase treatment with an extended (> 30 minutes) 
digestion time was performed to remove genomic DNA. Cell lysates were 
homogenized by passing them at least 5 times through a blunt 20-gauge needle 
(0.9mm diameter) fitted to an RNase-free syringe before transfer to the RNeasy spin 
columns. RNA was eluted in 30µl RNase-free water and quantified with a 
spectrophotometer. 
 
 
2.4.1.2 TRIzol Method for RNA Isolation 
Cells were washed twice with PBS and 1ml TRIzol reagent was added per 1x10
6
 
cells. Sterile cell scrapers were used to harvest RNA and lysate was transferred to 
sterile RNase-free 1.5ml tubes. 200µl of Chloroform were added per tube and mixed 
vigorously. Tubes were centrifuged at 14000rpm at 4°C for 15 minutes. Upper 
aqueous phase was transferred to a new RNase free 1.5ml tube. For RNA 
precipitation an iso-volume of 2-Propanol was added and after 10 minutes incubation 
at room temperature the mix was centrifuged for 10 minutes at 14000rpm at 4°C. 
After a 75% (v/v) ice cold Ethanol wash, the RNA pellet was allowed to air dry and 
resuspended in RNase free H2O. RNA samples obtained with the TRIzol method 
were further DNase treated to remove contaminating genomic DNA. Therefore, 1µg 
or 0.5µg RNA was incubated with 1U DNase (Promega) in DNase buffer (400mM 
Tris-HCl pH8.0, 100mM MgSO4, 10mM CaCl2 ) (Promega) at 37°C for 30 minutes. 
DNase was heat inactivated at 65°C for 10 minutes with 1µl DNase stop solution 
(20mM EDTA pH8.0). 
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2.4.2 cDNA synthesis 
DNase treated RNA samples (0.5-2g RNA) were incubated at 65°C for 5 minutes 
with 0.5µl of 500µg/ml Oligo dT (Promega) then kept on ice for at least 1 minute. 
RT-PCR was performed using first strand buffer (Invitrogen), 5mM DTT 
(Invitrogen), 2U/µl Rnasin plus (Promega), 0.5mM dATP, 0.5mM dTTP, 0.5mM 
dGTP, 0.5mM dCTP (Invitrogen) and 10U/µl Superscript III (Invitrogen). Samples 
were incubated at 42°C for 50 minutes for elongation, then at 70°C for 15 minutes to 
denature. The resulting cDNA was usually diluted 1:10 in sterile water and used as 
template for PCR analysis, cloning or stored at -20° for later use. 
 
 
2.4.3 Quantitative real-time PCR (qRT-PCR) 
Quantitative RT-PCR was performed on a Roche Molecular Biochemical 
LightCycler to quantify gene specific expression using appropriate primers (Table 
2.9). SYBR Green dye was used, which intercalates with double stranded DNA, 
resulting in an increase in fluorescence. Based on this principle, online monitoring 
and quantification of double stranded PCR product is possible using the Lightcycler. 
A master mix composed of 0.5µM primers, 3.5mM MgCl2, 1µl SYBR Green and 
sterile water to 8µl was added to pre-chilled capillaries, prior to addition of 2µl of 
diluted cDNA sample. The capillaries were then centrifuged at 4000rpm for 20 
seconds at 4°C. An amplification program with 40 cycles was run and melting 
curves were analysed to check the size of desired PCR product. For LightCycler 
program used see Table 2.8. LightCycler software (v4.0) uses monitored 
amplification slopes to calculate PCR efficiencies which are further used to calculate 
the relative quantification values normalized to the one of a calibrator. Gapdh or -
actin were used for normalisation. 
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Table 2.8 LightCycler program 
 
 
 
Table 2.9 Primers used for quantitative RT-PCR  
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2.4.4 Blunt end PCR for cloning 
Phusion® Hot Start High-Fidelity DNA polymerase (Finnzymes, F540) was used to 
amplify products from ES cell cDNA or 100ng plasmid, which were used as a 
template for PCR in a total reaction volume of 50l. Reactions were performed using 
a Techne Touchgene gradient PCR machine (Table 2.10). DNA was run on an 
agarose gel, stained with Ethidium bromide, and correct amplicon size was verified 
under UV light. PCR products were excised, purified with Qiagen gel extraction kit 
(Qiagen, 28704) and used for ligation reactions. 
 
Table 2.10 Blunt end PCR program 
 
 
 
2.4.5 Agarose gel electrophoresis 
Agarose gels were used to separate DNA by electrophoresis. Gels were prepared by 
dissolving the appropriate quantity of agarose ((1-4% (w/v) as required) by boiling in 
TAE buffer (50x TAE buffer: 2M Trizma base, 50mM Na2 EDTA (pH8.0) adding 
glacial acidic acid to pH7.6). Once cooled, the gel was poured into a gel tray sealed 
with masking tape and a well forming comb inserted. After the gel had set, the comb 
and tape were removed and gel was submerged in an electrophoresis tank containing 
1x TAE buffer. Samples were prepared by adding 6x gel loading dye (30% (v/v) 
glycerol, 0.05% (w/v) Xylene/Cyanol, 0.05% (w/v) bromphenol blue) to them. 
Samples were loaded into individual wells of the agarose gel and run at 70-90V until 
sufficient separation was achieved. The gel was then placed into a 0.5g/ml ethidium 
bromide 1x TAE solution for 15 minutes and visualised under UV light. Image was 
taken in a Syngene UV transluminator using Genesnap software. 
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2.4.6 Transient siRNA transfection 
Small interference RNAs (siRNA) were transiently transfected into mESCs to 
knockdown the expression of target genes. Richard Jorgensen and Carolyn Napoli 
were the first stumbling over the RNA interference (RNAi) phenomenon when 
trying to create a purple Petunia flower in 1986. Jorgensen proposed an “RNA-based 
information superhighway in plants” (Jorgensen et al., 1998). Work in the nematode 
worm c. elegans helped to understand the mechanisms of RNA interference (Fire et 
al., 1998) and the post-transcriptional gene silencing mechanism was later utilized in 
mammalian cells (Elbashir et al., 2001).   
 
RNAi is a post-transcriptional process of sequence-specific gene silencing, which is 
initiated by sequence homologous double-stranded RNA (dsRNA) (Elbashir et al., 
2001).  The RNA is cleaved into smaller siRNA fragments of 21 to 25 nucleotides in 
size by a dsRNA-specific endonuclease belonging to the family of RNAse III-like 
enzymes, and is also called Dicer (in Drosophila) (Bernstein et al., 2001; Elbashir et 
al., 2001). The RNA induced silencing complex (RISC) is a multiprotein complex 
that incorporates one strand of a small interfering RNA (reviewed in (Fuchs et al., 
2004)). The RISC complex that has bound this template siRNA is able to recognize 
complementary messenger RNA and degrades it, leading to a subsequent knockdown 
of targeted protein levels (Martinez et al., 2002).  
 
 
2.4.6.1 Endoribonuclease-prepared siRNA (esiRNA) 
Endoribonuclease-prepared siRNA was prepared according to the method first 
reported by Kittler (Kittler et al. 2004). Primers were designed to generate a PCR 
product of 200-400bp within the region of the gene of interest incorporating a T7 
promoter sequence (5‟-CGTAATACGACTCACTATAGGG) at the 5‟. PCR was 
carried out to generate cDNA using Hotstart Taq (Invitrogen) over 35 cycles. 
Ambion MEGAscript kit was used to generate dsRNA from cDNA in 10µl reactions 
according to the manufacturers protocol (1µl 10 x transcription buffer, 4µl 75mM 
ATP, GTP, CTP, and UTP mix, 4µl PCR product, 1µl T7 RNA polymerase enzyme 
mix). Reaction was incubated at 37°overnight and annealing was performed in a 
thermal cycler as follows: 90°C for 3min, ramp to 70°C with 0.1°C/sec, 70°C for 3 
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min, ramp to 50°C with 0.1°C/sec, 50°C for 3 min, ramp to 25°C with 0.1°C/sec. 
10µl dsRNA was then digested in 90µl dsRNA digestion buffer (pH 7.9 20mM Tris-
HCl, 0.5mM EDTA, 5mM MgCl2, 1mM DTT, 140mM NaCl, 2.7mM KCl, 5% (v/v) 
glycerol) plus 4µl Rnase III and incubated at RT room temperature for 4-5 hours. A 
2-4µl aliquot was run in 4% agarose (v/v) along with a 25bp DNA ladder marker to 
check the size range of digestion products. esiRNA RNA was then purified using 
BioRad MicroBio-spin chromatography columns to remove remaining DNA 
template, unincorporated nucleotides and longer dsRNAs. Purified esiRNA was 
resuspended in pH7.5 0.1mM Tris and stored at -80°C. 
 
2.4.6.2 Commercial small interference RNA (siRNA) 
Commercially available chemically synthesized siRNAs, specific to our genes of 
interest, were obtained from Dharmacon. Dharmacon Smartpool siRNAs, targeting 4 
different regions of specifc gene transcript, were in general used in the performed 
loss-of function experiments. 
 
 
2.4.6.3 Transfection of mES cells with siRNA 
siRNA/esiRNA was added in desired concentrations to 1.5ml tubes and made up to 
50µl with KO SR DMEM. In a second tube, Lipofectamine2000 (Invitrogen) was 
added (final concentration 1:500) and also made up to 50µl with KO SR DMEM. 
After 5 minutes the contents of both tubes were mixed and left on bench for 20 
minutes to allow for the formation of Lipofectamine-siRNA complexes. In the 
meantime, a single cell suspension was prepared, as described in 2.2.1 and added 
after 20 minutes to the Lipofectamine-siRNA mix. This cell mixture was then plated 
onto gelatin-coated multi-well cell culture dishes. Transfected cultures were 
maintained in humidified incubators at 37°C and 5% (v/v) CO2 over-night and 
medium was changed the following day. On day 3 after transfection RNA and/or 
Protein were harvested and expression of specific genes was analysed as described in 
sections 2.3.2 and 2.4.3.  
 
 
 
Chapter 2: Materials and Methods 
 
81 
 
2.4.7 Purification of plasmid DNA 
2.4.7.1 Phenol chloroform extraction 
The DNA containing solution was extracted with an equal volume of buffer saturated 
phenol:chloroform (1:1) and centrifuged for 1 minute at maximum speed in a 
microcentrifuge. The aqueous phase (top phase) was removed carefully to a clean 
tube and extracted with an equal volume of chloroform. This was centrifuged for 1 
minute and aqueous phase was removed. DNA was precipitated by ethanol 
precipitation. 
 
2.4.7.2 Ethanol precipitation of DNA 
0.1 volume of 3M sodium acetate (pH 5.2) and 2 volumes of 100% ethanol were 
added to the solution from which the DNA was to be precipitated. The mixture was 
placed at -20°C for at least 30 minutes, before the precipitated DNA was pelleted in 
a microcentrifuge at 4°C for 10 minutes at full speed. Ethanol was aspirated off and 
the pellet was washed in 70% (v/v) ethanol. Pellets were dried at room temperature 
and then resuspended in TE (10mM Tris-HCl pH 8.0, 0,1mM EDTA pH 8.0) or 
dH2O and stored at -20°C. 
 
2.4.7.3 Small-scale plasmid preparation 
 
Alkaline lysis protocol 
A single bacterial colony was picked and transferred to 3ml 2YT broth containing 
appropriate antibiotics. The culture was grown with vigorous shaking at 37°C 
overnight. 1ml of culture was transferred to an Eppendorf tube and pelleted for 1 
minute at full speed. The pellet was resuspended in 100l solution I (50mM glucose, 
10mM EDTA, 25mM Tris-HCl pH8.0). Then 200l of lysis solution II (0.2M 
NaOH, 1% (w/v) SDS) was added and the suspension incubated on ice for 5 
minutes. 150l of cold solution III (3M potassium acetate, 2M acetic acid) was 
added and mixture was incubated on ice for further 5 minutes after vortexing. Then 
debris was pelleted at full speed in a microcentrifuge at 4°C for 10 minutes. The 
supernatant was moved to a clean tube and the plasmid DNA was extracted using 
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phenol:chloroform extraction followed by ethanol precipitation (as described in 
sections 2.4.7.1 and 2.4.7.2). 
 
Macherey-Nagel Nucleospin protocol 
3ml of overnight bacterial culture was pelleted at 11000xg for 30 seconds and the 
pellet was resuspended in 250l cell buffer A1. Then 250l cell lysis buffer A2 was 
added and mixture was incubated for 5 minutes at room temperature. After addition 
of 300l stop buffer A3, lysates were clarified by centrifuging for 10 minutes at 
11000g. Supernatant was loaded in Nucleospin column and centrifuged at 11000g 
for 1 minute. Two washing steps followed with 500l buffer AW and 600l buffer 
A4, after each step columns were centrifuged for 1 minute at 11000g. Column silica 
membrane was dried by centrifuging for 2 minutes at 11000g and DNA was eluted 
with 50l of preheated (70°C) elution buffer AE. 
 
 
2.4.7.4 Large-scale plasmid preparation 
For large-scale plasmid preparation QIAGEN midi plasmid preparation kits were 
used, according to the manufacturer‟s guidelines. Briefly, 100ml of 2YT broth 
containing appropriate antibiotics were inoculated with a bacterial starter culture 
carrying the plasmid of interest. After culturing overnight, bacteria were pelleted in a 
Beckman M5 centrifuge with a JA-14 rotor at 5000rpm for 10 minutes. The 
supernatant was discarded and the pellet was resuspended in 4ml buffer P1. Then 
4ml of lysis buffer P2 were added and the solution was carefully mixed by inverting 
the tube and placed on ice for 15 minutes. Chilled stop buffer P3 was added (5ml) 
and mixture was centrifuged for 30 minutes at 15500rpm in the JA-20.1 rotor at 4°C. 
QIAGEN column 100 was equilibrated with 4ml QBT buffer before supernatant was 
moved to column. After washing twice with 10m QC buffer, DNA was eluted with 
5ml of buffer QF. The DNA was then extracted by ethanol precipitation (2.4.7.2). 
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Table 2.11 Plasmids used in this study 
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2.4.8 Manipulation of DNA 
2.4.8.1 Restriction enzyme digest 
New England Biolabs (NEB) restriction enzymes were used and are provided with 
the appropriate 10x buffer and if required with a 10x BSA stock. Digests were 
typically performed in a 10 or 20l reaction volume containing 10% (v/v) restriction 
enzyme and 10% (v/v) enzyme buffer, 1-5l of DNA to be cut and water to make up 
to 10 or 20l of total reaction volume. Digests were incubated at 37°C for 1 hour to 
overnight.  
 
2.4.8.2 Ligation 
Ligations of DNA fragments were performed with NEB T4 DNA ligase in a 10 or 
20l total reaction volume. 1l 10xT4 DNA ligase buffer, 100ng digested vector, 
DNA insert in a molar ratio of 3:1 (insert : vector), distilled water to 9ul and 1ul T4 
DNA ligase were mixed in a 1.5ml eppendorf tube and incubated at 16°C for at least 
1 hour.  
 
2.4.8.3 Sequencing 
DNA plasmids were prepared by the miniprep method (2.4.7.3) and sent together 
with sequencing primers to the Biochemistry Department of Oxford University for 
sequencing. Sequence analysis was performed with ApE plasmid Editor v1.17 or 
Clone Manager 9 Professional. 
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Table 2.12 Primers used for cloning in this study 
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2.4.9 Expansion of plasmid DNA 
2.4.9.1 Preparation of competent E. coli strain DH5
Bacteria from a frozen stock of the E. coli DH5were streaked out onto a fresh 2YT 
agar plate (16g Bactotryptone, 10g yeast extract, 10g NaCl, 15g bacto-agar made up 
to 1l and autoclaved). This plate was incubated inverted at 37°C overnight and the 
following day a colony was picked and transferred to a 4ml LB (10g tryptone, 5g, 
yeast extract, 10g NaCl) and cultured at 37°C overnight . The overnight culture was 
added to 1l pre-warmed LB medium and grown in a shaking incubator to an OD600 
of 0.5. Culture was then placed at 4°C for 30 minutes and subsequently centrifuged 
with a swing-out rotor at 5000g for 5 minutes at 4°C. Supernatant was discarded and 
pellet was resuspended in 100ml of ice cold 0.1M CaCl2. After at least 1 hour of 
incubation on ice, the mixture was added to 100% glycerol so that the final 
concentration was 17.5% (v/v). The mixture was aliquoted and snap frozen in a dry-
ice/ethanol bath and stored at -80°C. 
 
 
2.4.9.2 Transformation of E. coli strain DH5
Competent cells were thawed at room temperature and placed on ice for about 10 
minutes. DNA was added to a concentration of less than 100ng per 200l of cells 
and incubated on ice for 20 minutes. Cells were heat shocked at 42°C for 45 seconds 
and returned on ice for 1 minute. 4 volumes of LB medium were added and cells 
were placed in a water bath at 37°C for one hour. Required amounts were plated 
onto 2YT agar plates containing for selection necessary antibiotics and plates were 
incubated inverted at 37°C for 16-18 hours. 
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2.4.10 Electroporation 
After trypsinisation murine ES cells were washed three times with sterile PBS w/o 
Ca
2+
 and Mg
2+ 
and resuspended at a concentration of ~1x10
7 
cells per 0.8ml. 0.8ml 
were transferred into electroporation cuvette and 20g linearized DNA plasmid was 
added. Electroporation was performed at 3F/800V with a Bio-Rad Gene Pulser. 
Episomal vectors were electroporated as circular DNA with a pulse at 960F/200V. 
The pulsing cuvette was transferred onto ice for 5 minutes, before cells were seeded 
in ES cell medium supplemented with 1% (v/v) Hyclone FCS at a concentration of 
2x10
6
 cells/90mm plate. The next day, medium was changed and appropriate drugs 
required for selection also added.  
 
When colonies were clearly visible (7-10 days after electroporation), colonies were 
picked. Therefore, medium was aspirated and plates were washed with PBS and 5ml 
of PBS were added to dish. 10l of trypsin-EDTA were added to each well of a 
round bottom 96-well plate. Colonies were picked with a pipette and placed into 
prepared trypsin-EDTA wells. 100l of ES medium was used to resuspend the 
colonies by gentle pipetting and cells were transferred to individual wells of cell 
culture trays. Clones were then expanded for screening and freezing. 
 
 
2.4.11 Screening clones for tetracycline regulated expression 
G418 (Tet-off) resistant clones were expanded in the presence of 1g/ml 
tetracycline) and hygromycin (Tet-on) resistant clones were expanded in absence of 
doxycycline. Cells were washed 2x with PBS, trypsinised and plated out at 5x10
4
 
cells/ml in presence or absence of 1g/ml tetracycline/doxycycline in 48-well plates. 
Protein samples were taken at various time intervals up to 72 hours later by direct 
addition of Laemmli Lysis Buffer (2% (w/v) SDS, 10% (v/v) Glycerol, 60mM Tris 
pH6.8, 0.1M DTT, Bromophenol blue). Samples were placed on ice immediately, 
before boiling for 5 minutes. Samples were freeze/thawed at least once to shear 
genomic DNA, and subjected to SDS-PAGE to determine expression of the protein 
of interest. Following immunoblotting with the anti-V5 (Tet-off) or anti-GFP (Tet-
on) epitope tag antibodies, clones showing the most robust and inducible expression 
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of the protein of interest were selected, expanded, frozen down (2.1.2.2) and stored 
in liquid nitrogen for further use. 
 
 
2.4.12 PiggyBac transposon/transposase system 
The piggyBac (PB) transposon/transposase system is host-factor independent and 
only requires inverted terminal repeats at both ends of the transgene and the transient 
expression of the transposase enzyme which catalyses the insertion/excision (Fraser 
et al., 1996). It has been used successfully in ES cells and for the establishment of 
iPS cells (Cadinanos and Bradley, 2007; Kaji et al., 2009; Woltjen et al., 2009).  
 
One day before transfection 2x10
4
 cells/well were plated in 12-well cell culture 
trays. The following day, 1g of piggyBac vector containing the transgene under a 
CAG promoter (pPB-X) and 1g transposase expressing helper plasmid (pCAG-
PBase) were mixed in 25l of GMEM without serum. 25l Lipofectamine2000 
dilution (2l Lipofectamine2000 plus 23l GMEM) was added and the mix was 
incubated at room temperature for 10 minutes. Then 450l GMEM plus FCS were 
added and mixture was transferred to one well of the prepared 12-well plate. After 3 
hours of incubation, mixture was aspirated and 1ml fresh ES cell media (GMEM + 
FCS) was added per well. The successive day, medium was changed and appropriate 
antibiotics for selection were added. After three days of culture, mESCs were 
replated into 6-well cell culture plates at a density of 1x10
4
 cells/well and 2x10
3
 
cells/well in selection media. When colonies were clearly visible, they were 
expanded and frozen as described (2.1.2.2).  
 

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3.1 Introduction 
The class IA phosphoinositide 3-kinase (PI3K) family of lipid kinases regulate a 
variety of physiological responses and were previously reported to play an important 
role in proliferation and maintenance of self-renewal in mESCs (Jirmanova et al., 
2002; Kingham and Welham, 2009; Paling et al., 2004; Takahashi et al., 2003; 
Watanabe et al., 2006). Nanog, one of the major players in regulating ESC self-
renewal, was identified as a molecular target downstream of the PI3K pathway, and 
appears to be regulated in GSK-3 dependent manner (Storm et al., 2007).   
The aim of this part of the study was to identify novel genes involved in PI3K-
dependent regulation of mESC behaviour, initially based on a microarray screen 
previously performed in our laboratory. With this approach it was hoped to further 
delineate the molecular mechanisms of PI3K involvement in self-renewal of ESCs, a 
process that gained major attention through the establishment of iPS cells. With the 
rapid development of microarray technology in the last decade, it is now possible to 
perform global analyses on the expression of thousands of genes within the same 
sample simultaneously. Thus, RNA samples of mES cells treated with the PI3K 
inhibitor LY294002 over a defined time-course of 72h were used to perform 
expression profiling with Affymetrix GeneChips. Using filtering of greater than 1.5-
fold change in expression and an analysis of variance significance level of p < 0.05, 
a dataset was defined comprising 646 probe sets that detect changes in transcript 
expression (469 down and 177 up) on inhibition of PI3Ks. An initial hierarchical 
clustering of the 646 probe sets suggested that the dataset falls into 12 groups. This 
was used to cluster the data using k-means (k=12), and the corresponding heatmap is 
shown in Figure 3.1A. The 20 genes showing the most statistically significant 
changes in gene expression are shown in Figure 3.1B. Expression patterns of genes 
of interest (see below for selection criteria) were validated by qRT-PCR and in 14 
out of 16 cases, highly comparable expression patterns were measured by both 
microarray and qRT-PCR. In the other two cases, expression was similar, indicating 
a high degree of agreement between the two approaches. Figure 3.1C shows 
quantitative RT-PCR validation examples for Zscan4 and Shp-1.  
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Figure 3.1 Clustering and gene ontology analyses of gene expression changes 
occurring in embryonic stem (ES) cells upon inhibition of phosphoinositide 3-
kinases (PI3Ks). (A) k-means clustering of 646 probe sets into 12 clusters. (B) 
Probe sets with the 20 highest significance scores in the dataset are presented. The 
Affymetrix probe set ID is shown along with the ANOVA value and FC in 
expression between controls and LY294002-treated samples at each time point. (C) 
ES cells were cultured in the presence of leukemia inhibitory factor plus or minus 
5M LY294002 for the times indicated. Expression of Zscan4 and Shp-1 was 
analysed by quantitative reverse transcription polymerase chain reaction, and target 
gene expression was normalised relative to -actin levels. The averages and ±SEM 
of duplicate samples from each of three independent biological replicates are shown: 
*, p < .05; **, p < .005; ***, p < .0005, in a Student‟s t test.  
Microarray screen was performed prior to the start of this study by M. Storm and 
partners of the FunGenEs consortium (www.fungenes.org). (Storm et al., 2009). 
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3.2 Microarray analyses and data mining 
Microarray-based expression analyses are a powerful technology with huge potential 
to accurately detect transcriptional changes and provide detailed genome-wide 
molecular signatures of cellular states. The downside of this type of analysis is the 
large amount of data generated, which makes it very difficult to identify key 
functional regulators of the investigated biological processes. Therefore, it is 
necessary to apply computational analyses and data mining to aid the identification 
of targets that are of interest and to address the challenge of understanding specific 
biological phenomena. Analysis of microarray datasets encounters a number of 
challenges for data mining, the biggest of which is probably the finding of false 
positive probe set changes and, therefore, it is important to develop robust methods 
and validate the established models. A thorough selection of genes is crucial and can 
be done by attributing selection criteria, most strongly related to predicted classes. 
The clustering of genes showing similar patterns of expression, for example 
according to hierarchy, can reveal some interesting trends and help to determine key 
components of the genetic signature. 
 
3.2.1 Selection of Genes of interest 
To focus further functional analyses on the most promising candidates that could be 
playing a role in regulating mES cell self-renewal, downstream of PI3K signalling, 
additional selection criteria were applied to the significant probe set changes of the 
Affymetrix GeneChip expression analyses described. Briefly, the following criteria 
were applied; (a) significant downregulation within 24-48h of PI3K inhibition; (b) 
predicted to function as transcription factors; (c) predicted or known to be signalling 
pathway components; (d) genes with unknown function and (e) genes with 
expression restricted to early development. A preliminary loss-of-function screen, 
using esiRNAs generated to our target genes (Kittler et al. 2004) (2.4.6.1), was 
performed on 21 genes obtained with the described selection criteria (M. Storm, 
unpublished data). A list of seven genes (summarized in Table 3.1), namely 
AF067061, 1700061G19Rik, Ypel2, Baz1a, Shp-1, LOC327811 and Zscan4c, was 
established based on the outcome of the pre-screen, which had indicated their ability 
to reduce ES cell self-renewal. AF067061 belongs to the 2-cell-stage gene family 
and its precise function is to date unclear.  1700061G19Rik, appears to have 
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sequence identities with acyl-CoA synthetases of other species, suggesting it is most 
likely involved in lipid metabolism. Ypel2 encodes a putative zinc-binding protein 
found in association with mitotic spindles or the centrosome, highlighting a potential 
function in cell division (Hosono et al., 2004). YPEL family proteins have been 
shown to be present in effectively all eukaryotes and are therefore likely to play 
important roles in the maintenance of life. Baz1a encodes a protein with a 
bromodomain adjacent to a zinc finger domain. The bromodomain is a structural 
motif that is found in proteins involved in chromatin remodelling to regulate 
transcription. They commonly act in complexes with other proteins and frequently 
possess histone acetyltransferase activity (Bochar et al., 2000; Jones et al., 2000). 
Shp-1 encodes a protein tyrosine phosphatase which has been reported to be part of a 
signalling complex downstream of the stem cell factor receptor c-kit (Paulson et al., 
1996). It is known to be involved in the control of cellular proliferation and survival 
in other cell types (Bone et al., 1997) and was therefore considered to be a promising 
candidate. LOC327811, now annotated as Gm4340, is full-length protein coding and 
predicted to be THO complex 4-like, though nothing is reported about its exact 
function to date. The THO complex plays a role in transcription elongation as well as 
in the further formation and assembly of the mature messenger ribonucleoproteins 
(mRNP).  Binding of the THO complex to specific mRNA export factors recruits 
these export factors to the mRNA during transcription (Ho et al., 2002; Zenklusen et 
al., 2002). Possibly, LOC327811 could be part of a similar mechanism due to its 
predicted structure. Zscan4c, also known as Gm397, is a member of the Zscan4 
family. This family of proteins comprise a SCAN domain, which is a Leucine rich 
element and a highly conserved motif specific to vertebrates, and four zinc finger 
domains, usually responsible for DNA interaction (Falco et al., 2007). Other 
members of the family of the SCAN domain containing zinc finger proteins (SCAN-
Zfps) act as transcription factors and have been previously described to be involved 
in cell survival and differentiation (Edelstein and Collins, 2005). A more detailed 
description of the Zscan4 family is given in section 1.8. 
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Table 3.1 Summary of Genes of Interest (GOI)
 
 
3.2.2 Identification of signalling pathways downstream of PI3Ks involved in 
regulation of genes of interest 
PI3K signalling normally suppresses activity of GSK-3 via Akt, and therefore PI3Ks 
activity can be mimicked partly by artificial inhibition of GSK-3. It was 
demonstrated previously that PI3K-dependent inhibition of GSK-3 activity is 
involved in the regulation of Nanog gene and protein expression (Storm et al., 2007). 
To investigate if other genes identified by the microarray screen are regulated in a 
similar manner, the pharmacological inhibitors BIO and LY294002 were used for the 
inhibition of GSK-3 and PI3Ks respectively, both separately and in combination, to 
determine whether genes are regulated in a GSK-3-dependent manner (Figure 3.2 
A).  Based on these findings, it was of interest to determine if there was a 
relationship between common pathways regulating GOIs and their respective 
expression clusters. As expected, expression of all our genes of interest dropped 
significantly on inhibition of PI3Ks, confirming robustness of the Affymetrix dataset 
(Figure 3.2 B). Zscan4, AF067061, LOC327811, and Baz1a are all members of 
Cluster 1 and importantly their expression patterns after treatment with PI3K and 
GSK-3 inhibitors follows a similar trend. Interestingly, inhibition of GSK-3 was not 
able to overcome the effect of PI3K inhibition, suggesting that regulation of these 
genes is independent of GSK-3 (Figure 3.2 B). In contrast, inhibition of GSK-3 was 
able to overcome the effects of PI3K inhibition on expression of Shp-1 and 
1700061G19Rik (clusters 11 and 4, respectively), restoring the expression back to 
control levels in the presence of LIF alone. Consistent with this finding is the 
previous report that Nanog (also member of cluster 11) protein expression is 
regulated in an identical manner (Storm et al., 2007), reflecting the GSK-3 
dependency of all three genes of interest.  
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Figure 3.2 Glycogen synthase kinase 3 (GSK-3)-dependent and independent 
mechanisms are involved in the control of expression of phosphoinositide 3-
kinase target genes. (A) Schematic diagram of the action of PI3Ks on GSK-3 
activity and the inhibitors used to determine downstream gene regulation. (B) 
E14tg2a embryonic stem cells were cultured in the presence of LIF plus or minus 
5M LY294002, plus or minus 2M of the GSK-3 inhibitor BIO for 72 hours. 
Expression of selected genes was analysed by quantitative reverse transcription 
polymerase chain reaction, and target gene expression was normalised relative to -
actin levels. The averages and ±SEM of duplicate samples from each of two 
independent biological replicates are shown: *, p < .05; **, p < .005; ***, p < .0005, 
in a Student‟s t test.  
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Expression of Ypel2, mapping to cluster 10, was inhibited by either LY294002 or 
BIO, whereas addition of both together had no additive effect, suggesting a more 
complex pattern of regulation.  
 
GSK-3/double-knockout (DKO) ESCs show constitutively activated Wnt/-
catenin signalling (Doble et al., 2007) and were used to further confirm GSK-3 
dependency of regulation of selected genes. Zscan4 and AF067061 expression, 
earlier suggested to be GSK-3 independent, were also downregulated after inhibition 
of PI3K with LY294002 in GSK-3 DKO cells, confirming a GSK-3 independent 
regulation mechanism (Figure 3.3 A). Expression of both genes was also affected 
following treatment with the p110 selective inhibitor PIK-75, indicating regulation 
via this PI3K isoform, which will be discussed in more detail in section 3.4.1. Nanog 
and 1700061G19Rik, both from the regulation cluster 11 and postulated to be 
regulated by GSK-3, were neither downregulated by broad inhibition of PI3Ks with 
LY294002, nor by the more selective PIK-75 inhibitor, affirming an upstream 
regulation by GSK-3 (Figure 3.3 B). 
 
A summary of the inspected genes, including their cluster mapping, heatmap and 
their postulated regulation mechanisms are shown in Figure 3.4. Overall, these data 
suggest that PI3K signalling regulates changes in gene expression via both GSK-3-
dependent and independent processes. 
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Figure 3.3 Regulation of phosphoinoside 3-kinase target genes in GSK-3 double 
knock-out (DKO) mES cells. GSK-3 DKO mES cells were cultured in the presence 
of LIF plus or minus 5M LY294002 and plus or minus 25nM of the p110 specific 
inhibitor PIK-75 for 72 hours. Expression of selected genes was analysed by 
quantitative reverse transcription polymerase chain reaction, and target gene 
expression was normalised relative to -actin levels. (A) Gene members of Cluster 1 
and (B) Cluster 11 are pictured. The averages and ±SEM of duplicate samples from 
each of two independent biological replicates are shown:      *, p < .05; **, p < .005, 
in a Student‟s t test. 
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Figure 3.4 Overview of genes of interest and their regulation. This figure shows a 
summary of the analysed genes for GSK-3-dependent and independent regulation. 
Gene names, correlating probe sets of the affymetrix microarray screen, heatmap of 
the probe set changes, and their respective cluster are pictured.  
 
 
3.3 Functional Analysis of PI3K-Target Genes in Control of ES Cell Fate 
Several known regulators of self-renewal, i.e. Nanog, Tbx-3, Essrb, Klf2 and 4, were 
among the probe sets in the dataset that significantly changed, suggesting their 
regulation downstream of PI3Ks. A main aim of these studies was to determine the 
biological function of our selected genes of interest, in respect of their ability to 
maintain ES cell identity. An siRNA loss-of-function strategy was our first choice to 
investigate a potential role of our candidates in control of mES cell fate. RNA 
interference has been used by other groups to successfully identify genes that were 
previously not associated with maintaining mES cell self-renewal (Ivanova et al., 
2006).  
Two different types of siRNA, endoribonuclease-prepared siRNA (esiRNA) (Kittler 
et al., 2004) for initial screening and commercially available siRNA from 
Dharmacon, were used for gene silencing experiments. Both methods showed 
comparable results following transient transfection, though Dharmacon siRNA 
appeared to be more robust. This is possibly because in-house preparation of 
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esiRNAs on a small scale resulted in higher batch to batch variations. Dharmacon 
siRNAs of two different types were used, Smartpool siRNA, which is a pool of four 
single siRNAs targeting different regions of the same mRNA, and Dharmacon 
siRNA targeting only a single site of the specific mRNA. The use of a variety of 
different siRNA sources, targeting different regions of the same mRNA, reduces the 
risk of false positive findings, which might occur when siRNAs downregulate 
unexpected off-targets. Off-target effects upon use of siRNAs occur for instance by 
the binding of siRNA to mRNA with incomplete complementarity, which leads to 
undesired silencing of these genes, baring the risk of false positive data. Products 
like Smartpool siRNA ensure efficient knock-down, as all four siRNAs target the 
same gene, whereas off-target effects should be lower, but broader because the 
number of complementary binding sequence homologies are higher. Non-targeting 
Dharmacon siRNA was selected as a control and to establish siRNA toxicity effects, 
not associated specifically with silencing of targets. The homeodomain transcription 
factor Nanog, widely accepted as a key regulator of self-renewal, was selected as a 
postive control during siRNA experiments (Figure 3.5 A) (Chambers et al., 2003; 
Mitsui et al., 2003). 
This study focused on elucidating the function of Zscan4, AF067061, Ypel2, Baz1a 
and 1700061G19Rik using siRNAs targeting each of these genes and subsequently 
assessing their loss-off-function effect by a clonal assays, based on alkaline 
phosphatase staininng. In this self-renewal assay, differentiated colonies remain 
unstained, exhibiting a flattened morphology, while self-renewing colonies are dome 
shaped and stain violet. Differentiated and undifferentiated colonies are scored, 
which allows for quantification of the loss-off-function effect of the targeted gene. 
Despite achieving up to 80% reduction in expression of AF067061, and Baz1a, using 
Smartpool siRNAs (Dharmacon), no consistent significant effects on self-renewal in 
the presence of LIF and serum were observed (Figure 3.5 B). This was also observed 
for 1700061G19Rik, and Ypel2, but caution has to be taken, as knockdown 
efficiency was below 50%. No significant change in total number of colonies was 
observed upon siRNA knockdown. However, transient knock-down of Zscan4 
resulted in a reduction of self-renewal ability compared to control (see 3.3.1).  
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Figure 3.5 siRNA-mediated knockdown of Nanog, AF067061, Baz1a, 
1700061G19Rik, and Ypel2. (A) Knockdown of Nanog was used as a positive 
control. (i) Subsequent analysis of Nanog transcript expression was analysed by 
quantitative RT-PCR. (ii) Nanog protein expression was analysed by 
immunoblotting. 20µg of protein/sample were immunoblotted using Nanog 
antibodies. All blots were stripped and reprobed with anti-Shp2 antibodies to assess 
loading. (NTC = Non Targeting Control). (iii)  SiRNA-mediated Nanog expression 
knockdown leads to more differentiated colonies upon AP staining; a representative 
experiment is shown. (B) Knockdown of (i) AF067061, (ii) Baz1a, (iii) 
1700061G19Rik and (iv) Ypel2 did not significantly reduce the ability of embryonic 
stem (ES) cells to self-renew, as assessed by the alkaline phosphatase ES cell colony 
staining assay. Values correspond to the average ±SEM from three independent 
biological experiments, and significance was determined using a Mann-Whitney test. 
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3.3.1 Identification of Zscan4 involved in regulating self-renewal of mESCs 
Transient knockdown of Zscan4 with Smartpool siRNAs led to a consistent and 
significant reduction in the percentage of self-renewing colonies, compared to non-
targeting siRNA, shown in Figure 3.6 A. Zscan4 transcripts were decreased by 
approximately 80% compared to normal levels, after lipofection of Dharmacon 
targeting siRNA, assessed by quantitative RT-PCR (Figure 3.6 B). A single siRNA 
targeting the 3‟ untranslated region of Zscan4c also led to a reduction in alkaline 
phosphatase positive, self-renewing colonies, although this was less marked than 
with the siRNA pool. Comparable results were obtained with in-house generated 
esiRNAs (experiments performed by M. Storm; not shown). Consistent with this 
reduction in the number of alkaline phosphatase positive colonies, knockdown of 
Zscan4 also led to reduction in expression of markers of pluripotency, including 
Nanog, Oct4, and Rex1 (Fig. 3.6 B). The loss of these pluripotency associated genes 
was typically in the range of 30-40%, while the reduction of alkaline phosphatase 
positive self-renewing colonies was in the range of 10-20%. 
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Figure 3.6 siRNA-mediated knockdown of Zscan4 reduces the ability of 
embryonic stem (ES) cells to self-renew. Smartpool siRNA targeting the Zscan4 
family (pool), a single siRNA targeting the 3‟ untranslated region of Zscan4 (siRNA 
3‟) or NTC siRNA, were transiently transfected into E14tg2a ES cells. A 
concentration of 50nM for each siRNA was used. Three days post-transfection cells 
were replated at low density and self-renewal measured after a further 4 days. (A) (i) 
Photographic images of representative colonies are shown (scale bar is 200m) and 
(ii) the percentage of self-renewing, alkaline phosphatase positive colonies 
presented, with the values corresponding to the average ±SEM of three independent 
experiments. (B) (i) Knockdown of Zscan4, Rex1, Oct4, and Nanog transcripts was 
monitored by quantitative reverse transcription polymerase chain reaction and target 
gene expression was normalised relative to -actin levels. Values correspond to the 
average ±SEM from three independent biological experiments, and significance was 
determined using a Student‟s t test. *, p < 0.05; **, p <0 .01. (ii) Data of (B)(i) 
normalised to NTC = 100. 
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3.3.2 Behaviour of Zscan4 upon differentiation 
With the finding that Zscan4 plays a potential role in the regulation of ES cell 
pluripotency, it was of interest to examine how Zscan4 expression behaves in the 
transition from a pluripotent to a differentiated state. Zscan4 was previously 
published to be exclusively expressed in 2-cell stage embryos, with to date no 
transcripts of Zscan4 detected in any other in vivo cell type (Falco et al., 2007). Its 
re-expression in pluripotent embryonic stem cells, comes therefore as a surprise, 
with their in vivo counterpart, the inner cell mass cells of the blastocyst, not 
expressing Zscan4 at a detectable levels  (Falco et al., 2007).   
ES cells cultured in presence of serum and LIF under feeder-free conditions, 
expressed Zscan4, as measured with quantitative RT-PCR (Figure 3.7 B). For 
induction of differentiation either simple LIF withdrawal or an embryoid body (EB) 
differentiation assay were performed (Figure 3.7 A). EBs are cell aggregates, which 
allow the  initiation of differentiation of pluripotent ES cells, and  because of the 
three dimentional culture environment cells begin to a limited extent to recapitulate 
embryonic development (Martin and Evans, 1975). After induction of differentiation 
by embryoid body formation, Zscan4 levels drop dramatically compared to starting 
levels,  to about 6.75% after four days and 1.25% after six days (Figure 3.7 B (i)). 
Concurrent with the drop of Zscan4 levels, was the expected drop of Nanog 
expression, reflecting the differentiation induction, though the decline appeared to be 
slower as on day 4 levels had dropped only to ~23% and on day 6 to ~2% of the 
respective starting levels (Figure 3.7 B (ii)). A similar decline of Zscan4 expression 
could be detected at the protein level, when differentiation was induced by 
withdrawal of LIF, leading to a complete deprivation of Zscan4 protein after 4 days 
(Figure 3.7 C). 
GSK-3 is implicated in playing an important role in maintaining ESC self-renewal, 
shown by the use of pharmacological inhibitors and by genetic deletion of the two 
isoforms,  and , of GSK-3 (Bone et al., 2009; Doble et al., 2007; Sato et al., 
2004). Inhibition, as well as deletion, of GSK-3 enhances mouse ESC self-renewal 
and pluriopotency and therefore it was of interest to determine whether Zscan4 
expression is affected by either of these two forms of reducing GSK-3 activity. To 
assess the long-term effect of GSK-3 inhibition by pharmacological inhibitors, 
mESCs were cultured in presence of the GSK-3 inhibitors BIO or 1M for 14 days. 
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Long-term inhibiton of GSK-3 almost doubled the expression of Nanog (Figure 3.7 
B (ii)) compared to control, indicating an increase in self-renewal. Zscan4 expression 
also rose upon GSK-3 inhibition, but it is noteworthy that inhibition with the more 
specific GSK-3 inhibitor, 1M, resulted in an augmented elevation by about 225% 
compared to control, whereas the less specific inhibitor BIO increased expression by 
only 24%, which were statistically insignificant. It could be speculated that lower 
potency or off-target effects of BIO, such as inhibition of Erk (Bone et al., 2009), 
could influence regulation of Zscan4, and indeed preliminary experiments showed a 
reduction of Zscan4 when Erk was inhibited with the inhibitor U0126 (Figure 3.7 D). 
In addition to the small molecule inhibitor approach, GSK-3 DKO mES cells were 
analysed for the expression of Zscan4 protein, in comparision to E14tg2a wild-type 
control cells. The findings of these experiments support the inhibitor data, as Zscan4 
protein levels are markedly higher in mES cells with ablated GSK-3 loci. 
Nevertheless, these cells still respond to LIF withdrawal, in respect of a complete 
loss of Zscan4 expression over 4 days (Figure 3.7 C). These findings are of interest 
with regard to the PI3K cascade being critical in regulating GSK-3 activity via Akt 
mediating phosphorylation of Ser9/20 of GSK-3 / respectively, leading to GSK-3 
inactivation (Welham et al., 2011).  
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Figure 3.7 Monitoring expression of Zscan4 upon induction of differentiation. 
(A) Illustration of differentiation by (i) the embryoid body (EB) formation assay in 
presence of methylcellulose and absence of LIF or (ii) induction of differentiation in 
monolayers by LIF withdrawal. (B) E14tg2a embryonic stem cells were cultured in 
the presence of LIF as a control and in the presence of the GSK-3 inhibitors BIO 
(0.5M) or 1M (2M) for 14 days. RNA of day 4 (d4) and day 5 (d5) EBs was 
extracted and (i) Zscan4 and (ii) Nanog expression was analysed by quantitative 
reverse transcription polymerase chain reaction. Target gene expression was 
normalised relative to -actin levels. The averages and ±SEM of duplicate samples 
from each of two independent biological replicates are shown. (C) Immunoblot of 
E14tg2a and GSK-3 DKO lysates of mES cells grown over a 4-day LIF withdrawal 
time-course. Blots were probed with a Zscan4 antibody then reprobed with a Gapdh 
antibody to check for equal loading. (D) Quantitative RT-PCR of Zscan4 expression 
upon treatment with PI3Ks inhibitor LY294002 and/or MEK inhibitor U0126. (n=1). 
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3.3.3 Zscan4 expression in iPS cells 
The notion that induced pluripotent stem (iPS) cells gain expression of Zscan4 
during their reprogramming is of special interest (Takahashi and Yamanaka, 2006). 
With the recent publication reporting that Zscan4 plays a role in genome 
maintenance (Zalzman et al., 2010), it can be considered that Zscan4 is a key 
regulator in pluripotent stem cells, controlling both their genomic stability and their 
self-renwal ability (Welham et al., 2011). How and when exactly Zscan4 is re-
expressed during ES cell derivation from inner cell mass cells of the blastocyst, not 
expressing Zscan4, as well as during iPS cell generation, remains to be elucidated. 
To verify expression of Zscan4 in iPS cells  and to compare the levels with mES cell 
levels, quantitative RT-PCR was performed on samples taken of each. Both, mES 
and iPS cells express Zscan4 at comparable levels (Figure 3.8 A), and also Nanog 
levels are in a similar range, which is entirely consistent with the literature (Figure 
3.8 B). 
 
 
 
Figure 3.8 Zscan4 expression in mouse iPS cells. Quantitative RT-PCR was 
conducted to detect expression of Zscan4 and Nanog in E14tg2a mESCs and mouse 
iPS cells. The averages of duplicate samples and standard deviations from each of 
two independent biological replicates are shown. 
 
 
Chapter 3: Results 
107 
 
3.4 PI3Ks catalytic isoforms in mES cells 
PI3Ks have been implicated in the regulation of both ESC proliferation and self-
renewal (Kingham and Welham, 2009; Paling et al., 2004; Takahashi et al., 2003).   
It is noteworthy that PI3Ks of the class IA sub family, which are predominantly 
linked with mESC fate, are already expressed from as early as the one cell stage  of 
development and remain expressed through to the blastocyst stage of murine 
preimplantation embryo development (Riley et al., 2005). With Zscan4 being 
regulated downstream of PI3Ks, one aim of this part of the study was to investigate 
whether its regulation is coupled to a specific isoform of PI3Ks. Recent advances in 
the development of selective, cell-permeable, small molecule inhibitors provide a 
useful toolbox to study the different catalytic subunits of PI3Ks. These inhibitors 
typically interact in a reversible manner with the ATP binding pocket of the PI3K 
catalytic isoforms, competing directly with the substrate ATP. From the repertoire of 
available inhibitors we selected a few specific inhibitors to investigate the regulation 
of Zscan4 downstream of the p110,  and  isoforms. 
Two structurally distinct p110 inhibitors, namely PIK-75 and Compound 15e, were 
used to determine a possible role for p110 in the regulation of Zscan4. PIK-75 was 
characterised as a selective p110 inhibitor and was reported to inhibit p110 with 
an IC50 of 5.8nM (Knight et al., 2006). Besides inhibition of p110α, PIK-75 also 
inhibited DNA-PK with an IC50 of 2nM, but not mTORC1 (IC50=1M) or mTORC2 
(IC50=10M) at the typically applied concentration of 25nM (Dagia et al., 2010; 
Hers, 2007; Kim et al., 2009b; Marone et al., 2008). The other selective p110 
inhibitor, compound 15e, inhibits the catalytic alpha isoform with an IC50 of 2nM, 
while off-target effects of other isoforms are at higher concentrations (IC50: 
p110=16nM; p110=660nM). It was identified to inhibit growth of various 
cancerous cell lines like A375 melanoma cells (IC50=0.58µM), U87MG human 
glioblastoma cells (IC50=1.10.µM), A2780 human ovarian cells (IC50=0.27µM), and 
might be a potential anti-tumour compound (Folkes et al., 2008; Hayakawa et al., 
2006). 
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To assess the contribution of the p110isoform to regulation of Zscan4, TGX-121 
and the more potent TGX-221 inhibitors were used (Jackson et al., 2004; Robertson 
et al., 2001). TGX-221 was used previously to assess PI3K signalling and helped to 
elucidate a function of p110 in platelet activation, defining p110 as an important 
new target for antithrombotic therapy (Jackson et al., 2005). TGX-121 was described 
to have an IC50 of 50nM, while the more potent TGX-221 had an IC50 in the range of 
5-50nM, depending on the ATP concentrations of 50M and 1mM (Jackson et al., 
2005). For TGX-121 undesired inhibition of p110is describedwith an IC50 of 5M 
(Robertson et al., 2001), and TGX-221 also inhibits p110 (IC50= 5μM) and p110 
(IC50= 10μM) (Jackson et al., 2005). 
IC87114 was the first isoform-selective PI3K inhibitor described and was shown to 
be highly specific for the p110 isoform (Sadhu et al., 2001). In cell studies IC87114 
was used to inhibited p110 to establish a selective role in neutrophil polarization 
and directional migration at doses of 5-10μM (Sadhu et al., 2003). IC50 values of 
~60nM for p110, and >1M for p110+, were determined using PI3K lipid kinase 
assays on multiple preparations of recombinant protein (Chaussade et al., 2007). 
IC87114 is a very “clean” inhibitor, not targeting ATM, DNA-PK, ATR, and mTOR, 
even at high concentrations of 100M (Chaussade et al., 2007). 
 
A brief summary, including the chemical structures of all PI3K inhibitors used in 
this study are summarised in Table 2.2. Furthermore, a simple illustration shows the 
p110 specific inhibitors and their targets in Figure 3.9 A. Drawbacks of small 
chemical inhibitors are possible off-target effects, mostly on structural similar 
proteins, and it is therefore important to consider these carefully. Furthermore, IC50 
values are often obtained in cell-free assays, and a change of conditions can result in 
different values. For example, when ATP-competitive inhibitors are tested in kinase 
assays the IC50 varies, depending on the ATP concentration. In addition, there are 
many other factors that can cause variability, for instance inhibitor stability under 
cell culture conditions, cell permeability, differences in cell types, just to mention a 
few.  
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3.4.1 Contribution of specific PI3Ks isoforms in regulating Zscan4 
Murine ESCs were incubated with the pharmacological inhibitors, PIK-75, TGX-
121, TGX-221 or IC87114, for 48h in the presence of serum and LIF to inhibit the 
respective p110 isoforms (Figure 3.9 A). The broad spectrum PI3K inhibitor, 
LY294002, was used as positive control. Inhibitors were applied in typical 
concentrations for mESCs, based on the experience of work conducted in the 
Welham laboratory (Kingham and Welham, 2009). Quantitative RT-PCR analyses 
revealed a significant downregulation of Zscan4 expression upon treatment with 
LY294002, as expected from the microarray data. Interestingly, PIK-75 was the only 
specific catalytic isoform inhibitor to induce downregulation of Zscan4 expression, 
indicating regulation occurs solely through p110.  Neither of the two p110 
inhibitors, TGX-121 or TGX-221, nor the delta inhibitor IC87114 appeared to alter 
Zscan4 expression (Figure 3.9 B). 
Potential cumulative effects resulting from the combination of the different isoform 
specific inhibitors were assessed over a time-course of 3-5 days (Figure 3.10). The 
dramatic negative effects of PIK-75 (-90%) and LY94002 (-83%) on Zscan4 
expression were maintained over the entire time-course, when assessed with 
quantitative RT-PCR. On average levels of Zscan4 dropped upon p110 inhibition 
by ~90% and after LY294002 treatment by ~83%. Furthermore, inhibition with PIK-
75 was dominant in all the combinations of inhibitors tested. Inhibition of the 
p110and p110 isoforms alone did not affect Zscan4 levels, but the combination of 
both did show some cumulative effects, especially at the later time points (Figure 
3.10 B, C). Inhibition of one of the PI3K isoforms alone might not be enough to 
decrease PIP3 levels sufficiently to reduce Zscan4 expression. Dual inhibition of 
p110and p110 might decrease total PIP3 levels to an extent that leads to a 
reduction of Zscan4 expression. When all three PI3Ks inhibitors were used 
simultaneously the decrease in Zscan4 expression compared to PIK-75 treatment 
alone was 7.5% stronger, indicating some cumulative effects.  
By using another structural different p110 inhibitor, further strength was added to 
these previous findings. When mESCs were cultured in presence of Compound 15e 
for 48h at a concentration of 600nM, Zscan4 expression was reduced, similar to the 
levels observed after LY294002 treatment (Figure 3.11 A). 
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Figure 3.9 Contribution of specific PI3Ks isoforms to regulation of Zscan4 
expression. (A) Schematic diagram of specific p110 PI3K catalytic isoform 
inhibitors used. (B) (i) E14tg2a ESCs were cultured in the presence of LIF plus 
DMSO as control, 5M LY294002, 25nM PIK-75, 100nM TGX-221, (ii) 10M 
TGX-121 or 5M IC877114 for 48h. Expression of Zscan4 was analysed by 
quantitative reverse transcription polymerase chain reaction, and expression was 
normalised relative to -actin levels. Error bars represent standard deviation of 
duplicate samples from each of two independent biological replicates. 
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Figure 3.10 Time-course of Zscan4 expression after treatment with PI3K 
isoform selective inhibitors. OCRG9 mES cells were cultured in the presence of 
LIF and were treated with the PI3Ks inhibitors, 10M LY294002, 25nM PIK-75, 
100nM TGX-221, 5M IC87114, or combinations of these inhibitors as indicated. 
RNA samples were taken after (A) three (B) four and (C) five days. Expression of 
Zscan4 was analysed by quantitative reverse transcription polymerase chain reaction, 
and expression was normalised relative to Gapdh levels. The averages of triplicate 
samples from one biological replicates are shown. 
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Figure 3.11 Regulation of Zscan4 by the p110catalytic subunit of PI3K (A) 
E14tg2a cells were treated with 5M LY294002 or 600nM Compound 15e and 
samples were assessed by Q-PCR for the expression of Zscan4. (B) RNA was 
extracted 48h after inhibitor treatment as indicated, quantitative RT-PCR was 
performed and Zscan4 expression normalised relative to -actin levels. Graphs show 
standard deviation and are representative of three experimental repeats.  
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In adipocytes, PIK-75 was reported to be able to block activation of the mTOR 
pathway as measured by phosphorylation of S6 ribosomal protein (Knight et al., 
2006). To eliminate the possibility that a potential off-target effect of PIK-75 might 
be the cause for the Zscan4 alteration, mTOR was inhibited directly with the specific 
inhibitor Rapamycin. ESCs cultured in presence of Rapamycin for 48h did not 
exhibit any change in Zscan4 expression, ruling out that the downregulation seen 
with PIK-75 arises from mTOR inhibition (Figure 3.11 B). 
To further explore the mechanisms regulating Zscan4, a gain-of-function approach 
was applied to complement the loss-of-function studies described in the preceding 
section. To achieve this, the PI3K pathway needed to be artificially activated, and 
this was accomplished by creating myristoylated versions of the catalytic p110 
isoforms (further details are given in 5.2). The myr-p110 transgenes were 
overexpressed under the control of the CAG promoter (Niwa et al., 1991) in OCRG9 
mESCs, utilising the piggyBac transposon system (2.4.12). Colonies over-expressing 
myr-p110 isoforms were expanded after selection with respective antibiotics. Three 
independent clones over-expressing myr-p110were analysed with quantitative RT-
PCR for the expression of Zscan4. OCRG9 control mESCs and respective myr-
p110 clones were cultured in presence and absence of LIF for 4 days, before 
analysis. In line with the loss-of-function approach, activation of the PI3K p110 
pathway led to a significant upregulation of Zscan4 (Figure 3.11). Expression of 
Zscan4 was upregulated on average around 70-fold in presence of LIF compared to 
control. Interestingly, Zscan4 expression was also maintained at high levels in the 
absence of LIF in myr-p110 expressing cells (Figure 3.12). 
Taken together, these date provide strong evidence that p110is the main PI3K 
catalytic isoform responsible for the regulation of Zscan4. 
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Figure 3.12 Influence of over-expression of activated p110 PI3K catalytic 
isoform on Zscan4 expression. Clones over-expressing a myristoylated version of 
the p110catalytic subunit of PI3Ks were cultured in presence and absence of LIF. 
As a control parental OCRG9 ES cells were grown in presence and absence of LIF 
for 4 days. Expression of Zscan4 was analysed by quantitative RT-PCR and Zscan4 
expression was normalised relative to Gapdh levels. The averages and S.E. of 
triplicate samples from each of three independent biological replicates are shown: 
***, p < 0.0005, in a Student‟s t-test. 
 
 
3.4.2 Contribution of specific PI3Ks isoforms in regulating Shp-1 
The protein tyrosine phosphatase Shp-1 was also found to be important for ES cell 
self-renewal (work of Belinda Thompson reported in (Storm et al., 2009)). Isoform 
specific PI3Ks inhibitors were also used to examine regulation of Shp-1 expression. 
In contrast to Zscan4, the p110 catalytic isoform appeared to be dominant for the 
regulation of Shp-1, with some additional contribution of p110(Figure 3.13 A). As 
for Zscan4, there was no change in Shp-1 expression when mTOR or the p110 
catalytic isoform were targeted (Figure 3.13 B).    
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Figure 3.13 Catalytic Class IA PI3K isoform-mediated signalling regulates 
expression of Shp-1 (A) (B) RNA was extracted 48h after inhibitor treatment as 
indicated, quantitative RT-PCR was performed and Shp-1 expression normalised 
relative to -actin levels. The data are the average of one biological experiment run 
in duplicates.  
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3.4.3 Effect of PI3K isoform selective inhibitors on mESC fate 
Members of the class-IA PI3K family of lipid kinases regulate key signalling 
pathways in many cell types leading to a variety of physiological responses, 
including cell proliferation, self-renewal and survival (section 1.6). How the 
different catalytic isoforms couple to functional responses is a hot topic in current 
biomedical research, and a promising field for drug development. In ESCs PI3K 
activity has been linked with self-renewal (Paling et al., 2004), growth and 
tumorigenicity (Jirmanova et al., 2002; Takahashi et al., 2003) and previous work in 
our laboratory has provide some evidence that specific p110 catalytic isoforms are 
related to different functions in mESCs (Kingham and Welham, 2009). 
To gain further insights into the mechanisms of PI3K function, OCRG9 mESCs were 
treated with catalytic isoform specific PI3K inhibitors described above (cross-ref 
section). OCRG9 ES cells contain an EGFP-IRES-blasticidin cassette in exon 4 of 
the Rex1 gene (Toyooka et al., 2008). This knock-in ES cell line can be used to track 
Rex1 expression by detecting the corresponding EGFP fluorescent protein levels. 
Rex1 (also known as Zfp42) is a well-recognized pluripotency marker, which is 
strongly expressed in the ICM and self-renewing mESCs, but downregulated upon 
differentiation (Rogers et al., 1991). To address whether PI3K isoforms affect Rex1 
expression, ESCs were cultured with additional specific PI3K inhibitors, and 
subsequently EGFP expression was measured with flow cytometry (Figure 3.14). 
Broad inhibition of PI3Ks with LY294002 resulted in a drop in the proportion of 
EGFP positive cells by almost 70%, confirming previous reports of its ability to 
reduce self-renewal. PIK-75 was also able to reduce the proportion of cells 
expressing EGFP (Rex1) after treatment for 5 days, but the reduction observed was 
only 19% drop in comparison to controls. PI-103, described to inhibit p110 and 
mTOR, but with potential off-target effects on other PI3K-related enzymes, also led 
to a reduction in proportion of EGFP positive cells of 18%. Inhibitors for the p110 
and p110 isoforms, TGX-221 and IC87114, did not appear to change EGFP 
expression compared to untreated or vehicle controls. This came as a surprise as the 
p110 isoform was related previously to self-renewal in mESCs (Kingham and 
Welham, 2009). Further investigations are necessary to clarify the discrepancy 
between the experimental results, possibly a consequence of the inhibitor batch, 
stability of the inhibitor or the use of different cell lines. Combinations of the three 
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specific isoform inhibitors, PIK-75, TGX-221 and IC87114, further enhanced the 
decrease in the proportion of EGFP/Rex1 expressing cells to a total of 26%. It is 
noteworthy that the combination of the three specific inhibitors did not lead to a loss 
of self-renewal to the same level as LY294002 inhibition. There might be several 
potential reasons for this observation, such as incomplete inhibition of all three 
isoforms, different inhibitor stabilities, or additional off-target effects of LY294002. 
Large numbers of intracellular interacting targets have been found for LY294002, at 
doses close to typical used concentrations used for PI3Ks inhibition (Gharbi et al., 
2007). One common target of PI3K inhibitors is the mTOR pathway, which was for 
this reason addressed with stimulation experiments (Figure 3.15). When ESCs were 
cultured in presence of the PI3K inhibitors and stimulated with LIF, only treatment 
with LY294002 at a concentration of 10M, led to a strong reduction in 
phosphorylation of S6, a read-out for mTOR activity. PI-103, which is reported to 
inhibit p110 and mTOR, also resulted in a loss of S6 phosphorylation, but to a 
lesser extent. The inhibitors PIK-75, TGX-221, and IC81774 did not alter 
significantly mTOR activity, judged by S6 protein phosphorylation. It should be 
noted that these experiments were performed in standard cell culture conditions in 
the presence of serum, which can like, LIF, stimulate the mTOR pathway.  
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Figure 3.14 Effects of PI3K isoform selective inhibition on Rex1/EGFP 
expression in OCRG9 mES cells. OCRG9 cells were grown for 5 days in the 
presence and absence of PI3K inhibitors as indicated and fluorescence intensity was 
measured with flow cytometry. The Y-axis represents cell number, while the X-axis 
represents fluorescent intensity. (B) Summary of four independent experiments 
plotting the percentage of Rex1 (EGFP) positive cells upon inhibitor treatment on 
day 5. Values correspond to the average ±SEM from four independent biological 
experiments, and significance was determined using a Mann Whitney test.*, p < 0.05 
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Figure 3.15 Identifying off-target effects of applied PI3Ks inhibitors on mTOR.  
ES cells were cultured in the absence of LIF for 12h hours with the indicated 
inhibitors for the last 1 hour. Inhibitors were used at following concentrations: 
LY294002 (10M), PIK-75 (25nM), TGX-221 (1: 100nM, 2: 200nM), IC81774 
(5M), PI-103 (100nM). Cells were treated with vehicle (DMSO), or left untreated 
(UT), as control. Then LIF was added to the culture (1000 Units/ml) and whole cell 
lysates were prepared at 10 minutes after addition of LIF for western blot analyses of 
total and phosphorylated (Ser235/236) forms of S6.  
 
 
Cell density is an important parameter for maintaining optimal self-renewal and for 
survival in mESCs in culture. Autocrine signalling has been reported to play a role in 
self-renewal and therefore a reduction in cell or colony numbers might negatively 
impact self-renewal (Guo et al., 2006; Singla et al., 2008; Welham et al., 2007). In 
order to verify that our PI3K inhibitors don‟t affect cell-density or cell survival, 
colony size and numbers were assessed upon culture of mESCs with the respective 
inhibitors. After culture for five days, ESC colonies were fixed and stained with 
Leishman‟s reagent. Average colony size and number per condition were assessed 
after scanning and digital image analysis with NIST‟s Integrated Colony Enumerator 
(NICE) software (http://physics.nist.gov/nice) (Figure 3.16). For optimal automatic 
analysis scanned images were changed to grayscale (Figure 3.16 A i) and detected 
colonies were marked by NICE with a red cross (Figure 3.16 A ii, iii). 
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PIK-75 alone, or in combination with other PI3K selective inhibitors, markedly 
decreased colony size by about 75% compared to untreated or vehicle controls, 
which might account for some of the effects on self-renewal determined via Rex1 
FACS analysis (Figure 3.16 B). This finding is not inconsistent with a previous 
report of PIK-75 leading to a reduction in ESC proliferation (Kingham and Welham, 
2009). Interestingly, total colony numbers did not change after ESC culture with 
PIK-75 at 25nM for 5 days, as detected with NICE (Figure 3.16 C). Only the two 
broader PI3K inhibitors, LY294002 and PI-103, lead to a reduction in total colonies, 
probably occurring as a consequence of toxicity effects arising from off-targets. 
Overall, the p110 inhibitor PIK-75 exhibited the largest impact on ESC 
proliferation, which was possibly a major contributor to the effects seen on self-
renewal. 
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Figure 3.16 Effects of PI3K selective inhibitors on ES cell colony number and 
size (A) OCRG9 ES cells were plated at a density of 400 cells/well in a 12 well cell 
culture tray. PI3K selective inhibitors were added to the cell culture medium after 
allowing cells to attach. Following 5 days of culture emerged colonies were stained 
with Leishman‟s stain. (i) Scanned and for analysis purposes processed image of 
Leishman-stained d5 colonies. (ii) Colony size and numbers were assessed with 
NIST‟s Integrated Colony Enumerator (NICE) software 
(http://physics.nist.gov/nice). (iii) Close up of untreated (UT) condition, each colony 
count is highlighted by a red cross. (B) Colony size in square pixels assessed with 
NICE software of untreated and vehicle control verses p110 inhibition by PIK-75. 
(C) Colony numbers were automatically counted with algorithm of NICE. One 
representative out of three total experiments is shown. 
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3.5 Discussion and Summary 
Prior to the start of this study, a microarray screen was performed in our laboratory 
to identify novel regulators of self-renewal downstream of PI3Ks (Storm et al., 
2009). From the resulting dataset of this PI3Ks inhibition screen, candidate genes, 
AF067061, Baz1a, LOC327811, Shp-1, 1700061G19Rik, Ypel2, and Zscan4c, were 
chosen for further analysis. 
 
3.5.1 Summary 
 GSK-3-dependent and independent regulatory mechanisms were determined 
by inhibition of PI3Ks and GSK-3 with LY294002 and BIO. Further 
confirmation was gained by the use of GSK-3 DKO ES cells, and 
subsequent analysis of candidate gene expression via quantitative RT-PCR. 
 
 Hierachical clustering of the significant probesets resulted in 12 separate 
groups. Genes regulated by common mechanisms fell into similar expression 
clusters, indicating a relationship between regulation and the clusters 
defined. 
 
 Functional involvement of Zscan4 in ES cell identity was established by 
siRNA loss-of-function studies, and subsequent analysis of self-renewal 
markers and use of the clonal alkaline phosphatase assay. 
 
 Zscan4 expression was shown to be lost upon differentiation, as assessed 
with embryoid body formation and LIF withdrawal experiments. Zscan4 
levels were elevated at the transcriptional and protein levels upon long-term 
inhibition of GSK-3 with the specific GSK-3 inhibitor 1M or the use of 
GSK-3 DKO mES cells.  
 
 In induced pluripotent stem cells, Zscan4 expression was comparable to  
expression in embryonic stem cells. 
 
 Inhibition of the p110 PI3K catalytic isoform with the specific inhibitors 
PIK-75 and Compound 15e, resulted in a loss of Zscan4 expression, strongly 
suggesting a regulation of Zscan4 via this isoform. Additional evidence was 
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generated by artificial activiation of p110 leading to an increase of Zscan4 
expression. 
 
 Shp-1 was another gene identified by data mining the microarray screen and 
functional studies indicated its involvement in regulating self-renewal 
(Belinda Thompson (Storm et al., 2009)). In contrast to Zscan4, it appeared 
to be mainly regulated by the p110 isoform upon specific inhibitor 
treatment, with some contributions of the p110 isoform. 
 
 Rex-1 expression, mirrored by GFP expression in OCRG9 knock-in mES 
cells, was significantly lower  in comparison to control upon inibition of 
p110 with PIK-75, as assessed using flow cytometry.  
 
 PIK-75 negatively affected proliferation of mESCs, leading to colonies that 
were smaller in size. Despite the reduction in size, colony numbers did not 
change when digital images were analysed. 
 
 
3.5.2 Discussion 
The characterization of the PI3K-dependent transcriptome in murine ES cells, 
facilitated the identification of  novel molecular mechanisms potentially involved in 
regulating ES cell fate (Storm et al., 2009). The importance of the PI3K pathway in 
ES cell self-renewal was first reported by the group of Prof. M. Welham at the 
University of Bath (Paling et al., 2004). Further definition of the gene expression 
patterns regulated via PI3K helps to provide a clearer understanding of the 
underlying mechanisms maintaining ES cell pluripotency. Gene ontology analysis of 
the dataset revealed that the most over-represented functional group were 
transcription factors (Storm et al., 2009). Consistent with this notion is the widely 
accepted theory that a core trsancriptional regulatory circuitry is driving self-renewal 
of ESCs and its disturbance ultimately causes differentiation (Boiani and Schöler, 
2005; Boyer et al., 2005; Kim et al., 2008; Loh et al., 2006). In line with previous 
research conducted in our laboratory, Nanog, a key component of the self-renewal 
core transcription factor network was susceptible to inhibition of PI3Ks by 
LY294002 (Storm et al., 2007). Other regulators of pluripotency, Tbx-3, Esrrb 
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(Ivanova et al., 2006) and Klf4 (Jiang et al., 2008; Li et al., 2005), were also 
downregulated, possibly as a cause of being regulated to some extent by Nanog (Loh 
et al., 2006). Interestingly, expression of Sox2 and Oct4, also belonging to the 
intrinsic core circuit of self-renewal, were not decreased over the 72h time-course of 
PI3K inhibition. Half a year after our publication, work of Niwa et al. described a 
parallel circuit downstream of LIF signalling, maintaing pluripotency of mouse ES 
cells. In this work, Tbx-3 was implicated as being regulated by the PI3K-Akt 
pathway downstream of LIF signalling, predominantly stimulating Nanog (Niwa et 
al., 2009). This work could explain why the levels of Sox2 and Oct4 were not 
reduced after 72h of LY294002 treatment, with LIF stimulating the second parallel 
pathway, integrating the signal via Jak/Stat3 into the core transcription factor 
network by Sox2 and Oct4. Such a functional hierarchy of transcription factors could 
be the evolutionary cause for increasing the robustness of the pluripotent state, which 
needs to be guarded from fluctuating environmental triggers inducing differentiation. 
Significant changes in gene expression upon LY294002 treatment were clustered 
according to similar expression patterns into 12 groups by applying the k-means 
nonhierarchical method (Storm et al., 2009). We were interested in whether there 
was a correlation of expression patterns and regulation by pathways downsteam of 
PI3Ks. The Wnt signalling pathway was considered as it is an important downstream 
signalling pathway in ESCs (Sato et al., 2004; Storm et al., 2007; Ying et al., 2008). 
GSK-3 is known to negatively regulate Wnt signalling, by marking -catenin 
through phosphorylation which leads to its degradation (Aberle et al., 1997; 
Rubinfeld et al., 1996). For this reason Wnt signalling can be mimicked by GSK-3 
inhibition with pharmcological inhibitors, which were used in this study to 
investigate GSK-3-dependent or independent regulation. The hypothesis of a 
correleation between regulatory pathways and expression cluster was confirmed by 
the finding that all genes analysed from cluster 1, AF067061, Baz1a, LOC327811, 
and Zscan4c, appeared to be regulated downstream of PI3Ks independently of GSK-
3. In contrast, others which were in the same or very similar expression clusters, 
including Nanog (Storm et al., 2007), Shp-1, and 1700061G19Rik, exhibited GSK-3-
dependent regulation. This is of particular interest given the discovery that inhibition 
of GSK-3 is required for the ground state of ES cell pluripotency (Ying et al., 2008). 
These studies have shown that it is sufficient to maintain self-renewal of mESCs in a 
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serum-free minimal medium when GSK-3 and MEK were inhibited with two 
specific pharmacological inhibitors (Wray et al., 2010; Ying et al., 2008). This 
culture condition, was also termed „2i‟ conditions, and does not require any 
exogenous growth factors, but additional LIF was shown to have beneficial effects 
on clonogenic self-renewal of ES cells (Silva et al., 2008). Furthermore, it was 
shown that GSK-3 DKO cells could be propagated without loss of pluripotency 
solely by inhibition of MEK, which blocks the differentiation inducing effects of 
autonomously secreted FGF4 (Kunath et al., 2007; Stavridis et al., 2007). The 
population doubling times were reduced in these conditions, but could be restored by 
addition of LIF, showing that LIF-mediated signalling through STAT3 operates 
independent of GSK-3 inhibition (Matsuda et al., 1999; Niwa et al., 1998; Ying et 
al., 2008). 
Zscan4, a gene that provoked our special interest because it belonged to a small 
group of genes that were detected to have a significant decrease in their expression 
within 24 hours of PI3K inhibition, appeared to be regulated via GSK-3-independent 
mechanisms. Evidence from experiments using the inhibitors LY294002 and BIO, to 
block PI3Ks and GSK-3 signalling, alone or in combination, demonstrated that 
GSK-3 inhbition was not able to overcome the effects of inhibiting PI3Ks on Zscan4 
expression. In contrast, Nanog was previously shown to be reguated in a GSK-3-
dependent manner (Storm et al., 2007). Additional experiments with GSK-3 DKO 
ESCs strenghtened these findings, as PI3K inhibition could reduce the transcriptional 
levels of Zscan4, but not the levels of GSK-3-dependent Nanog. However, it is 
noteworthy that Zscan4 expression was increased at the RNA and protein levels, 
when GSK-3 was inhibited with the specific 1M compound or by the use of GSK-3 
DKO mES cells. This observation might be the cause of an increase in the overall 
self-renewal capacity of the ESC culture, rather than a direct cause of GSK-3 
inhibition, as it is reported that GSK-3 inhibition in serum plus LIF conditions 
increases self-renewal (Bone et al., 2009). Furthermore, Wnt proteins in combination 
with LIF were shown to be sufficient for ESC self-renewal (Berge et al., 2011). In a 
recent report it was suggested that GSK-3 inhibition acts through relieving negative 
pressure of the T-cell factor 3 (Tcf3) on the pluripotency network. (Wray et al., 
2011).  
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When an siRNA loss-of-function method was used on our selected candidate genes, 
knock-down of Zscan4 resulted in a loss of self-renewal, assessed by measuring 
alkaline phosphatase activity and expression of self-renewal associated marker 
genes. Besides the role we proposed for Zscan4 in regulating pluripotency, Zscan4 
was recently reported to play a key role in telomere elongation and genome stability 
in murine ESCs (Zalzman et al., 2010). These two mechanisms of Zscan4 are not 
necessarily contradictory, as an increase in genomic instability is likely to result in 
alterations that could bring the metastable state of pluripotency out of balance, 
resulting in differentiation or apoptosis. In addition, there might be other functions of 
Zscan4 contributing to the mentioned effects, as roughly 500 significant up- and 
downregulated gene changes were detected upon its overexpression in ES cells 
(Nishiyama et al., 2009). Zscan4 can be regarded a master regulator of ES cells as 
ablation of Zscan4 drives ES cells into crisis, which might arise from multiple 
functions of Zscan4 ((Zalzman et al., 2010) and personal communication with 
Minoru Ko).  
Expression of Zscan4 was previously reported to be restricted to early embryo 
development and ES cells (Falco et al., 2007; Zhang et al., 2006b). But there is a 
discrepancy in these reports, as Falco et al. described expression of Zscan4 to be 
transient with the highest expression in the late 2-cell embryos, while Zhang et al. 
report the peak of Zscan4 expression in the 3-4 cell stage. Falco et al. presents data 
of quantitative RT-PCR and whole mount in situ hybridization (WISH), whereas the 
other group only presented qRT-PCR results, but where the differences arise from is 
unclear at the moment. Interestingly, in both reports Zscan4 expression was very low 
or undetectable at the blastocyst stage, the biological in vivo counterpart of ES cells. 
This could be due to the fact that Zscan4 exhibits an extremely mosaic expression 
pattern, with only around 5% of cells being positive for Zscan4 in ESCs (Falco et al., 
2007; Zalzman et al., 2010). On the other hand, it might be that the specific functions 
of Zscan4 are not required anymore after the 2-cell stage in vivo, but are transiently 
required for stable long-term culture of pluripotent cells under in vitro conditions. In 
light of this restricted expression of Zscan4 it is of interest that induced pluripotent 
cell types, reprogrammed from somatic cells, managed to reactivate Zscan4 
expression to similar levels as in ESCs.  
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One of the few pieces of evidence regarding regulation of Zscan4 expression derives 
from a report identifying Zscan4 to be among a small set of ES cell and early embryo 
developmental specific transcripts, which are postively regulated by Zfp206 (Zhang 
et al., 2006b). Zfp206, recently renamed to Zscan10, is a putative SCAN-Zinc finger 
transcription factor that plays a role in regulating the pluripotency of mouse and 
human ES cells (Wang et al., 2007c; Yu et al., 2009a). Expression of Zfp206 was 
reported to be expressed predominantly in the ICM of blastocysts (Yoshikawa et al., 
2006), which does not match with the finding of Zfp206 peaking at the 2-cell stage, 
with no further upregulation shown up to the ES cell level (Zhang et al., 2006b). It is 
noteworthy that the relatively homogenous ICM expression of Zfp206, as well as the 
absence of Zscan4 expression in the ICM was detected at the RNA level using in situ 
hybridization by the same group led by Minoru Ko, which should rule out inter-
laboratory technical variations. Further evidence backing Zfp206 epxression in the 
ICM comes from studies detecting the protein levels of Zfp206 by 
immunohistochemistry, which located Zfp206 protein at the blastocyst stage in the 
nucleus of all cells, both trophectoderm and ICM (Wang et al., 2007c). While this 
data supports the findings of Zfp206 expression in the ICM, it highlights a 
discrepancy between the preferential localization of Zfp206 mRNA to the ICM and 
the additional protein detected in the trophectoderm. A possible explanation could be 
that Zfp206 is a relatively stable protein, remaining abundant in trophectoderm 
despite the loss of RNA. This could be of interest as Zscan4 levels were so far only 
traced at the RNA level during preimplantation development, and therefore a stable 
Zscan4 protein might result in Zscan4 function also at later than reported stages of 
development. Protein studies during preimplantation development, by either 
histochemistry or western blot could shed light on this possiblity.  
How the homogenously expressed transcription factor Zfp206 can regulate the 
reported mosaic expression of Zscan4, with only a low percentage of Zscan4 positive 
cells in the total population, was not determined in the studies of Zhang et. al. Six 
different isoforms were reported for Zfp206, and it maybe that the different 
alternatively spliced products regulate their targets in a positive or negative way, 
resulting in a mosaic pattern. Zfp206 was also reported to be part of the core 
transcriptional regulatory network in ES cells, and is positively regulated by the 
transcription factors Oct4 and Sox2, but in turn also binds to the Oct4 promoter 
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regulating its expression. In addition, it was found that Zfp206 also interacts directly 
with both Oct4 and Sox2. Such protein complexes might regulate Zscan4 expression 
in a mosaic fashion and, depending on the composition, they might be able to bind to 
the Zscan4 promoter driving its expression. Noteably, homogenously expressed Oct4 
has also been reported to regulate the heterogenously expressed transcription factor 
Nanog. Epigenetic cell cycle regulated mechanisms, were recently shown to 
contribute to the mosaic expression of Nanog (Villasante et al., 2011). Similar 
regulatory mechanisms could be also an explanation for the mosaic expression of 
Zscan4. 
With the reports of restriced Zscan4 expression during early embryonic development 
and ESC culture, the behaviour of Zscan4 expression under differentiation inducing 
conditions were investigated. Differentiation was triggered by embryoid body 
formation or LIF withdrawal and, as expected, both methods led to loss of Zscan4 
expression at the protein and RNA levels. Interestingly, Zscan4 appeared to be very 
sensitive to differentiation with expression dropping rapidly to almost undetectable 
levels around day 5. This decrease appeared to precede even the drop of Nanog 
expression, a relative sensitive marker of pluripotency, in comparison to Oct4 (Brill 
et al., 2009).  
One major disparity between differentiated cell types and ES cells is that somatic 
cells are limited in their number of times they are able to divide, whereas ES cells 
can be propageted indefinitely while maintaining a relative stable karyotype 
(Cervantes et al., 2002; Suda et al., 1987). The phenomenon of this limited cell 
division ability of somatic cells was termed the „Hayflick limit‟ and describes the 
number of times a normal cell population will divide before it stops (Hayflick, 1965; 
Hayflick and Moorhead, 1961). This limit has been found to correlate with the 
telomere length (Bodnar et al., 1998; Harley et al., 1990; Olovnikov, 1996; Watson, 
1972). Telomeres are repetitve DNA sequence regions at the end of a DNA strand, 
which, together with associated proteins, protect the ends of the chromosomes 
(Blackburn, 2001; Blackburn and Gall, 1978). Because of the nature of DNA 
replication, with DNA polymerases only working in the 5' to 3' direction, one finds a 
leading and a lagging strand on the DNA molecule being replicated. On the lagging 
strand, short RNA primers are needed for the DNA polymerase to bind, which are 
later replaced with DNA fragments. However, at the very end of the DNA strand the 
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RNA primer cannot be replaced leading to loss of a short DNA fragment at each cell 
division (Watson, 1972). This shortening is also known as the end replication 
problem and oxidative stress contributes significantly to shortening of telomeres in 
cell culture conditions (von Zglinicki, 2000). The enzyme telomerase can counteract 
the shortening of telomeres, and indeed in ES cells telomerase activity is elevated 
(reviewed in (Hiyama and Hiyama, 2007)).  
Interestingly, Zscan4 has been implicated in regulating telomere length and genomic 
stability by another mechansism, one that is more similar to the alternative 
lengthening of telomeres (ALT) phenomomenon (Zalzman et al., 2010). ALT 
regulates telomere length via recombination, however, the exact mechanism of this 
pathway is yet to be determined and it is normally associated with abnormal cell 
types like immortalized cells or cancerous cells (Bryan et al., 1995; Henson et al., 
2002). Interestingly, a telomerase-independent lengthening of telomeres has been 
found in early stages of embryo development and it was postulated that a 
recombineering mechanism underlies this observation (Liu et al., 2007). At the 
blastocyst stage a strong upregulation of telomerase was described, mainly 
functioning to maintain the telomere length established by the ALT mechanism (Liu 
et al., 2007). This temporal restricted recombination event correlates well with the 
published Zscan4 function and expression during early development (Falco et al., 
2007; Zalzman et al., 2010; Zhang et al., 2006b). With Zscan4 being the potential 
cause of ALT, which is reported to be involved in the maintenance of some forms of 
cancers (Bryan et al., 1997; Bryan et al., 1995), the possibility to alter expression 
levels of Zscan4 by, for instance small chemical inhibitors, could become of 
therapeutic interest.  
Zscan4 was identified as a downstream target of PI3Ks by applying the broad 
spectrum inhibitor LY294002, which targets all PI3Ks isoforms, to murine ESCs 
(Storm et al., 2009). To investigate whether a specific PI3Ks isoform might play a 
prominent in the regulation of Zscan4 expression a more selective approach was 
needed. Selective PI3K catalytic isoform inhibitors, for the p110 alpha, beta and 
delta isoforms were used, and inhibition of p110 by PIK-75 resulted in a rapid drop 
of Zscan4 expression. This finding was complemented by overexpression of an 
activatived form of p110resulting in a strong increase in Zscan4 expression. 
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Therefore, p110 is proposed to be the major PI3K isoform involved in regulating 
Zscan4 expression. Expression of p110 plays also an indispensable role during 
embryo development, with an early expression already detectable at the zygote stage 
of mouse embryonic development and its transient knockdown results in a G2/M 
arrest, preventing the activation of Akt (Xu et al., 2009). Genetic homozygous 
deletion of  p110 was reported to be embryonic lethal around E9.5, because of 
proliferative defects (Bi et al., 1999).  
Unsurprisngly, inhibition of p110 with PIK-75 resulted in growth retardation, with 
a significant reduction of ES cell colony size. This is consistent with previous reports 
implicating the catalytic alpha isoform in growth and metabolism (Foukas et al., 
2006; Kingham and Welham, 2009; Knight et al., 2006). In ES cells a specifically 
expressed Ras-like gene, termed Eras, was found to be important for the tumour-like 
growth properties of ES cells and was shown to act through activation of PI3Ks 
(Takahashi et al., 2003). Deletion of Eras causes proliferative defects, which can be 
rescued, at least in part, by over-expression of activated p110(Takahashi et al., 
2003). The ERas/PI3K pathway was shown to act via Akt, but the authors did not 
rule out other factors likely to be involved. Akt is a pathway that is strongly 
proposed to be important also for mES cell self-renewal, as artificial activation can 
lead to LIF independency (Pritsker et al., 2006; Watanabe et al., 2006). Furthermore, 
the PI3K/Akt pathway was implicated in the regulation of other important self-
renewal regulators, like Tbx3 and Nanog (Niwa et al., 2009; Storm et al., 2007). In 
line with the importance of Akt for self-renewal, inhibition of p110 with PIK-75 
leads to a reduction in phosphorylated Akt (Kingham and Welham, 2009), and was 
also found in this study to reduce Rex1-Gfp expression after 5 days in OCRG9 ES 
cells. Reduction of Rex1 expression could have been also caused by the lower cell 
density, which will lead to a lower concentration of paracrine and autocrine secreted 
factors known to be important for optimal self-renewal (Berge et al., 2011; Guo et 
al., 2006; Welham et al., 2007).  
Taken together, these findings highlight the important role of Zscan4 in ES cell 
identity, and a proposed regulation via the PI3Ks catalytic alpha isoform opens up 
the possibility to alter Zscan4 expression levels.  
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4.1 Introduction 
Having  identified Zscan4 as a novel contributor to mouse ES cell self-renewal, the 
aim of the next phase of this study was to further explore its mechanism of action. 
The very recent discovery of Zscan4 playing a role in maintaining genomic stability 
and telomere length, together with our findings, suggest that the Zscan 4 family may 
play a number of roles in ES cells, although its precise molecular mechanisms are 
not yet understood (Nishiyama et al., 2009; Zalzman et al., 2010).  
To complement loss-of-function experiments (section 3.3.1) previously performed, 
an over-expression strategy was applied for studying potential functions of Zscan4. 
Zscan4c was found to be the predominant paralogous gene expressed in mES cells 
and was, therefore, the chosen family member for our expression studies (Falco et 
al., 2007). A variety of Zscan4c overexpressing cell lines were established and 
characterised as part of this investigation, including both constitutive and inducible 
expression systems. Studying Zscan4 at the protein level was of special interest, as at 
the time of experimental design no protein data and no murine anti-Zscan4 antibody 
was available. Creation of murine ES cell lines with an inducible eGFP-Zscan4c 
fusion protein allowed tracking of the protein and was used for identifying potential 
protein binding partners using a combined immunoprecipitation (IP) - mass 
spectrometry strategy. Protein interaction partners are a promising route towards 
elucidating mechanisms of Zscan4c. 
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4.2 The Zscan4 family 
Zscan4 was found to be a gene family consisting of nine paralogous genes, which are 
tightly clustered in a 0.85Mb region on mouse Chromosome 7 (Falco et al., 2007). 
According to Falco et al. three of these nine genes are not transcribed and are, 
therefore, considered to be pseudogenes. Zscan4c is the predominant transcript in ES 
cells, whereas Zscan4d was found to be prominent at the late 2-cell stage (Falco et 
al., 2007). Inconsistent with this report, work from our group has shown that both 
Zscan4-ps2 and Zscan4-ps3 can be cloned out from mESC cDNA, challenging their 
previous classification (Storm et al., 2009). Since the first publication describing the 
Zscan4 family (Falco et al., 2007), the composition of the family has changed, 
implicated by a recent Ensembl database search (July 2011). Previously Zscan4c, d 
and f were the only transcripts encoding full-length protein of with 506 amino acids 
(aa) in length, while now pseudogene two (Zscan4-ps2-201) appears to encode a 
protein of 506aa in the database. For Zscan4f, an additional smaller isoform of 77aa 
was found in Ensembl. Zscan4b and e are now published in the Ensembl database to 
encode a protein consisting of 505aa, in contrast to the earlier report of 195aa. The 
other reported pseudogenes, Zscan4-ps1 and Zscan4-ps3, are not listed anymore in 
Ensembl. A summary of all Zscan4 members as found in Ensembl database from a 
search in July 2011 are listed in Table 4.1. 
 
Table 4.1 Summary of Zscan4 family members (http://www.ensembl.org) 
 
 
The protein sequences of the different Zscan4 paralogs were aligned to compare 
sequence similarities (Figure 4.1). As previously reported, sequences are highly 
similar to each other (Falco et al., 2007) and are in a range from 92 to 99%. Protein 
sequences were aligned to each other and the percentage of sequence similarity is 
shown in Table 4.2. 
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Figure 4.1 Alignment of 
Zscan4 family members. 
Zscan4 paralogues were aligned 
to Zscan4b with Global-Ref of 
Clone manager 9.    
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Table 4.2 Protein homology of Zscan4 family members 
 
 
To show the evolutionary relation of the different Zscan4 family members a 
phylogenetic tree based on the Ensembl protein database sequences was created by 
using Neighbour-Joining phylogeny in Clone manager 9 professional (Figure 4.2). 
Zscan4d branches the earliest from the other paralogs, and Zscan4c and Zscan4f are 
the closest to each other. Interestingly, Zscan4c (40%) was the major transcribed 
isoform in ES cells, followed by significant levels of Zscan4f (24%) (Falco et al., 
2007). The more distant Zscan4d family member was only expressed 5% in ES cells, 
whereas it was the predominant form (90%) in 2-cell stage embryos. How these 
expression levels are regulated is not currently known to and whether their sequence 
differences result in an alteration of their function still need to be investigated. 
 
 
 
 
Figure 4.2 Phylogenetic tree of Zscan4 family members. Phylogenetic tree was 
calculated by exhaustive pairwise alignments of Zscan4 protein sequences and 
progressive assembly of alignments using Neighbour-Joining phylogeny. Multi-way 
alignment of Clone manager 9 professional was used.   
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4.3 Episomal supertransfection of Zscan4c 
An episomal vector was used to over-express Zscan4c in mouse ES cells (Figure 4.3 
A). The episomal approach is based on work performed by Gassman et al., and uses 
the polyoma virus replication system (Gassmann et al., 1995). Vectors that contain 
the polyoma viral origin of replication (ori), can be propagated without chromosomal 
integration in ES cells expressing the large T protein (Niwa et al., 1998). As the 
vector is not integrating into the cellular genome, unpredictable changes due to the 
chromosomal integration are avoided. Furthermore, the yield for establishing stable 
transfectants is at least 100-fold higher in comparison to conventional transfection 
protocols and was termed supertransfection (Niwa et al., 1998).  
 
Zscan4c-V5-His was subcloned from the pcDNA3.1-Zscan4c-V5-His vector by PCR 
amplification and ligated into the episomal over-expression vector pPyCAGIZ. The 
episomal vector contains a Zeocin resistance cassette, which should allow for the 
selection of stable transfectants by addition of Zeocin. The pPyCAGIZ-Zscan4c 
vector was transfected by electroporation into E14/T mES cells expressing the large 
T protein and selection was applied 24h after transfection. Surprisingly, no colonies 
emerged upon selection with Zeocin in three independently performed experiments. 
This suggests that the high expression levels of Zscan4c potentially achieved with 
the episomal system cannot be tolerated by ES cells. High levels of Zscan4c might 
drive cells into crisis, omitting the formation of ES cell colonies. To investigate 
whether Zscan4c could be expressed from this vector, a transient transfection 
approach was taken. Cells were electroporated, but no selection was applied after 
transfection and protein samples were taken after 48 and 72 hours. Samples were 
analysed by immunoblotting with an anti-V5 antibody and Zscan4c-V5 was shown 
to be expressed 48h after transfection (Figure 4.3 B). Expression was lost 24 hours 
later, which could be the result of a loss of the vector or because of toxicity effects. 
Toxicity effects appear to be more reasonable, as a loss of the vector would have 
been avoided in the previous experiments due to the presence of Zeocin. It was 
reported that the pluripotency associated genes Tbx3 and Klf4 also failed to produce 
ES cell colonies when over-expressed with an episomal vector system (Niwa et al., 
2009), indicating a tight dosage regulation of these genes. 
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Figure 4.3 Episomal supertransfection of Zscan4c cloned in the pPyCAGIZ 
vector into E14/T ES cells. (A) cDNA encoding Zscan4c with a C-terminal V5-
epitope tag, was subcloned into the pPyCAGIZ episomal expression vector 
containing the Zeocin resistance gene (ZeoR). This plasmid carries a polyoma origin 
with the F101 mutation, allowing episomal replication in ES cells. The plasmid also 
contains a Human cytomegalovirus immediate early enhancer (HCMVIEE), globin 
poly A signal (beta-globin pA), SV40 ori (simian virus 40 origin), ampicillin 
resistance gene (AmpR), and internal ribosome entry site (IRES). Zscan4c was 
subcloned into the Multiple Cloning Site (MCS), and expression is driven by the 
modified chicken beta-actin promoter (CAG). (B) Immunoblotting was performed on 
cell extracts following transient transfection with the pPyCAGIZ-Zscan4c plasmid. 
Expression of Zscan4c was detectable with an anti-V5 antibody 48h after 
electroporation of episomal expression vector into E14/T cells. Expression was lost 
after 72h. Blots were reprobed with a Shp2 antibody to demonstrate equal loading. 
 
4.4 Inducible expression of Zscan4c 
The tetracycline-OFF (Gossen and Bujard, 1992) and advanced tetracycline-ON 
(Urlinger et al., 2000) inducible expression systems were used to overcome the 
limitations of the episomal expression system (Figure 4.4). These systems contain a 
transcipritional activator protein (transactivator), which consists of a fusion protein 
of the Tet repressor and a VP16 activation domain. Tet-off and Tet-on 
transactivators can bind to the tetracycline response elements (TREs) consisting of 
multiple repeats of the bacterial tet operator sequence located within an inducible 
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promoter (CMVmin). In both systems, Tet-on and Tet-off, the transactivator activates 
gene expression, the difference arises form their response to tetracycline. In the Tet-
off system the transactivator drives gene expression in the absence of tetracycline, 
whereas the Tet-on advanced system requires the presence of the tetracycline 
analogue doxycycline to induce expression of the gene of interest.   
There are several advantages of a tetracycline inducible expression system over a 
constitutive active system. 
 During the generation of stable cell lines the transgene can be switched off 
and therefore cell lines with proteins that are normally toxic for the host cells 
can be established. 
 
 It is possible to alter the dose of transgene expression by titrating the amount 
of tetracycline. In this respect the tet-regulated systems are more versatile 
than, for example, the inducible Cre-lox system, in which protein expression 
is induced by site-specific recombination leading to a permanent transgene 
expression. 
 
 The level of transgene expression is similar or greater than in a constitutive 
expression system using the same CMV promoter (Yin et al., 1996). 
 
 The use of tetracycline or doxycycline does not induce cytotoxic effects at 
the required dose for expression induction. This is in contrast to other 
inducible systems where the inducing agents can have non-specific effects, as 
for instance steroids, heat shock, heavy metals, which can in turn interfere 
with experimental results (Saez et al., 1997). 
 
 The tet-regulated expression systems are based on prokaryotic regulatory 
proteins binding specifically to their targets, circumventing pleiotropic 
effects (Harkin et al., 1999). 
 
 Compensatory effects as a result of transgene over-expression are avoided 
during the establishment of stable cell lines. 
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Figure 4.4 Mechanisms of tetracycline regulated Tet-off and Tet-on expression 
systems. (A) The Tet-off system uses a constitutively expressed regulatory plasmid 
pCAG20-1, which produces a transactivator (tTA). The transactivator binds to a tTA 
dependent promoter on the response plasmid pUHD10-3neo. The system is regulated 
by tetracycline that binds to tTA and prevents it from binding to the tTA-dependent 
promoter. When tetracycline is removed tTA binds to the hybrid promoter and drives 
expression of the Gene of Interest (GOI). (B) Tet-on advanced system from Clontech 
drives expression of GOI in the presence of doxycycline (Dox). Target cells 
constitutively express the Tet-on advanced transactivator (rtTA) that can bind to the 
pTRE-Tight expression vector only in presence of Dox.  
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4.4.1 Generation of ES cells expressing Zscan4c under the control of the Tet-off 
inducible system 
For the generation of Zscan4c Tet-off inducible cell lines, Zscan4c, with a C-
terminal dual V5-His epitope tag was PCR amplified from a pcDNA3.1vector 
containing the required insert (Storm et al., 2009). The fragment was blunt end 
ligated into the Tet-off response plasmid pUHD10-3, which was beforehand digested 
with XbaI and blunted (Figure 4.5A). Prior to transfection, the construct was 
sequenced to verify the correct sequence and orientation. To generate inducible 
Zscan4c-Tet-off mES cell lines the linearized construct was transfected by 
electroporation into E14tg2A (Clone R63) murine ES cells (Era and Witte, 2000). 
These cells contain the stable integrated pCAG20-1 vector, that constitutively 
expresses the tetracycline transactivator (tTA) driven by the CAG promoter. 
Following electroporation transfectants were selected in G418 and surviving clones 
were expanded (performed as described in 2.4.10/11). Clones were screened by 
immunoblotting for the induction of Zscan4c expression after withdrawal of 
tetracycline and  high expressing clones were expanded, frozen and used for further 
analyses. Four clones with the highest degree of inducible expression (clones 7, 17, 
43, 45) were selected for further analyses in the remainder of this study. Clones were 
routinely cultured in presence of 1g/ml tetracycline to keep the transgene 
expression switched off. For induction of transgene expression tetracycline was 
removed. 
As demonstrated by Figure 4.5B, Zscan4c-V5 protein was reproducibly and stably 
expressed when induced by removal of tetracycline. Zscan4c expression was 
maintained also upon LIF withdrawal (Figure 4.5 B (i)), and was detectable at a 
similar level over a time-course of 120 hours (Figure 4.5 B (ii)). 
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Figure 4.5 Generation of Zscan4c-Tet-off inducible mES cells. (A) Schematic 
showing how pUHD10-3-Zscan4c-V5-His expression vector was generated. 
Zscan4c-V5-His fragments were amplified from the respective pcDNA3.1 vector (a 
kind gift of Michael Storm) and ligated into the pUHD10-3 vector. (B) Immunoblots 
showing induction of Zscan4c-V5 protein (clone 43) upon withdrawal of tetracycline 
(tet) detected with anti-V5 antibody. (i) Expression after 24h of induction under 
different concentrations of LIF as indicated. (ii) Expression was maintained over a 
time-course of 120h. Immunoblots were stripped and re-probed with Oct-4 antibody. 
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4.4.1.1 Localisation of Zscan4c 
At the time of the study, nothing was known about the protein localisation of the 
Zscan4 protein, as most work had been done at the RNA level (Falco et al., 2007). 
Establishment of the Zscan4c-V5 inducible cell lines allowed  for immunostaining of 
cells for Zscan4c with an anti-V5 antibody. Immunostaining revealed a strong 
accumulation of Zscan4c-V5 protein in the nucleus of the cell (Figure 4.6A; red 
staining). The nucleus was counterstained with DAPI (in blue) and images were 
merged with the Zeiss LSM Image Browser (Version 4.2.0.121). Smaller amounts of 
Zscan4c-V5 protein were also observed in the cytosol. Additional confirmation was 
gained by immunoblotting protein lysates of cytosolic and nuclear fractions (Figure 
4.6B). Nuclear and cytoplasmic separation was achieved using the NE-PER nuclear 
and cytoplasmic extraction reagents from PIERCE Biotechnology. The 
immunoblotting results were similar to the ones obtained by immunochemistry, 
though Zscan4c-V5 protein levels appeared to be slightly higher in the cytosolic 
fraction in comparison to immunostaining. This observation could result from an 
incomplete seperation of the cytosolic and nuclear proteins. This can be seen from 
the nuclear reprobe for the anti-TATA binding protein (TBP), which was also 
detected in the cytsolic fraction. Furthermore Gapdh, marking the cytosolic fraction 
was also detected to a lower extent in the nuclear fraction on the immunoblots, 
suggesting some contamination.  
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Figure 4.6 Nuclear accumulation of Zscan4c. (A) Localisation of Zscan4c-V5 
protein was assessed with immunostaining of Tet-off inducible cell lines grown in 
the absence of tetracycline. Anti-V5 antibody was used to detect Zscan4c-V5 protein 
in clone 45 (red). Cell nuclei were counter-stained with DAPI (blue). (B) Zscan4c-
Tet-off inducible mES cell lines were grown in the presence and absence of tet. 
Cytosolic and nuclear proteins were separated and immunoblotting was performed 
with anti-V5, anti-TBP (nuclear) and anti-Gapdh (cytosolic) antibodies. 
Immunostaining and immunoblot were performed of four independent Zscan4c-V5 
inducible clones. 
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4.4.1.2  Heterogeneous expression of Zscan4c in Tet-off clones 
Immunohistochemical staining for Zscan4c-V5 were performed on clones grown in 
the presence and absence of tetracycline (Figure 4.7). Upon removal of tetracycline, 
a highly heterogenous expression of Zscan4c-V5 protein (in red) was detected. Only 
a few cells expressed high levels of Zscan4c-V5, while the majority (>90%) 
appeared to be low or completely absent in ectopic Zscan4c expression. The precise 
reasons for this heterogenous expression are still not known, but as expression of  the 
transgene is driven by the Tet-off CMVmin promoter a more homogenous expression 
was expected. A number of possibilities could explain these observatons. Based on 
previous results using the episomal expression system, the Zscan4 protein could be 
unstable or some regulatory mechanisms could act directly on the protein level, 
leading to a quick degradation and so loss of Zscan4 protein. Alternatively, it could 
be that the clones analysed by immunohistochemistry had integrated the transgene at 
a disadvantageous place in the genome, so that, for instance, epigenetic mechanisms 
hindered their homogenous expression. It is noteworthy that sub-cloning of Zscan4c 
Tet-off clones did not resolve the heterogenous expression. Possibly screening more 
clones by immunostaining, rather than immunoblotting, could resolve this issue. 
Another possibility could be that the constitutively transcribed transactivator is 
integrated at a unfavourable place or is being silenced. Other lab members using this 
same ES cell line (Bone and Paling unpublished observations) have also previously 
observed differing levels of transgene induction in the same ES cell population. This 
possibility could be ruled out by performing immunostaining for the Tet-off 
transactivator. Should silencing be contributing to heterogeneity in expression, 
transgenes could be integrated at a defined locus known to be favourable for 
homogenous and stable expression, as for example the Rosa26 locus (Masui et al., 
2005).  
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Figure 4.7 Heterogeneous expression of Zscan4c in Tet-off inducible cell lines. 
Zscan4c-Tet-off inducible cell lines were grown in the presence (+tet) or absence (-) 
of 1g/ml tetracycline for 48 hours. Immunocytochemical staining with anti-V5 
antibodies (red) detects a heterogeneous expression pattern upon induction of 
Zscan4c (-tet). Images show two representative independent clones, clone 17 and 
clone 45.  
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4.4.1.3  Zscan4c protein stability 
Zscan4c protein stability was assessed to test whether heterogenous protein 
expression might have arisen from an unstable Zscan4c protein. Intracellular 
Zscan4c-V5 protein stability was investigated with experiments applying 
cycloheximide to block protein biosynthesis. Cycloheximide is produced by the 
bacterium Streptomyces griseus, from which it was originally isolated (Leach et al., 
1947). It acts on eukaryotic but not prokaryotic protein assemby. Inhibition of 
protein biosynthesis occurs by interfering with the translocation step in protein 
synthesis. Elongation was shown to be blocked by binding of cycloheximide to the 
ribosome, where it inhibits eEF2-mediated translocation (Obrig et al., 1971). 
Cycloheximide is a useful tool to determine the half-life of a protein by treating the 
cells in time-course experiments followed by immunoblotting. Cycloheximide 
treatment can be used to assess the half-life of a protein without mistaken 
contributions from transcription or translation.  
In the experimental setup used, murine Zscan4c-Tet-off clones were grown in the 
absence of tetracycline to induce Zscan4c-V5 expression, and cycloheximide was 
added to the cell culture to examine protein degradation. Protein whole cell lysates 
were taken at 0, 2, 4, and 6 hours after addition of cycloheximide, and 
immunoblotting was performed to compare Zscan4c-V5, Nanog and Oct4 protein 
levels.  Zscan4c-V5 protein was stable over the chosen time-course, with a slight 
decrease at 6 hours. Zscan4c appears to be much more stable than Nanog protein, 
which vanished to almost undetectable levels after 6 hours of protein synthesis 
inhibition. Over 6 hours cycloheximide treatment, Oct4 protein stability was 
comparable to Zscan4c stability. 
Zscan4c protein containing a His tag was also over-expressed in bacteria and 
subsequently purified  using nickle columns (Figure 4.8). Protein stability of purified 
protein was also stable over the handling period of a few days, which rules out a 
potential degradation-sensitive amino acid sequence.   
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Figure 4.8 Assessment of Zscan4c protein stability. (A) Zcan4c-Tet-off ES clones 
were grown in absence of tetracycline and 10g/ml cycloheximide was added for 1, 
3 and 6 hours to block protein synthesis. Zscan4 protein stability was determined by 
immunoblotting of whole cell lysates with anti-V5 antibody. Blots were stripped and 
re-probed with an anti-Nanog and an anti-Oct4 antibody for comparison of protein 
stabilities. Results shown represent two independent biological experiments 
performed with separate clones. (B) (i) Zscan4c was subcloned into the bacterial 
expression vector pET15b. (ii) Zscan4c-pET15b was transformed into the bacterial 
strain Rosetta-gami B from Novagen and grown to an OD600 of ~0.6 before inducing 
expression by addition of 1mM IPTG. After 4 to 5 h induction with IPTG, the 
bacteria were harvested and lysates were purified by FPLC using nickel columns and 
an imidazole gradient (20mM to 500mM). Image shows a coomassie stained gel of a 
typical His-tagged Zscan4c purification. M= Marker, F= Flow through, Wash shows 
two representative samples taken throughout the imidazole gradient, Elution 
fractions (1-5) show samples of 1ml collected fractions at 500mM imidazole.  
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Taking these findings together, the heterogenous expression observed by 
immunochemical analyses are unlikely to arise from an unstable protein. Regulatory 
effects by other proteins cannot be completely ruled out as the protein synthesis of 
the regulators are also stopped by cycloheximide, although existing proteins in the 
cell at the time of cycloheximide addition should be still active. 
 
4.4.1.2  Cell cycle analysis of Zscan4c in Tet-off clones 
Murine embryonic stem cells proliferate very actively, with a generation time 
typically of less than 10 hours (Jirmanova et al., 2002), the cause of which is a 
reduction in the the duration of G1 phase (Savatier et al., 1994). Under normal 
culture conditions the majority of the population, around 70%, is in the S phase of 
the cell cycle (Savatier et al., 2002). This is in strong contrast to, for instance, 
embryonic fibroblasts where only ~25% of the population is in S phase and ~70% 
are in the G1 phase (Savatier et al., 2002). When ES cells are induced to 
differentiate, their cell cycle profile shifts substantially towards the G1 phase (Egozi 
et al., 2007; White et al., 2005). 
With Zscan4 being specifically upregulated during the two cell stage of embryo 
development it was of interest to investigate whether ES cells expressing Zscan4c in 
the Tet-off clones experience a change in their cell cycle profile. Therefore,  Tet-off 
clones were grown in the presence and absence of tetracycline for 48h. Subsequent 
Zscan4-V5 staining was performed with an anti-V5 antibody and a FITC-labeled 
secondary. Cell cycle analysis was performed with the 7-AAD DNA dye as 
described in 2.3.6.1. A classical cell cycle profile consists of two peaks separated by 
a lower intermediate population. The first peak represents the G1 phase, in which 
each cell contains a single genome. In the intermediate phase are cells in the S phase 
of the cell cycle, replicating their DNA content. The second peak are cells containing 
two genomes just before their division (G2 phase), and consequently take up double 
the amount of 7-AAD in comparison to cells of the G1 phase. Zscan4c expression 
and 7-AAD staining were monitored by flow cytometry and an example of an 
experimental profile is shown in figure 4.9. Figure 4.9 A shows Zscan4c-Tet-off 
cells grown in presence of tetracycline in contrast to panel B which depicts cells 
grown in the absence of tetracycline and therefore express Zscan4c-V5 (in blue). 
Consistent with the observation of the immunochemistry, only a minority of cells of 
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the whole population express Zscan4c-V5 at a detectable level (Gate P2). As 
expected, two smaller peaks could be detected with the 7-AAD staining, marking G1 
and G2 phase, flanking the broader intermediate population of the S phase (Figure 
4.8A (i) and B (i)). Cells expressing Zscan4c-V5 (blue) after induction by removal of 
tetracycline did not appear to be enriched in a particular phase of the cell cycle 
Figure 4.8B (ii). It is unlikely that only cells in a particular cell cycle express 
Zscan4c-V5, nor that Zscan4c-V5 affects the cell cycle. A slight change of the cell 
cycle profile towards the G2 peak of the whole population was noted after induction 
of Zscan4c in this particular experiment shown, but as in most of these cells Zscan4c 
was undetectable it is likely to be an artefact.  
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Figure 4.9 Cell cycle analysis of Zscan4c-Tet-off ES cell lines. Zscan4c-Tet-off 
Clones were grown +/- tet for 48h in the presence of serum and LIF before 
trypsinisation and fixation in ice-cold 70% (v/v) ethanol. Cells were rehydrated and 
stained with the DNA dye 7-AAD at 25 µg/ml. Zscan4c was labelled with an anti-V5 
antibody and a FITC conjugated secondary antibody. Zscan4c expression (in blue) 
and 7-AAD staining (in green) was monitored by flow cytometry. G1, S, and G2 
phase of the cell cycle are indicated in images (ii). Images show one representative 
experiment of three independent experiments performed with separate clones. 
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4.4.1.2  Effects of sub-optimal LIF concentrations on self-renewal 
With Zscan4c found to play a role in maintenance of ES cell self-renewal (Chapter 
3), it was of interest whether over-expression of Zscan4c in Tet-off clones can 
shelter cells from differentiation events. To determine the potential effect of Zscan4c 
over-expression, cells were grown for 5 days at clonal density in decreasing 
concentrations of LIF (1000, 500, 200, 20, 10, 0 Units/ml). Experiments were set up 
in the presence and absence of tetracycline for different Tet-off clones, as shown in 
Figure 4.10. ES cell colonies were fixed and stained for alkaline phosphatase 
activity,  and scored into two categories, differentiated and self-renewing colonies. 
Colonies negative in alkaline phosphatase activity increased upon LIF withdrawal to 
almost 100% at 0 units/ml. In comparision to plus tetracycline controls, no 
significiant benefical effects on self-renewal were observed upon over-expression of 
Zscan4c when LIF concentrations were reduced. This could be due to the very 
heterogenous expression of Zscan4c, with a minority of cells expressing high levels. 
On the other hand, over-expression of Zscan4c might not be enough to maintain self-
renewal under sub-optimal growth conditions. 
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Figure 4.10 Effect of reduced LIF concentrations on self-renewal of transgenic 
mES cells expressing Zscan4c. Tet-off inducible Zscan4c ES cell clones were 
cultured in the presence and absence of tetracycline for 5 days. ES cell colonies were 
stained and scored for alkaline phosphatase activity, marking self-renewing colonies. 
The percentage of self-renewing (blue bars) and differentiated (red bars) colonies are 
shown for three independently analysed clones.  
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4.4.2 Tet-on advanced system 
To overcome the limitations encountered with the Tet-off system, the Tet-on 
advanced expression system from Clontech Laboratories was chosen.  According to 
the manufacturer‟s manual, the system has several advantages over other inducible 
mammalian gene expression systems. The expression is extremely tightly regulated, 
with virtually no residual binding of the Tet-on advanced transactivator to the TRE 
sequence, thus basal expression is extremely low. Cells do not need to be cultured 
permanently in the presence of doxycycline and concentrations required for 
induction of the Tet-on systems are far below cytotoxic levels. The induction of 
transgene expression after addition of doxycycline is very high and quick, and can be 
already detected within 30 minutes. It is worth noting that the Tet-on advanced 
system only  works in presence of doxycycline and not with tetracycline. 
 
4.4.2.1 Tet-on inducible eGFP-Zscan4c 
The labeling of proteins with a fluorescent marker like eGFP allows us to track 
intracellular localisation of proteins easily by for instance confocal microscopy. 
Potential artefacts of antibody staining can be avoided by labeling proteins in this 
way. Furthermore, eGFP can be used to purify proteins or isolate protein complexes 
by immunoprecipitation technologies for instance the GFP Nanotrap from 
Chromotek. A version of Zscan4c that was N-terminal tagged with the enhanced 
green fluorescent protein (eGFP) (Figure 4.11 A i) was generated through a cloning 
strategy. This fusion protein (eGFP-Zscan4c) was used for inducible over-expression 
studies  in the pTRE-Tight expression vector of the Clontech Tet-on advanced 
system. Stable transgenic cell lines were established by transfecting R1 ES cells 
(2.1.1.2), constitutively expressing the Tet-on transactivator, with linearised pTRE-
Tight-eGFP-Zscan4c vector as described in 2.4.10. A linear hygromycin resistance 
cassette was co-transfected with the pTRE-Tight-eGFP-Zscan4c vector to allow for 
selection. Selection was performed in 300g/ml Hygromycin B and emerging clones 
were picked, expanded and screened (2.4.11).  
The correct karyotype (Mus musculus, 2N = 40) was assessed by counting DAPI 
stained metaphase chromosome spreads of confocal images (Figure 4.11 A ii).  
Established eGFP-Zscan4c-Tet-on inducible clones were tested for the induction of 
fusion protein expression and an example is shown in Figure 4.11B. The time 
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necessary for induction and expression over 48h was assessed by immunoblotting. 
Doxycycline was added at a concentration of 1g/ml to transgenic cell cultures and 
cell lysates were harvested after 0, 6, 12, 24, 36 and 48 hours. Nuclear and cytosolic 
proteins were prepared as described in 2.3.3 and nuclear fractions were run on SDS-
PAGE gels to perform immunoblotting with an anti-GFP antibody (Figure 4.11B 
(i)). Nuclear reprobes were performed with an anti-TBP antibody to assess loading. 
After as little as six hours from addition of doxycycline, transgenic eGFP-Zscan4c 
protein was detectable and remained stably expressed over the 48 hour time-course. 
Induction of eGFP-Zscan4c was also detectable at the transcriptional level by 
quantitative RT-PCR with primers specifically binding the GFP sequence (Figure 
4.11B (ii)). EGFP fluorescence was also detectable with confocal microscopy, one 
example of an eGFP-ZScan4c positive colony grown for five days and in presence of 
doxycycline for the last two of them, is shown in Figure 4.11B panel (iii). Induction 
of GFP was also determined over a defined time-course via fluorescent microscopy 
and correlated well with the previously described expression data derived using 
immunoblotting, indicating a robust expression of eGFP-Zscan4c. 
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Figure 4.11 Establishment of eGFP-Zscan4c-Tet-on inducible cell lines. (A)(i) A 
fusion protein was generated, by cloning eGFP in frame to the N-terminus of 
Zscan4c. The cDNA fusion fragment was subcloned into Tet-on advanced system 
from Clontech (see Figure 4.4) and transfected into R1 mES cells containing the Tet-
On Advanced transactivator (a kind gift of Giusi Manfredi). (ii) Karyotype of 
established clones were analysed by metaphase chromosome spreads stained with 
DAPI. (B)(i) Following induction with 1g/ml doxycycline cells were lysed and 
nuclear lysates immunoblotted with an anti-GFP antibody. Blots were stripped and 
re-probed with an anti-TBP antibody to assess the equality of protein loading. (ii) 
Quantitative RT-PCR was used to confirm induction of Zscan4c expression. (iii) 
Confocal images of day five eGFP-Zscan4c-Tet-on colony after induction with 
1g/ml doxycycline for 48h. (iv) Fluorescent images showing expression of eGFP-
Zscan4c (green) after addition of doxycycline as indicated.   
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Flow cytometry analysis was used to measure eGFP-Zscan4c fluorescence in four 
independent clones (clone N2, N3, N71, N73), which were screened for robust and 
high levels of protein expression by immunoblotting. Tet-on clones were grown in 
the absence or in presence of 1g/ml doxycycline for 72h before performing flow 
cytometry analysis (Figure 4.12). In all four clones analysed about 40% of the cell 
population were GFP positive and, therefore, expressed eGFP-Zscan4c protein. The 
proportion of cells expressing the transgene was significantly higher in comparison 
to the Zscan4c-V5-Tet-off clones, but still around 60% of the population was 
negative. Where this heterogeneous expression arises from is not clear at present, 
possibly the genomic region of integration is sub-optimal for homogenous 
expression. But with the proportion of eGFP-Zscan4c positive cells being 
significantly higher than the Zscan4c expression in Tet-off clones, a downregulation 
by direct regulation mechanisms seems unlikely. The clones N2, N3, N71, and N73 
were used in the further experiments to study effects of eGFP-Zscan4c over-
expression.     
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Figure 4.12 Observation of eGFP-Zscan4c expression after doxycycline 
induction by flow cytometry. Images show flow cytometry pictures of four 
independent eGFP-Zscan4c-Tet-on clones (N2, N3, N71, N73) cultured in the 
absence and presence of 1g/ml doxycycline for 72h. Images in the left column 
show FSC/SSC plots and gating for respective clone. Images of middle and right 
columns show histogram plots from one experiment depicting comparative eGFP-
Zscan4c expression. The Y axis represents cell number and the X axis represents 
fluorescent intensity.  
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4.4.2.2 Metabolic activity in eGFP-Zscan4c ESCs 
Knockdown of Zscan4 in the two cell stage embryo delays the development of 
preimplantation embryos, and furthermore blastocyst outgrowth do not proliferate in 
in vitro culture (Falco et al., 2007). To investigate whether Zscan4c plays a role in 
modulating proliferation of ES cells, XTT bio-reduction assays were performed upon 
doxycycline-induced expression of eGFP-Zscan4c. The colourimetric XTT 
metabolism assay is based on the reduction of tetrazolium salts (XTT) by 
dehydrogenases and reductases, only present in metabolically active cells. The 
yellow XTT salt is metabolised to an orange, water-soluble, formazan dye product, 
and the colour change, reflecting the metabolic activity of the cell population, can be 
measured with a spectrometer at an optical density of 490nm (Mosmann, 1983; 
Roehm et al., 1991; Scudiero et al., 1988).  
Shown in Figure 4.13 are the results of XTT bio-reducion assays performed on 
eGFP-Zscan4-Tet-on cells grown in absence or presence of 1g/ml doxycycline for 
six days prior to the assay (2.3.7.2). Experiments shown were performed with two 
independent clones, but neither of them exhibited a statistically significant change in 
metabolic activity when eGFP-Zscan4c was expressed (Figure 4.13A). GMEM plus 
serum and KO medium plus KO serum replacment culture media conditions were 
applied to assess whether different growth environments might influence the 
metabolic activity (Figure 4.13B). Metabolic activity of ES cells was significantly 
higher in GMEM plus serum conditions, in contrast to KO medium plus serum 
replacement, which is probably caused by growth factors present in the Hyclone 
serum. Nevertheless, no differences were observed between eGFP-Zscan4c induced 
and non-induced cell lines, ruling out beneficial or hindering contributions of eGFP-
Zscan4c on ES cell metabolism or proliferation.  
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Figure 4.13 Effect of eGFP-Zscan4c doxycycline-induced expression on ESC 
metabolism. eGFP-Zscan4c-Tet-on mESCs were plated in 96-well plates and 
cultured +/- doxycycline for six days. XTT-PMS solution was added to each well 
and incubated for a further 4 hours. Plates were read for the absorbance of light at a 
wavelength of 490nm. (A) Graphs show comparable metabolic activity between 
clones, N2 and N71. (B) Metabolic activity of clone N2 in GMEM plus serum and 
KO plus Knockout serum replacement (KSR). Data are the average of a minimum of 
eight replicates for each condition and error bars represent s.e.m. Experiments shown 
are representative of three independent experiments. 
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4.4.2.3 Immunocytochemistry anlaysis of eGFP-Zscan4c ESCs 
With the finding of Zscan4 playing a role in maintenance of ES cell self-renewal 
(Chapter 3), it was of interest to investigate whether there is a relationship between 
Zscan4 expression and the expression of other pluripotency markers. 
Immunocytochemistry was performed to investigate eGFP-Zscan4c co-localisation 
with the known pluripotency markers Nanog and Oct4. Transgenic eGFP-Zscan4c-
Tet-on ES cells were cultured in the presence of doxycycline for 48h prior to 
immunostaining, which was performed as described in 2.3.5. Confocal images were 
taken and cells expressing high and low levels of eGFP-Zscan4c were analysed for 
Nanog or Oct4 expression levels.  
 
The homeodomain transcription factor Nanog is itself known to be expressed in a 
heterogeneous fashion, both in the ICM of the blastocyst (Chazaud et al., 2006) and 
in embryonic stem cells (Chambers et al., 2007; Singh et al., 2007). This 
heterogeneous expression pattern of Nanog was also observed in the eGFP-Zscan4c-
Tet-on clones (Figure 4.14). In the transgenic ES cell culture various expression 
levels of GFP (in green) and Nanog (in red) were detected, but no correlating trend 
could be observed. In Figure 4.14 one cell expressing high levels of Nanog is 
highlighted by a blue arrow, while a white arrow highlights a Nanog low expressing 
cell. 
Expression of Oct4 was, homogenous in the clonal cell population, as detected by 
immunocytochemistry staining (Figure 4.15). This is consistent with reports of a 
widespread expression of Oct4 in pluripotent ES cells (Canham et al., 2010; Niwa et 
al., 2000; Toyooka et al., 2008). Oct4, was expressed in eGFP-Zscan4c positive cells 
(Figure 4.15), but was also homogeneously expressed in absence of eGFP-Zscan4c, 
confirming a pluripotency. These data suggest that Zscan4c is not actively driving 
expression of the important self-renewal core transcription factors Nanog and Oct4 
(Loh et al., 2006). This might have been expected with the proposed involvement of 
Zscan4 in regulating ES cell self-renewal, and the predicted Zscan4c protein 
structure containing 4 zinc finger domains commonly associated with transcription 
factors (Falco et al., 2007; Storm et al., 2009).  
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Figure 4.14 Nanog expression in eGFP-Zscan4c-Tet-on ES cells. Transgenic 
eGFP-Zscan4c-Tet-on ES cells were cultured in the presence of doxycycline for 48h 
in Lumox 24-well trays prior to immunostaining. Nanog expression was analysed by 
immunofluorescence (red). Light blue arrow highlights a Nanog high cell, while 
white arrow highlights a Nanog low cell. GFP was used as a read-out for eGFP-
Zscan4c over-expression (green). Cells were counterstained with DAPI (blue) for 
nuclear localization.  
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Figure 4.15 Oct4 expression in eGFP-Zscan4c-Tet-on ES cells. Transgenic eGFP-
Zscan4c-Tet-on ES cells were cultured in the presence of doxycycline for 48h in 
Lumox 24-well trays prior to immunostaining. Oct4 expression was analysed by 
immunofluorescence (red). GFP was used as a read-out for eGFP-Zscan4c over-
expression (green). Cells were counterstained with DAPI (blue) for nuclear 
localization.  
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When analysing confocal images, in about 30% of the GFP positive cells a focal 
expression was noticed (Figure 4.16). Whether these foci are random accumulations 
of eGFP-Zscan4c fusion proteins, or have any functional relevance is not currently 
clear. Typically, one or two bigger foci could be seen per cell, therefore, a potential 
co-localisation with the centrosomes was considered. To investigate this hypothesis, 
immuncytochemical staining with an anti-pericentrin antibody was performed 
(Figure 4.16; in red). No co-localisation of eGFP-Zscan4c foci with percentrin 
staining could be detected. Figure 4.16 shows a representative staining, with blue 
arrows marking centrosomal staining and white arrows indicating eGFP-Zscan4c 
foci. 
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Figure 4.16 Intracellular localisation of eGFP-Zscan4c. Transgenic eGFP-
Zscan4c-Tet-on ES cells (clone N3) were cultured in the presence of doxycycline for 
48h in Lumox 24-well trays prior to immunostaining. eGFP-Zscan4c expression 
(green) was localised in the cell nucleus (blue) and a focal formation was observed in 
~20% of eGFP-Zscan4c positive cells (white arrows). Centrosome localisation was 
assessed with -pericentrin antibody (red; blue arrows) and colocalisation with 
eGFP-Zscan4c foci (white arrows) was investigated. Cells were counterstained with 
DAPI for nuclear localization.  
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4.4.3 Identification of Zscan4c Protein interactions  
Understanding the molecular mechanisms by which Zscan4c functions should help 
to shed further light on the unique properties of its actions in embryonic stem cells. 
The special ES cell state of pluripotency is not solely governed at the transcriptional 
level, but also complex regulatory mechanisms at the protein level are  important for 
correct function. For instance, homodimerzation of Nanog protein was demonstrated 
to be critical for promotion of ES cell pluripotency (Wang et al., 2008). The ES cell 
identity is likely to be influenced by multiprotein complexes, that can change 
through association and dissociation of proteins (Wang et al., 2006). Furthermore, it 
was shown that Nanog forms multiple protein complexes, predominantly with 
nuclear factors, of which many were associated with ES cell self-renwal (Wang et 
al., 2006). In this study it was further investigated whether Zscan4c might act as a 
part of such multi-protein complexes. 
 
4.4.3.1 Size Exclusion Chromatography (Gel Filtration) 
To ascertain whether Zscan4c can form protein homodimers or other protein 
complexes in vivo, size exclusion chromatography of ES cell nuclear extracts was 
performed to fractionate eGFP-Zscan4c-containing protein complexes. For creating 
nuclear extracts, eGFP-ZScan4c-Tet-on cells were grown in 175T culture flasks, and 
1g/ml doxycycline was added 48h prior to harvest for induction of eGFP-Zscan4c 
protein expression. Gel filtration was performed with a Superdex200 10/300 GL gel 
filtration column and collected fractions were tested for GFP fluorescence using a 
spectrometer. Results revealed three major GFP peaks, indicated as GFP1, GFP2, 
and GFP3 in Figure 4.17. The eGFP-Zscan4c monomer is about 100kDa in size, 
which would resemble the detected GFP3 peak. Interestingly, the GFP2 peak was 
with approximately 200kDa double the size, suggesting possible dimer formation. 
The GFP1 peak was far bigger than 200kDa, and must therefore arise from 
multiprotein complexes containing eGFP-Zscan4c. Fluorescence levels were the 
highest for the second GFP peak, indicating that dimerization plays an important role 
in the mechanisms of Zscan4c function.  
 
 
Chapter 4: Results 
 
166 
 
 
 
 
Figure 4.17 Gel filtration of nuclear protein fractions from eGFP-Zscan4c-Tet-
on ESC lysates. Cells were cultured in six tissue culture 175T-flasks and expression 
of eGFP-Zscan4c was induced for 48h by addition of 1mg/ml doxycycline. Cytosolic 
and nuclear proteins were extracted and the nuclear fraction was separated with 
FPLC by a Superdex200 10/300 GL gel filtration column from GE Healthcare. GFP 
yield of collected 0.5ml fractions was determined on a fluorescent plate reader and is 
plotted in displayed graph (green line). Total protein was measured by FPLC at 
280nm (black line). The Y axis represents intensity and the X axis represents flow in 
ml. Markers for 13, 43, 67, 135 and 200kDa were run through gel filtration column 
and are shown in graph. Three major GFP peaks, GFP1 (>200kDa), GFP2 
(~200kDa), GFP3 (~100kDA) were detected.  
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4.4.3.2 Identification of Zscan4c binding partners 
With eGFP-Zscan4c found to be bound in larger protein complexes, it was of interest 
to identify binding partners, as they could reveal important clues to the mechanism 
of action of Zscan4 proteins. To achieve this an immunoprecipitation strategy, 
followed by mass spectrometry analysis was chosen. Immunoprecipitation was 
performed using GFP-Nanotrap beads from Chromotek, which are able to very 
specifically bind GFP (2.3.4). The beads consist of the variable part of an camelidae 
antibody that binds to GFP, coupled to agarose beads (Figure 4.18A (i)). For 
Nanotrap immunoprecipitation cytosolic and nuclear proteins were separated as 
described in 2.3.3 and Figure 4.18A panel (ii) shows a scanned immunoblotting 
image of a representative separation, with eGFP-Zscan4c enriched in the nuclear 
fraction. The protein fractions were pre-cleared with hydrated agarose before 
performance of immunoprecipitation (Figure 4.18B (i)). For Nanotrap 
immunoprecipitation, the GFP-Trap®_A (Chromotek) beads were incubated on a 
rotator for one hour at 4°C (Figure 4.18 B ii), which was sufficient to bind ~88% of 
eGFP-Zscan4c protein present in the nuclear fraction. After washing, bound proteins 
were eluted with 200mM glycine at pH 2.5 and 1M Tris-base (pH 10.4) was added 
for neutralization. Eluted fractions were run on SDS-PAGE gels, which were 
subsequently stained with colloidal coomassie. Examples of coomassie stained gels 
after performance of GFP-Nanotrap affinity purification experiments are shown in 
Figure 4.19. 
Protein bands which were only present upon eGFP-Zscan4c induction were sent to 
mass spectrometry facilities at the University of Bristol for sequencing. Data was 
compared to a mouse protein database, with a protein score threshold value of 84. 
Protein scores >64 are classed as significant (p<0.05). The over-expressed transgene, 
eGFP-Zscan4c, was identified by this type of analysis, proving the correct function 
of GFP-Nanotrap immunoprecipitation (Figure 4.20A). Further protein sequences 
identified by mass spectrometry were, lysine specific histone demythelase 1A 
(LSD1), C-terminal binding protein2 (Ctbp2), 40S ribosomal protein S7, and 
histidine triad nucleotide-binding protein 1 (HINT1) (all highlighted in Figure 4.20 
A). Surprisingly, a protein of approximately 75kDa in size was identified as eGFP, 
which must result from cleavage of eGFP-Zscan4c, as eGFP alone would be smaller 
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in size. The reason for the shortening of eGFP-Zscan4c is not known to date, but 
protease and phosphatase inhibitors were included in protein lysates at all times. 
 
Figure 4.18 (A) Immunoaffinity purification-mass spectrometry (IP-MS) 
approach for identifying protein interaction partners of eGFP-Zscan4c. GFP-
Nanotrap technology was used for identifying Zscan4c protein-protein interaction 
partners (http://www.chromotek.com). (A) (i) GFP-Nanotrap from Chromotek 
consists of a variable single domain antibody fragment, highly specific for GFP, 
linked to agarose beads. (ii) Cytosolic and nuclear extracts were prepared of eGFP-
Zscan4c-Tet-on cells grown in presence of 1g/ml doxycycline for 48 hours. 
Immunoblots showing eGFP-Zscan4c protein with anti-GFP antibody and Gapdh 
enriched in cytosolic fraction detected with anti-Gapdh antibody. (B) GFP intensity 
was measured of cytosolic and nuclear protein fractions with a fluorescent plate 
reader. (i) Graph shows GFP intensity of nuclear and cytosolic protein fractions 
obtained from eGFP-Zscan4c-Tet-on ESC grown in 32 tissue culture 175T-flasks for 
48 hours in presence of doxycycline before and after pre-clearing with agarose 
beads. (ii) GFP intensity of cytosolic and nuclear fractions before and after 
incubation for 1 hour with GFP-Nanotrap beads. 
Chapter 4: Results 
 
169 
 
 
 
 
 
Figure 4.19 Elution of GFP Nanotrap. Colloidal coomassie stained gradient SDS-
PAGE gels of GFP-Nanotrap (Chromotek) elution (cyt= cytosolic, nuc= nuclear 
fraction). (A) Nuclear protein fraction was obtained from eGFP-Zscan4c-Tet-on 
clone N73 lysates. ESCs were grown in 18 tissue culture 175T-flasks for 48 hours in 
the presence and absence of 1g/ml doxycycline. Protein bands visible only in 
presence of doxycycline are highlighted by the black arrows. (B) Cytosolic and 
nuclear protein fractions were obtained from the eGFP-Zscan4c-Tet-on clone N3, 
grown in 32 tissue culture 175T-flasks for 48 hours in the presence of doxycycline. 
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Figure 4.20 Interaction partners identified by IP-MS. (A) Colloidal coomassie 
stained gradient SDS-PAGE gel after immunoprecipitation of nuclear protein 
fraction (nuc) with GFP-Nanotrap beads. Proteins indicated were identified by mass 
spectrometry. Protein fractions were obtained from eGFP-Zscan4c-Tet-on clone N3 
ESCs grown in 32 tissue culture 175T-flasks for 48 hours in presence of 
doxycycline. (B) GFP-Nanotrap immunoprecipitates were prepared with 60g of 
nuclear extract from eGFP-Zscan4c clone N3 grown for 72h ± Dox. Immmunoblots 
were probed with anti-Ctbp2, anti-LSD1 or anti-GFP antibody (kindly provided by 
Prof. Melanie Welham). 
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Lysine-specific demethylase 1 (LSD1) was the first discovered protein lysine 
demethylase and removes methyl groups from histone H3 lysine 4, through an FAD-
dependent oxidative reaction (Shi et al., 2004).  It was found previously to be a 
component of various protein complexes containing transcriptional co-repressors and 
several zinc finger proteins (Hakimi et al., 2002; Lee et al., 2005; Shi et al., 2005). 
Interestingly, it was discovered to be associated with the transcriptional co-repressor 
Ctbp, which was also identified in our IP experiments (Shi et al., 2003).   
C-terminal-binding protein 2 (Ctbp2) was first reported to play a role in negative 
modulation of oncogenic transformation by binding to the C-terminus of the 
adenovirus E14A proteins (Boyd et al., 1993). Ctbp was identified to exhibit 
important roles during development (Chinnadurai, 2003). Ctbp is recruited to DNA 
by transcription factors that contain a PXDLS core motif (Chinnadurai, 2002; Nibu 
et al., 1998), but how it acts after recruitment to the DNA is unknown. It is 
reassuring that Zscan4c also exhibits a PXDLS motif at position 263-268, and in fact 
all Zscan4 family members contain this binding domain, suggesting that each of 
them can bind Ctbp. 
Histidine triad nucleotide-binding protein 1 (HINT1) is a haploinsufficient  tumor 
suppressor gene with unknown molecular working mechanism (Li et al., 2006). It is 
involved in ionizing radiation induced DNA damage responses (Li et al., 2008a). 
Radiated cells respond quickly with phosphorylation of the histone variant H2AX, 
leading to the phosphorylated protein that is called -H2AX, forming distinct foci in 
the nucleus. -H2AX serves as a scaffold for other DNA repair factors to bind (Paull 
et al., 2000). HINT1 deficient fibroblasts (HINT1
-/-
) exhibit prolonged -H2AX foci, 
and HINT1
-/-
 mice, have an increased cancer risk (Li et al., 2008a; Li et al., 2006).  
40S ribosomal protein S7 (Rps7) is a subunit of the ribosomes, the organelles that 
catalyse protein synthesis (Wool et al., 1995). Ribosomes are assembled in the 
nucleolus, and are exported to the cytoplasm after assembly, where they translate 
mRNA (Karbstein, 2011). 
To this end, immunoprecipitation using GFP-Nanotrap (Figure 4.20B) and co-
immunoprecipitations with murine Zscan4 antibody were performed for LSD1 and 
CtBP, confirming their interactions (experiments were performed by Prof. Melanie 
Welham). 
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4.5 Discussion and Summary 
In this chapter experiments were performed to gain further insights into the potential 
action mechanisms of the Zscan4 family. To achieve this, the predominant 
paralogous gene Zscan4c was investigated by over-expression in mES cells. 
 
4.5.1 Summary 
 Ensembl database comparisons revealed a change in the composition of the 
Zscan4 family members reported by Falco et al. (Falco et al., 2007). 
Pseudogene two (Zscan4-ps2-201), was now found to be also full-length 
coding with 506aa in length. Zscan4b + e paralogous genes are in the 
database with 505aa, in contrast to previously reported 195aa. Furthermore, 
Zscan4f was found in the Ensembl database to have an additional splice 
variant with 77aa in size. 
 
 Protein alignments were performed with Clone manger 9 professional, to 
compare sequence homologies of all paralogs. 
 
 Episomal supertransfection was used to drive high levels of Zscan4c over-
expression, which did not lead to stable cell lines. 
 
 Zscan4c-Tet-off inducible cell lines were established. 
 
 Nuclear accumulation of Zscan4c protein was determined by 
immunocytochemistry and immunoblotting of cytosolic and nuclear  protein 
fractions.  
 
 Tet-off clones exhibited extremely heterogeneous expression of Zscan4c-V5 
protein, as detected with immunocytochemistry, despite robust expression 
detection by immunoblotting. 
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 Zscan4c protein half-life was significantly higher than half-life of Nanog 
protein, as determined with cycloheximide protein synthesis inhibition 
experiments. 
 
 Heterogeneous expression of Zscan4c-V5 in Tet-off cell lines was cell cycle 
independent. 
 
 Induced expression of Zscan4c protein in Tet-off clones could not 
compensate for the differentiation inducing effects of sub-optimal 
concentrations of LIF. 
 
 Tet-on advanced system from Clontech Laboratories was used to establish 
stable mES cell lines that can be induced with doxycycline to over-express an 
eGFP-Zscan4c fusion protein.  
 
 With ~40% of the population being positive for eGFP after expression 
induction, the induction levels were significantly higher than in Tet-off 
clones. 
 
 No change in metabolic activity was observed by the XTT bio-reduction 
assay upon induction of eGFP-Zscan4c expression for six days. 
 
 Immunocytochemistry experiments revealed no correlation of eGFP-Zscan4c 
levels with either Nanog or Oct4 expression levels. A focal accumulation of 
eGFP-Zscan4c protein was observed, which did not co-localize with 
centrosomal staining by an anti--pericentrin. 
 
 Potential dimer formation of eGFP-Zscan4c, and eGFP-Zscan4c – protein 
interaction complexes are likely to exist, as detected by size exclusion 
chromatography.   
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 GFP-Nanotrap immunoprecipitation experiments, followed by mass 
spectrometry analysis revealed the potential Zscan4c binding partners: LSD1, 
Ctbp2, HINT1, and Rps7. 
 
4.5.2 Discussion 
The Zscan4 family was first described in 2007 and is a very novel gene family 
exhibiting a number of unique features (Falco et al., 2007). Originally, only three of 
the nine described Zscan4 paralogs were full length (506aa), whereas a further three 
were thought to be pseudogenes (Falco et al., 2007). Despite this early report, we 
were able to clone some of the pseudogenes from mES cell cDNA, indicating their 
transcription (Storm et al., 2009). Recent Ensembl database searches revealed that 
some changes had occurred since the first publication on the Zscan4 family, which is 
a consequence of the on-going research and updates in this area (see Table 4.1). The 
recent changes highlight the necessity for a consequent in-depth investigation of the 
Zscan4 family to rule out any misinterpretation of the data. To determine the precise 
function of each of the family members, with assessment of redundancy, regulation 
and interactions holds great benefit for the understanding of ES cell biology.   
Zscan4 family members are highly similar in sequence, which has been described in 
the literature and could be confirmed by protein sequence alignments (Falco et al., 
2007; Storm et al., 2009). Because of the very high sequence homologies, a similar 
function seems likely. Interestingly, Zscan4d was described to be the predominant 
form in the 2-cell stage, whereas Zscan4c was the most prominent in ES cells (Falco 
et al., 2007). How this expression regulation occurs is not known yet, but 
deciphering the promoter regions appears to be a helpful analysis. Attempts to map a 
promoter region were endeavoured, but failed due to a lack of known binding motifs. 
For Zscan4c a promoter region was found that, when cloned upstream of the 
fluorescent emerald GFP protein, mirrored the described heterogeneous expression 
in ES cells (Zalzman et al., 2010). It would be of interest to determine also promoter 
regions for other Zscan4 paralogs, which might contribute to identifying the 
mechanisms regulating their expression. Zscan4f-003 was only 77aa in size and 
might play a role in negatively regulating the function of other family members by 
disturbing for instance correct dimer formation.   
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Over-expression was chosen to shed further light into the functional mechanisms of 
Zscan4c. The episomal supertransfection is based on the polyoma virus replication 
system (Gassmann et al., 1995) and was successfully adapted to the ES cell 
environment (Niwa et al., 1998). This system allows high yield of target transgene 
expression, and was used to over-express Zscan4c. Surprisingly, when E14/T mES 
cells were transfected with the episomal expression vector containing Zscan4c-V5 
under the CAG promoter (Niwa et al., 1991) no stable transfectants were obtained 
upon respective antibiotic selection. Correct expression of the transgene was 
detected by transient transfection, but was lost after 72 hours. ES cells might not be 
able to tolerate high levels of Zscan4c for a long period of time and subsequently go 
into crisis leading to cell death. A similar cytotoxicity was described for other 
pluripotency associated genes, namely Tbx3 and Klf4, which when over-expressed 
by the episomal expression system did not result in stable clones (Niwa et al., 2009). 
A tight dosage effect of these genes was postulated and this accounts most likely as 
well for Zscan4c. 
To achieve a better control over Zscan4c expression, tetracycline inducible systems 
were utilized. The Tet-off system was first used for over-expressing Zscan4c protein, 
which was C-terminal V5-epitope tagged. An inducible expression system has many 
advantages, but when using the Tet-off system a highly heterogeneous expression 
pattern, with only a small percentage of cells in the population expressing the 
transgene, was encountered. Despite the limitations, transgenic Zscan4c-Tet-off cell 
lines were used to study Zscan4c protein localisation and stability. A nuclear 
accumulation of Zscan4c protein was determined by immunocytochemistry and 
immunoblotting of separated nuclear and cytosolic protein fractions. This suggests a 
predominant function in the nucleus, which fits well with the later reported function 
of Zscan4c in maintaining genomic stability and telomere length (Zalzman et al., 
2010). Furthermore, protein domain prediction revealed four zinc fingers in the 
Zscan4c protein structure, which are commonly associated with DNA binding and 
transcription factor activity (Falco et al., 2007). Zscan4c is postulated to have 
multiple functions and might also act as a transcription factor, as its over-expression 
was reported to result in transcriptional changes (Nishiyama et al., 2009).  
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Zscan4c-V5 protein stability was assessed by blocking protein bio-synthesis with 
cycloheximide, and performing immunoblotting of subsequently harvested protein 
lysates over a six hour time-course. Zscan4c protein stability was found to be about 
two fold greater than Nanog protein stability. Zscan4f RNA was described to be 
extremely restricted in expression and transcribed only at the 2-cell stage of mouse 
embryo development, as detected with in-situ hybridization (Falco et al., 2007). 
There is no published protein data yet relating to how long Zscan4 protein can persist 
after induction at the 2-cell stage and is of considerable interest as Zscan4 function 
could last further if protein levels are maintained. With the novel and highly 
selective Zscan4 antibody recently developed in our laboratory, this kind of analysis 
can now be performed.  
Zscan4c-Tet-off clones were used to assess the ability of Zscan4c to protect cells 
from differentiation-inducing environmental triggers. With the heterogeneous 
expression of Zscan4c in the clonal population, it was perhaps not surprising that 
Zscan4c was not found to shelter ES cells from differentiation upon LIF withdrawal. 
This is in contrast to the findings that ES cell lines, expressing Zscan4c by a 
constitutive active CMV promoter, had an advantage in generating undifferentiated 
ESC colonies, when cultured under optimal and suboptimal levels of LIF (Storm et 
al., 2009). With only a few cells expressing high levels of Zscan4c in the Tet-off 
cells, such an effect would be masked and probably not detected. On the other hand, 
in ESC culture Zscan4 expression is tightly regulated and long-term expression of 
Zscan4c might have negative impacts on ES cell identity (personal communication 
Minoru S. H. Ko). 
To overcome the limitations encountered with the Tet-off system, I changed to the 
Tet-on advanced expression system from Clontech Laboratories. A fusion protein 
was created by fusing enhanced GFP to the N-terminus of Zscan4c and this construct 
was used for expression by the Tet-on system. Established eGFP-Zscan4c-Tet-on 
clonal cell lines exhibited a robust expression induction with around 40% of the 
population expressing the fusion protein. Induction proportions did not reach 100%, 
which might potentially arise from integration into sub-optimal locus in the genome. 
Such risks of sub-optimal genome integration could be bypassed in the future by 
directed integration into known stable genome loci, for example the ROSA26 locus 
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(Masui et al., 2005). It could be also that high levels of Zscan4c cannot be tolerated 
for long-term and therefore these cells are selected out of the population.  
Metabolic activity was assessed in eGFP-Zscan4c-Tet-on clones upon induction of 
transgene expression by doxycycline. Therefore, the XTT bio-reduction assay was 
performed, on eGFP-Zscan4c-Tet-on stable cell lines, grown in presence and 
absence of doxycycline for six days. No negative or beneficial effects of eGFP-
Zscan4c over-expression could be detected on ES cell metabolism, which is often 
used as a read-out for cell proliferation. A higher metabolic activity was detected 
when ES cells were grown in GMEM plus Serum media, compared to culture in KO 
DMEM media, which might be caused by cytokines present in the Serum stimulating 
growth. Even though there were no growth stimulating benefits observed by eGFP-
Zscan4c over-expression for six days, it might be worth mentioning that occasionally 
an increase in colony size was observed when Zscan4c expressing clones were 
cultured for more than ten days and therefore the contributions might be very small 
and only observable after a longer time period.  
The great benefit of a GFP-Zscan4c fusion protein was the possibility of tracking the 
fusion protein easily by fluorescence-based detection methods. Confocal image 
analysis commonly showed a clear nuclear localisation, consistent with previous 
observations and described function of maintaining genomic stability and regulation 
of telomere length, functions which would obviously take place in the nucleus 
(Zalzman et al., 2010). Correlation of Zscan4c expression with known pluripotency 
associated regulators, Nanog and Oct4, was investigated by immunocytochemistry 
analysis. No positive correlation of eGFP-Zscan4c with Nanog and Oct4 was 
detected on the protein level upon over-expression of eGFP-Zscan4c. GFP high cells 
did not exhibit higher levels of Nanog or Oct4, which rules out a direct effect on 
pluripotency of Zscan4c by altering their levels. Interestingly, a focal accumulation 
of eGFP-Zscan4c protein was observed in about 30% of the GFP positive cells. No 
functional effects of the foci could be observed, and co-localisation studies with -
pericentrin, marking centrosomes, were negative. Zscan4 was postulated to elongate 
telomere length via meiosis-specific homologous recombination mediators and to 
form foci at telomeres (Zalzman et al., 2010). But foci observed of the eGFP-
Zscan4c protein, were smaller in number than expected for telomere foci. However, 
the described recombination mechanisms that account for the telomerase 
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independent elongation of telomeres (Zalzman et al., 2010) could be similar to the 
alternative lengthening of telomeres (ALT) phenomenon (Bryan et al., 1997; Bryan 
et al., 1995). ALT maintains telomere length in some immortalized cell lines, and in 
a sub-set of cancers that are negative in telomerase activity (Bryan et al., 1997; 
Bryan et al., 1995), but the molecular mechanisms are not yet discovered. ALT cells 
contain so called PML nuclear bodies (APBs), and consist of various proteins, of 
which telomere binding proteins, recombination proteins, and heterochromatins were 
described (Jiang et al., 2011). It is possible that the focal expression of eGFP-
Zscan4c arises from a localisation in APBs. Their function is unknown, and they are 
likely to be functionally heterogeneous (Jiang et al., 2011). 
The eGFP-Zscan4c-Tet-on cells were also used to understand how Zscan4c might 
function at the protein level by potential protein interactions. Initially, size exclusion 
chromatography was performed with nuclear eGFP-Zscan4c-Tet-on protein lysates 
to fractionate proteins by size, and individual fractions were tested for GFP 
fluorescence. Three GFP peaks could be detected, with the sizes of ~100kDa, 
~200kDa, and >200kDa, which are likely to reflect eGFP-Zscan4c monomers, 
dimers, and eGFP-Zscan4c complexed with other proteins. Other important 
pluripotency regulators, like Nanog or Oct4, are also shown to predominantly exhibit 
their function as dimers or in protein complexes (van den Berg et al., 2010; Wang et 
al., 2008). For Oct4 an interactome of >160 proteins was reported, of which many 
were documented self-renewal regulating components, including chromatin-
modifying complexes and transcription factors (van den Berg et al., 2010). 
After establishing the possibility that Zscan4c might also act in multi-protein 
complexes an immunoprecipitation (IP) - mass spectrometry strategy was used to 
identify potential interactors, as this might give hints on the molecular mechanisms 
of Zscan4c action. For immunoprecipitation the GFP-Nanotrap from Chromotek, 
which highly specifically binds GFP protein, was used. Mass spectrometry revealed 
the potentially interacting proteins LSD1, Ctbp2, HINT1 and Rps7.  
LSD1 (also known as Kdm1 and AOF2) is a lysine-specific demethylase, which was 
shown to demethylate histone H3 on lysine 4 (H3K4) and lysine 9 (H3K9) (Metzger 
et al., 2005; Shi et al., 2004). It was implicated to be important during mouse 
embryogenesis, especially for gastrulation (Wang et al., 2009). Furthermore, Wang 
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et al. proposed that LSD1 stabilizes Dnmt1 by demethylation and thus provides a 
link between histone and DNA methylation systems. Dnmt1 deficient mouse ES 
cells have dramatically elongated telomeres, likely to be a result of increased 
telomeric recombination (Gonzalo et al., 2006). Heterochromatic marks, like H3K9 
and H4K20 trimethylation, remained at subtelomeric and telomeric regions of 
Dnmt1 deficient ES cells. Whether Zscan4 might be involved in some of these 
molecular processes is not known, but Zscan4c over-expression also leads to an 
increase in telomere length by a recombineering event (Zalzman et al., 2010). It 
could be speculated that high levels of Zscan4, as a result of ectopic over-expression 
or endogenous, through promoter activation, lead to an inactivation of LSD1 by 
binding to Zscan4c, which results in Dnmt1 destabilisation and subsequent 
alternative lengthening of telomeres. How this theory would match with the recent 
finding of LSD1 regulating the balance between self-renewal and differentiation in 
human ES cells (Adamo et al., 2011), is not clear. Knockdown of LSD1 by shRNA 
constructs resulted in differentiation of human ES cells through loss of control of 
H3K4 methylation (Adamo et al., 2011). Another mechanism of how LSD1 could 
act on ES cell self-renewal might be through the interaction with long intergenic 
noncoding RNAs (lincRNAs) (Tsai et al., 2010). LincRNAs were shown to be able 
to bind multiple histone modification enzymes, among them LSD1 (Tsai et al., 
2010). Furthermore, loss-of function studies revealed that lincRNAs play key roles 
in the circuitry controlling ES cell identity (Guttman et al., 2011). If Zscan4c is 
interacting with LSD1, a contribution of some of these effects might be arise from 
either direct Zscan4c action, or by acting as a linker to recruit complexes to, for 
instance, telomeric regions. 
Ctbp2, a 48kDa cellular phosphoprotein, was also found to associate with Zscan4c, 
and is likely to have bound via the PXDLS binding motif of Zscan4 (Boyd et al., 
1993; Quinlan et al., 2006). Murine Ctbp1 is expressed from the embryo to the adult 
animal, whereas Ctbp2 is predominantly expressed during embryonic development 
(Furusawa et al., 1999). Ctbp1 and Ctbp2, collectively referred as Ctbp, are broadly 
expressed within different tissues of the developing embryo and function as 
transcriptional co-repressors. Ctbp forms dimers and interacts with a transcriptional 
repressor and a chromatin modifying protein complex comprised of enzymes such as 
histone deacetylases and LSD1 that suppress gene transcription (Balasubramanian et 
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al., 2003). The repression activity is dependent on intracellular NADH, which binds 
to Ctbp‟s dehydrogenase/NADH binding domain (Mani-Telang et al., 2007; Zhang 
et al., 2002). Ctbp acts as a redox sensor for regulating transcription as a 
consequence of the cellular metabolic environment (Fjeld et al., 2003; Zhang et al., 
2006a). Interestingly, Ctbp is phosphorylated in a cell cycle dependent manner and 
its phosphorylation pattern suggests regulation by a cell cycle-regulated kinase 
(Boyd et al., 1993). Furthermore, Ctbp contain consensus DNA-PK phosphorylation 
sites, and were shown to interact with the Ku 70 subunit of DNA-PK, which make it 
possible that its activity is modulated through phosphorylation by DNA-PK or 
similar protein kinases (Chinnadurai, 2002; Schaeper et al., 1998; Vo et al., 2001). 
Regulation of Ctbp is also reported by the serine/threonine kinase HIPK2, which 
upon UV triggering participates in a pathway leading to ubiquitination of Ctbp and 
subsequently to proteasomal degradation (Zhang et al., 2005). Zscan4c might help to 
recruit these repressive complexes to target sites, to alter specific gene transcription. 
Because of the change of protein functions due to dependency on NADH and 
phosphorylation levels, multiple effects could arise from the specific cellular 
microenvironment. 
The potential Zscan4c interactor HINT1 also reveals interesting properties matching 
some characteristics of the other identified binding partners. Homodimer formation 
of HINT1 protein was reported (Lima et al., 1996) and functioning in protein 
complexes postulated (Korsisaari and Makela, 2000; Wang et al., 2007b). HINT1 
participates in ionizing radiation-induced DNA damage responses not by affecting 
the formation of -H2AX foci, but rather impairing their removal (Li et al., 2008a). It 
acts as a tumour suppressor, at least in part by enhancing the DNA damage response 
through regulating functions of -H2AX and ATM (Li et al., 2008a). HINT1 
deficient cells exhibit prolonged -H2AX foci and impaired acetylation of -H2AX. 
Furthermore, MEFs deficient in HINT1 display a decrease in genomic stability 
accompanied by a high number of various types of chromosomal abnormalities (Li et 
al., 2008a). Interestingly, Zscan4c over-expression was shown to be indispensable 
for long-term genomic stability in mES cells (Zalzman et al., 2010).  Furthermore, 
Zscan4 was reported to be transiently upregulated through retinoids, oxidative stress 
and DNA-damaging agents (Ko and Zalzman, 2011). More important, Zscan4 over-
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expression can enhance survival of cells which were exposed to DNA-damaging 
agents like mitomycin C (MMC) and cisplatin (Ko and Zalzman, 2011).  
The identified 40S ribosomal protein S7 is a subunit of the ribosome (Wool et al., 
1995) and, therefore, it might be an indication that protein complexes were 
associated with the ribosomes, possibly an indication for active translation. The 
association was not further investigated by immunoprecipitations to date and in 
comparison with the other identified binding partners it appears less compelling in 
regards of unravelling the molecular mechanisms of Zscan4c action.    
Zscan4 is a fascinating novel gene family with potentially a number of functions, 
guarding genomic stability, regulating telomere length, and protecting ES cell 
identity (Ko and Zalzman, 2011; Storm et al., 2009; Zalzman et al., 2010). 
Interestingly, the majority of potential Zscan4c interacting proteins identified are 
associated with functions related to transcriptional regulation and DNA damage 
response, all characteristics linked with Zscan4. It is not unlikely that interacting 
proteins like LSD1, Ctbp, and HINT1 are actively involved in enabling the full 
functionality of Zscan4. With this knowledge it should be now possible to address 
the precise working mechanisms of Zscan4. 
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Chapter 5: Artificial activation of Class 
IA PI3K catalytic subunits in mESCs 
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5.1 Introduction 
In embryonic stem cells, PI3K-dependent signalling has been reported to regulate 
cell proliferation (Hallmann et al., 2003; Jirmanova et al., 2002; Sun et al., 1999; 
Takahashi et al., 2003) and furthermore PI3Ks are also required for optimal self-
renewal of mES cells (Niwa et al., 2009; Paling et al., 2004; Pritsker et al., 2006; 
Watanabe et al., 2006) In addition, expression of the well-known core pluripotency 
regulator Nanog and several Nanog target genes, are regulated in a PI3K-dependent 
manner (Storm et al., 2007). In the microarray screen introduced earlier (Chapter 3) 
novel regulators of mES cell self-renewal were identified downstream of PI3K 
signalling (Storm et al. 2009). Zscan4 was among the novel regulators and a 
predominant regulation via the p110 isoform was proposed. How specific PI3K 
isoforms couple to distinct functional responses in mES cells is of interest and was 
addressed in a recent study by applying a loss-of-function approach (Kingham and 
Welham, 2009). The p110 catalytic isoform was suggested to be mainly important 
for proliferation, whereas the p110 isoform appeared to exhibit some contribution 
to ES cell self-renewal (Kingham and Welham, 2009). 
The aim of this chapter was to further investigate the function of specific PI3K 
isoforms in ES cells by an artificial genetic activation approach. It was of interest to 
determine whether constitutively activated PI3K isoforms were able to relieve the 
requirement of mouse ESCs for LIF.   
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5.2 Generation of ES cells expressing activated PI3K isoforms 
Artificial activation of specific Class IA PI3K isoforms was achieved through over-
expression of myristoylated versions of the different catalytic subunit isoforms. N-
myristoylation is a process catalysed by the enzyme N-myristoyl transferase (NMT), 
which covalently attaches myristate, a 14-carbon saturated fatty acid, to the N-
terminal glycine of proteins after removal of the initial methionine residue (Figure 
5.1 A) (Lindwasser and Resh, 2002). In general, N-myristoylation occurs co-
translationally and is irreversible, promoting weak and reversible protein-membrane 
and protein-protein interactions (Murray et al., 1997; Peitzsch and McLaughlin, 
1993; Towler et al., 1987; Wolven et al., 1997). Myristoylation often plays a role in 
signal transduction cascades by localising proteins to the intracellular membrane, 
triggering the activation of signalling events, and it was therefore hoped to activate 
the PI3K pathway, similar to work that was done with myr-Akt in mESCs 
(Watanabe et al., 2006).  
N-myristoyl transferase requires an N-terminal recognition peptide sequence, 
MGSSKSKPK-, which was fused to p110,  and  PI3K catalytic isoform coding 
sequences in the pPBCAGcHAIN piggyBac vector (Figure 5.1 B). The piggyBac 
system is host-factor independent and only requires inverted terminal repeats at both 
ends of the transgene and the transient expression of the transposase enzyme, which 
catalyses the insertion/excision (Fraser et al., 1996). The piggyBac helper plasmid, 
pCAG-PBase, encoding for the transposase enzyme, was co-transfected with the 
piggBac vector containing the myristoylated p110 isoforms into EB5 or OCRG9 
mESCs. Transcription of the myr-p110 transgenes was driven by the CAG promoter, 
which achieves high expression levels in eukaryotic cells (Niwa et al., 1991). Stable 
clonal transgenic cell lines (pPBCAG-myr-p110x) were established by selecting for 
G418 resistance.  
Furthermore, C-terminal eGFP fusion proteins for all three myristoylated isoforms 
were established, to verify correct membrane localisation initiated by the 
myristoylation mechanism (Figure 5.2). A confocal image of an ES cell colony 
expressing membrane-localised myr-p110-eGFP is shown in Figure 5.2 A, 
confirming function of myristoylation sequence. Correct expression of fusion 
proteins was determined by immunoblotting (Figure 5.2 B). 
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Figure 5.1 Mechanism of myristoylation and generation of myristoylated p110 
piggyBac constructs. (A) Myristoyl group is covalently attached to the N-terminal 
glycine by the enzyme N-myristoyltransferase. (B) Schematic showing how myr 
tagged p110 isoforms were generated. P110, were PCR amplified from RIKEN 
Fantom (Functional Annotation Of Mouse) cDNA clones F630002D04 and 
F83017C10.  Fragments were ligated first into piggyBac vector pPBCAGcHAIN to 
add a myr tag encoding sequence in frame with the p110 coding sequences.  P110 
was subcloned from pCAG-myr-p110-IH vector into pPBCAGcHAIN. 
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Figure 5.2 Membrane localisation of myr-p110-eGFP fusion proteins. (A) 
Confocal microscopic images showing myr-p110-eGFP fusion proteins and E-
cadherin detected by Alexa 594. Stable cell lines were established by lipofection of 
myr-p110-eGFP piggyBac with the PCAGPBase helper plasmid into EB5 ES cells, 
and subsequent selection with G418. Cell nuclei were stained with Hoechst (blue), 
and E-cadherin antibody staining is shown in turquoise. Original magnification, x63. 
(B) Whole cell lysates were resolved by SDS-PAGE and immunoblotting carried out 
using the antibodies indicated to detect full length fusion proteins and specific p110 
isoforms. The p110 isoform was not checked by immunoblotting due to the 
unavailability of an antibody.  Gapdh antibody was used to confirm equal loading. 
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5.3 Screening for LIF-independent clones 
Activation of Akt signalling was previously reported to be sufficient to maintain 
pluripotency in mouse and primate embryonic stem cells (Watanabe et al., 2006). 
With activation of PI3Ks being upstream of Akt, an artificial activation of PI3Ks 
might potentially be enough for attaining LIF independency. To test this hypothesis, 
OCRG9 mES cells were transfected with the constructed piggyBac transposon 
vectors, resulting in transgenic cell lines over-expressing myristoylated class IA 
catalytic isoforms and therefore predicted to exhibit activated PI3K-dependent 
signalling. OCRG9 mES cells, rather than EB5 mES cells, were chosen because 
selection with puromycin for Oct4 is stronger and therefore quicker than selection 
with blasticidin. After transfection ES cells were selected in absence of LIF but in 
the presence of G418 for transgene expression. Furthermore, OCRG9 cells were 
grown in presence of puromycin, which selects the population for Oct4 positive, self-
renewing ES cells. Thus, differentiating cells, which would be expected in a culture 
environment without LIF, are eliminated and surviving clones will express both myr-
p110 isoforms and Oct4. 
Indeed, some LIF independent colonies emerged when the myr-p110isoform was 
over-expressed in the OCRG9 mES cells cultured under the mentioned selection 
conditions. It was possible to expand these myr-p110expressing colonies in the 
absence of LIF but in the presence of antibiotics, resulting in a stable clonal 
population. For the other p110 isoforms the results were not as clear-cut and 
emerging colonies did not proliferate as well and also had a more differentiated 
phenotype. More experiments are needed to further assess their potential to maintain 
ES cell self-renewal in absence of LIF. It should be noted that even myr-p110 
clones did have a less stable phenotype with a more flattened morphology when 
grown in absence of LIF, but it was possible to maintain them in culture for more 
than 1 month in presence of puromycin. They still remained responsive to LIF, even 
after LIF starvation for one month, leading to ES cell colonies with a highly self-
renewing phenotype of very tight, round and domed colonies.  
To rule out that LIF independency might have arisen from potential culture artefacts 
because of high density culturing, LIF independent myr-p110clones were plated at 
a clonal density of 10
4
 cells per 10cm cell culture dish in the absence and presence of 
LIF (Figure 5.3). Parental OCRG9 ES cells were used as a control and puromycin 
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was added to cultures to select for Oct4 positive cells. Myr-p110expressing cell 
lines formed colonies in the presence and absence of LIF, whereas parental OCRG9 
cells only gave rise to healthy colonies in the presence of LIF. When transgenic cells 
were cultured in the presence of LIF a higher number of colonies formed than in 
absence of LIF, this might be caused by fluctuating expression of the transgene, or 
by the pleiotropic effect of the PI3K, leading to differentiation of a certain proportion 
of the population due to a sub-optimal intracellular environment.  
 
                                              
 
 
Figure 5.3 Myr-p110 supports LIF-independent self-renewal of mouse ES 
cells. Rex1-GFP/Oct3/4-CFP double knock-in ES cells (OCRG9) were transfected 
with pPBCAGcHAIN-CAG-myr-p110 and the PCAGPBase helper plasmid and 
clones were obtained after selected with G418 (selection for pPBCAGcHAIN) and 
Puromycin (selection for Oct3/4+ cells) in absence of LIF. Clones were expanded in 
presence of antibiotics and 10
4
 cells were plated per 10cm dish +/- LIF for 7 days. 
Images show ESC colonies stained with Leishman stain (blue). 
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Autocrine signalling can contribute to ES cell self-renewal (Guo et al., 2006; Singla 
et al., 2008; Welham et al., 2007) and, therefore, it was important to rule out that 
autocrine factors might have stimulated the LIF pathway, maintaining self-renewing 
colonies. An inhibitor to block Janus-associated tyrosine kinases (Jak), downstream 
of the LIF signalling pathway, was applied to investigate complete LIF 
independency of myr-p110clones. When the Jak pathway is blocked even 
autocrine factors are no longer able to activate the LIF signalling pathway, because 
the signal cannot be integrated into the core circuitry (Niwa et al., 2009). Cells were 
plated at 1x10
3 
cells per well of a 6-well cell culture tray and cultured for five days 
with the addition of a Jak pathway inhibitor (jaki) (Jak inhibitor I (Calbiochem)) at a 
concentration of 5, 2, 1, 0.5 and 0.1M. Cultures contained puromycin and parental 
OCRG9 ES cells were used as controls. On day five, colonies were stained with 
Leishman‟s stain, to assess colony formation and morphology. 
All established myr-p110 over-expressing clones formed tight round colonies when 
the Jak pathway was inhibited, indicating their complete relief from LIF-dependent 
signalling (Figure 5.4B). In contrast, the OCRG9 parental control cells only formed 
healthy colonies in the absence of Jak pathway inhibition, and colonies with a 
flattened partly differentiated appearance were observed at a low concentration 
(0.1M) of Jak inhibitor (Figure 5.4A). At Jak inhibitor concentrations of between 
5M – 0.5M no colonies formed, because of the applied puromycin selection for 
Oct4 positive cells. These data suggests that myr-p110over-expression can lead to 
complete LIF independency of ES cells.  
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Figure 5.4 Myr-p110 transgenic ES cells were resistant to treatment with a 
Jak inhibitor.  (A) OCRG9 parental cell line and (B) myr-p110LIF-independent 
clones were grown in the presence of Jak inhibitor I (Calbiochem) at the indicated 
concentrations. Cells were plated at a density of 10
3
 cells/well in 6-well cell culture 
trays and cultured for five days in the presence of puromycin. OCRG9 cells were 
cultured in the presence of LIF, whereas myr-p110 clones were grown without LIF. 
Images show Leishman stained colonies.    
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5.4 Characterisation of LIF-independent clones 
Three LIF-independent myr-p110clones, clone 3, 6, and 10, were further 
characterised for the expression of pluripotency associated genes. Rex1 is a well-
known marker for pluripotency in mES cells and the OCRG9 cell line used in this 
study expresses an eGFP under the control of the Rex1 promoter (Toyooka et al., 
2008). This makes it possible to use eGFP fluorescence as a read-out for Rex1 
expression. EGFP expression was detected by flow cytometry (Figure 5.5A) and 
fluorescent microscopy (Figure 5.5B).  
In comparison to control OCRG9 ES cells, relatively homogeneous expression levels 
of eGFP/Rex1 were observed by flow cytometry analyses in the established myr-
p110clones, when cultured in presence of LIF (Figure 5.5A). Furthermore, myr-
p110clones were grown in presence and absence of LIF for five days, and 
subsequently assessed for eGFP/Rex1 expression by fluorescent microscopy (Figure 
5.5 A). OCRG9 cells were previously reported to lose GFP fluorescence within 2-3 
days when cells were cultured in medium without LIF (Toyooka et al., 2008). 
Interestingly, eGFP/Rex1 expression was maintained, even upon LIF withdrawal, 
backing up the finding of their ability to self-renew in the absence of LIF.  
Expression of the well established pluripotency marker Nanog, which has a 
functional role in maintaing self-renewal (Chambers et al., 2003; Mitsui et al., 2003), 
was also investigated. Nanog is heterogeneously expressed in the inner cell mass of 
E3.5 preimplantation blastocysts and also in embryonic stem cells (Chazaud et al., 
2006; Singh et al., 2007). Surprisingly, myr-p110over-expressing clones appeared 
to express Nanog homogenously in the presence of LIF, as assessed with 
immunocytochemistry (Figure 5.6). Some differences in Nanog expresseion were 
observed between the analysed clones. Clone3 (Figure 5.6A) and clone10 (not 
shown), exhibited a heterogenous expression of Nanog in absence of LIF, whereas 
clone 6 also expressed Nanog at high levels in the absence of LIF (Figure 5.6B). It is 
unclear at the moment why there is a difference in Nanog expression between the 
clones, one possible reason might be the integration site of the transgene. This 
highlights the importance of analysing multiple clones to reduce the risk of 
characterising artefacts as a result of the genetic engineering process. 
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Figure 5.5 Observation of myr-p110-OCRG9 clones by flow cytometry and 
microscopy. (A) Result of analysis of control OCRG9 mES cells and  myr-p110-
OCRG9 clones by flow cytometry. Cells were cultured in the presence of serum and 
LIF and GFP-Rex1 was detected (FITC on x-axes). (B) Morphology and 
fluorescence of myr-p110-OCRG9 colonies under puromycin selection (selection 
for cells expressing Oct3/4) after day 5 of culture in the presence of serum +/- LIF. 
Bf (bright field) and Rex1-GFP fluorescence was detected by fluorescent microscopy 
with low magnification.  
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Figure 5.6 Confocal microscopic images of immunostained myr-p110-OCRG9 
ES cells. Cells were cultured in serum, +/- LIF and immunostained for Nanog. 
Images show untypical homogenous Nanog protein expression in the presence of 
LIF. Nanog was detected by Alexa 594 and nuclei were stained by hoechst. (A) 
Shows confocal images of clone 3, and (B)  images of clone 6. Original 
magnification, x63. 
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To gain further insights into the molecular mechanisms that might be involved in 
establishing LIF independency in myr-p110 over-expressing clones, levels of 
known pluripotency regulators were assessed. Relative expression levels of the 
pluripotency associated genes, Tbx-3, Nanog, Klf4, Zscan4 and Oct4, were assessed 
by quantitative RT-PCR in myr-p110 clones. LIF independent myr-p110 clones 
(clone 3, 6, and 10) were plated in multi-well cell culture trays in the absence or with 
the addition of LIF for 4 days, before RNA was harvested. Quantitative RT-PCR 
revealed that all pluripotency marker genes assessed in the three selected clones were 
elevated in the absence of LIF in comparison to parental control OCRG9 cells grown 
without LIF for four days (Figure 5.7). This indicates their enhanced self-renewal 
ability, as a result of transgene over-expression. Interestingly, Tbx-3 and Oct4 
expression levels were also elevated in the presence of LIF, when compared to 
control cells grown with LIF, highlighting a beneficial effect of myr-p110 over-
expression also under standard culture conditions (Figure 5.7A & D). Furthermore, 
clones 6 and 10 also showed elevated Nanog and Klf4 levels compared to control, 
whereas with clone 3 expression reached the same levels as measured in control cells 
(Figure 5.7B &C). The higher responsiveness of Tbx-3 expression to PI3K activation 
by myr-p110over-expression, in contrast to Nanog, might reflect the hierarchy in 
the functions of these transcription factors. Tbx3 was postulated to be upstream, 
whereas Nanog is placed downstream of Tbx3, supporting activation of Oct4 
expression required for proper self-renewal (Niwa et al., 2009). As described earlier, 
Zscan4 levels were also strongly upregulated in myr-p110clones, both in the 
presence and absence of LIF (Chapter 3, Figure 3.12), which might be another 
contributing factor to the self-renewing phenotype observed. Taking these data 
together, ES cell clones with activated PI3K signalling appear to have a clear self-
renewal advantage over control ES cells, which was supported by this evidence of 
pluripotency gene expression at the transcriptional level.  
 
Immunoblotting was used to examine protein expression of Nanog and p110 in 
myr-p110 clones 3, 6, and 10, grown for three days with or without LIF. In 
accordance with the immunocytochemistry results, Nanog protein levels are high in 
the presence of LIF in all of the clones analysed (Figure 5.8). In addition, Nanog 
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protein levels in the absence of LIF were also higher compared to levels seen in 
control ESCs.  Consistent with the cytochemistry observations, clone 6 also showed 
a higher expression of Nanog in absence of LIF, in comparison to clone 3 and 10 
(Figure 5.8). 
 
 
Figure 5.7 Expression of pluripotency-associated transcription factors in LIF-
independent ES cell lines. Transgenic myr-p110 ES cell clones (3, 6, 10) were 
cultured in absence of LIF and reintroduced to LIF for 4 days. Quantitative RT–PCR 
analysis were performed to assess the expression levels of (A) Tbx-3, (B) Nanog, (C) 
Klf4, and (D) Oct4. The expression levels in parental OCRG9 ES cells cultured +/- 
LIF for 4 days are also shown. Error bars indicate standard deviation of three 
independent experiments run in triplicate and expression was normalised relative to 
Gapdh. *, p<.05; **, p<.005, p<.0005, in a Student‟s t test.   
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Furthermore, Akt  phosphorylation (S473) was assessed, as PI3K activation is 
known to activate Akt through phosphorylation (reviewed in (Dreesen and 
Brivanlou, 2007)), which in return can lead to LIF-independent self-renewal 
(Watanabe et al., 2006). All the clones tested show a higher level of Akt 
phosphorylation in the presence of LIF in comparison to parental control cells 
(Figure 5.8). Surprisingly, Akt phosphorylation was also increased in parental 
control cells when LIF was absent, suggesting that some of the randomly 
differentiated cells that arise following LIF withdrawal exhibited elevated p-Akt 
levels. A similar trend in Akt phosphorylation upon differentation of ES cells was 
also observed earlier by our group (Kingham and Welham, 2009).  
 
 
Figure 5.8 Western blot analyses of myr-p110 ES cell clones. Transgenic cells 
were cultured in GMEM plus serum minus LIF and reintroduced with LIF for three 
days. Parental cells were grown in presence of LIF and were LIF starved for three 
days prior of harvesting whole lysates. Immunoblotting was used to detect Nanog, 
p110, and phosphorylated Akt (S473) (pAkt) protein. Immunoblots were stripped 
and reprobed with appropriate antibodies detecting Akt and with antibodies detecting 
Gapdh to confirm equal loading. The data shown are representative of two 
independent experiments. 
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5.5 Model for mechanism of LIF independency 
ES cells can be propagated when Erk and GSK-3 signalling are simultaneously 
inhibited by pharmacological agents (Ying et al., 2008), with further beneficial 
effects on clonogenicity observed upon the addition of LIF (Wray et al., 2010). 
These culture conditions are considered optimal for mES cell self-renewal, leading to 
the proposed „ground state‟, a basal proliferative state, without epigenetic barriers 
and only minimal needs for extrinsic stimulation (Wray et al., 2010). Activation of 
the PI3K pathway by over-expression of a myristoylated p110catalytic isoform 
was shown to liberate murine ES cells from LIF dependency, but addition of LIF did 
increase homogeneity of Nanog in the clonal populations and furthermore 
clonogenicity was increased in presence of LIF. This liberation might be linked to 
the proposed „ground state‟ by dual inhibition of Erk and GSK-3 signalling.  
Zscan4c was one of 50 transcription factors that were over-expressed in  ES cells to 
further explore the functioning of these biologically important networks (Nishiyama 
et al., 2009). Upon induced over-expression of Zscan4c, DNA microarray analysis 
was performed to assess changes in the global transcriptome (Nishiyama et al., 
2009). Of more than 25000 assessed microarray probsets, Pramel7 was the most 
upregulated gene after induction of Zscan4c expression for 48 hours. Figure 5.9 
shows the 50 most upregulated genes after over-expression of Zscan4c. Interestingly, 
Pramel7 was recently reported to mediate LIF/STAT3-dependent self-renewal in 
murine ES cells (Casanova et al., 2011). This group reported that over-expression of 
Pramel7 is sufficient to relief ES cells from LIF dependence and to promote self-
renewal when grown on LIF-knockout feeders. Under feeder- and serum-free 
conditions, self-renewal was impaired, but GSK-3 inhibition could restore self-
renewal. Pramel7 over-expression promoted Erk dephosphorylation and this was 
proposed to prevent ES cells from differentiation (Casanova et al., 2011). 
Over-expression of myr-p110was also reported to result in phosphorylation of 
GSK-3, leading to inhibition of GSK-3 activity (Popkie et al., 2010). This dual 
function of activated p110 could, therefore, lead to the „2i ground state‟, and this 
could be an explanation for the LIF-independent self-renewal ability of the myr-
p110 over-expressing clones (Figure 5.10).  
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Figure 5.9 Top 50 upregulated genes upon overexpression of Zscan4c in mES 
cells. Chart shows the 50 most upregulated genes after 48h of doxycycline induced 
overexpression of Zscan4c (Nishiyama et al., 2009).  
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Whether myr-p110exhibits this proposed dual function by two separate pathways, 
or solely through Akt activation, which in turn stimulates GSK-3 inhibition and 
Zscan4c/Pramel7 activation is not clear to date. The latter could be possible, as 
activated Akt alone is also able to liberate ES cell‟s requirement for LIF (Watanabe 
et al., 2006). 
 
 
 
 
 
Figure 5.10 Model of activated p110function on ES cell self-renewal. 
Activation of p110 is proposed to act positively on ES cell pluripotency through at 
least two independent mechanisms. Firstly, by activation of Akt leading to inhibition 
of GSK-3 and secondly by upregulating expression of Zscan4, which consequently 
upregulates Pramel7, which inhibits Erk. Inhibition of both Gsk-3 and Erk is 
sufficient to maintain ES cells in the „ground state‟ of pluripotency.  
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5.6 Discussion and Summary 
This chapter described the artificial activation of class IA PI3K catalytic subunits by 
myristoylation and their function on mES cell self-renewal. 
 
5.6.1 Summary 
 An N-terminal recognition peptide sequence for N-myristoyl transferase was 
fused to Class IA PI3Ks catalytic subunits p110, , and  (myr-p110, , 
). 
 
 Myr-p110, , and were overexpressed under the contol of the CAG 
promoter in murine ES cell lines using the piggyBac transposon/transposase 
expression system. 
 
 eGFP was fused C-terminal of myr-p110 isoforms and correct membrane 
localisation was determined by confocal microscopy. 
 
 LIF independent ES cell lines could be established by over-expression of 
myr-p110 in OCRG9 ES cells in absence of LIF and by selection for Oct4 
positive cell with puromycin.  
 
 Liberation of LIF was confirmed by growing transgenic cell lines in the 
presence of a Jak inhibitor. 
 
 Rex1/GFP expression was determined in myr-p110OCRG9 LIF 
independent clones by flow cytometry and fluorescent microscopy. 
 
 Nanog expression in the myr-p110OCRG9 LIF independent clones was 
assessed by immunocytochemistry, and found to be heterogeneous in the 
absence of LIF and more homogenously expressed in the presence of LIF. 
 
 Quantitative RT-PCR analysis was used to determine expression levels of 
pluripotency associated genes, Tbx-3, Nanog, Klf4, Zscan4, and Oct4, in 
myr-p110clone. Overall, expression levels in the absence of LIF were 
elevated compared to control OCRG9 control ES cells grown without LIF. 
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 Immunoblotting confirmed elevated expression levels for Nanog on the 
protein level. 
 
 Activation of the Akt signalling pathway in myr-p110 stable cell lines was 
also determined by immunoblotting, demonstrating activation of the PI3K 
signalling pathway. 
 
 A model for the mechanism of LIF liberation in myr-p110over-expressing 
cell lines was proposed. Activation of PI3K signalling might lead to the „2i 
ground state‟ through inhibition of GSK-3 by activated Akt signalling and on 
the other hand by stimulating Zscan4/Pramel7 expression, resulting in a 
decrease in Erk phosphorylation. 
 
 
5.6.2 Discussion 
The PI3K pathway is an important signalling pathway involved in regulating a wide 
range of cellular functions. However, a detailed understanding of the precise 
function of different isoforms, in different cell types as well as the critical substrates, 
and spatial dynamics of the processes, are still to be unravelled (reviewed in 
(Cantrell, 2001)). In murine ES cells the class IA PI3K family of lipid kinases have 
been previously implicated in regulating ESC self-renewal (Kingham and Welham, 
2009; Paling et al., 2004; Storm et al., 2007). Downstream signalling from PI3Ks, 
affecting Akt and GSK-3 activity, have also reported to be important for maintaining 
undifferentiated mESCs (Bone et al., 2009; Niwa et al., 2009; Pritsker et al., 2006; 
Sato et al., 2004). In this chapter the hypothesis tested was whether specific class IA 
PI3K subunits couple to self-renewal in ES cells. A genetic activation strategy was 
applied by fusing a myristoylation target sequence to the p110, , and  isoforms, 
which promotes constitutive membrane attachment and activation (Klippel et al., 
1996). The piggyBac transposon system was used for over-expressing these 
constructs in mES cells with a CAG promoter. Myristoylation approaches for the 
activation of signalling pathways were previously used successfully in ES cells, and 
for instance myr-Akt was found to be sufficient to liberate ES cells from the 
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requirement of LIF (Watanabe et al., 2006). Furthermore, over-expression of 
activated p110 was reported to be able to rescue impaired growth and 
tumorigenicity in Eras (a Ras-like gene) knockout ES cells (Takahashi et al., 2003).  
LIF independent clones were obtained when the activated p110 isoform was over-
expressed in OCRG9 ES cells and clones were selected in the absence of LIF. 
Selection for transgene expression was performed with G418, while Oct4 negative 
cells were displaced by puromycin. It should be noted, however, that LIF 
independent clones were rare and further experiments are necessary to rule out that 
potential culture artefacts or compensatory mechanisms accounted for this 
phenomenon. An ideal approach would be a system in which the transgene can be 
excised again after LIF independency was established. The Cre-Lox recombination 
system would be one example that could be applied (Sauer, 1987); in this system 
floxed transgenes can be excised by transient expression of the Cre recombinase. If 
ES cell self-renewal is truly dependent on myr-p110 expression, differentiation 
should be induced upon its excision.  
For the activated p110 and  isoforms, self-renewal in the absence of LIF was not 
as clear -cut, but cannot currently be ruled out. More experiments are needed to 
investigate the precise effects of their overexpression in ESCs. Another alternative to 
activation by myristoylation would be the activation by introduction of activity 
enhancing mutations. For instance, in human p110 two point mutations, H1047R 
and E545K, are described to potently activate PI3K signalling and increase 
oncogenic properties (Zhao et al., 2005).  
LIF independency of myr-p110cell lines was further confirmed by addition of a 
Jak pathway inhibitor, which did not affect their ability to self-renew, in contrast to 
parental control cells. This indicates that artificial stimulation of only one of the two 
parallel LIF integration pathways was sufficient to drive ES cell self-renewal (Niwa 
et al., 2009). When myr-p110cells were reintroduced to culture conditions 
including LIF, they were still responsive to the cytokine, resulting in beneficial 
effects on self-renewal as assessed by colony morphology and ES cell marker 
expression. Rex1 (GFP) and Nanog expression appeared to be more homogeneous 
compared to OCRG9 control ES cells, when investigated with flow cytometry and 
immunocytochemistry. The homogeneous expression of Nanog was lost in two out 
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of the three analysed clones upon LIF withdrawal, and was then comparable to 
Nanog expression under serum plus LIF culture conditions, where Nanog is known 
to be heterogeneously expressed (Chambers et al., 2007; Singh et al., 2007). In one 
clone (clone 6) Nanog remained to be highly expressed with a homogeneous 
distribution even in the absence of LIF. 
At the transcriptional level, pluripotency marker genes Tbx-3, Nanog, Klf4, Zscan4 
and Oct4 were elevated in myr-p110 over-expressing clones compared to parental 
control expression, showing that activation of p110leads to a broad shift in the 
transcriptional profile towards a more self-renewing signature. It is not clear yet how 
PI3Ks integrate their signals that influence the proliferation, self-renewal and 
survival of ES cells. A potential cause for the changes observed at the transcriptional 
level, could be the activation of Akt by myr-p110, which was determined by 
immunoblotting for phosphorylated Akt (S473), and previously reported to be 
sufficient for ES cell self-renewal (Watanabe et al., 2006). A common upstream 
regulator of Akt is PDK1, and, therefore, it is somewhat surprising that ES cells in 
which both copies of the PDK1 gene were disrupted, did not exhibit any reported 
defects in proliferation or self-renewal (Williams et al., 2000). However, disruption 
of PDK1 did only affect Akt phosphorylation at its T-loop residue (T308), whereas 
phosphorylation at its hydrophobic motif (S473) was unaffected (Williams et al., 
2000). Over-expression of myr-p110 resulted in an increase in S473 
phosphorylation of Akt in this and in other studies (Popkie et al., 2010; Takahashi et 
al., 2003). This suggests that PI3Ks might have alternative pathways for regulating 
the hydrophobic motif of Akt, or that the PI3K/PDK1 pathway might have a 
supportive, but dispensable, role in self-renewal (Burdon et al., 2002). Interestingly, 
PDK1 null ES cells were found to have upregulated Nanog expression, which was 
proposed to result from compensatory alterations during either their initial derivation 
and/or subsequent culture (Welham et al., 2007).  
Immunoblotting revealed high levels of Nanog protein in myr-p110 clones in the 
presence of LIF and elevated levels of Nanog in the absence of LIF in comparison to 
parental control ES cells. Nanog protein levels in the presence of LIF appear to be 
higher in myr-p110 cell lines, than expected from quantitative RT-PCR data, when 
compared to control. The observed uncoupling of mRNA and protein levels for 
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Nanog might be due to the reported inhibition of GSK-3 by the activated 
p110transgene (Popkie et al., 2010). Inhibition of GSK-3 was recently found in 
our laboratory to positively regulate Nanog translation (Yolanda Sanchez Ripoll and 
Melanie Welham, unpublished data). 
In one clone (clone 6) Nanog expression remained at high levels even in the absence 
of LIF, which must result from a difference in transgene integration or other 
compensatory mechanisms triggered throughout the selection process. As the results 
of the other two analysed clones (clone 3 and clone 10) were comparable, it is more 
likely that these clones reflect the real effect of the transgene expression, but further 
experiments are necessary to address this issue.  
A homogeneous ES cell population was postulated for cells cultured under 2i 
conditions, by addition of small-molecule inhibitors of MEK and GSK-3, leading to 
the stable ground state of pluripotency (Wray et al., 2010). It is likely that ES cells 
over-expressing myr-p110are also in a more stable pluripotent state, but for this 
reason their differentiation ability could be impaired, as even in the absence of LIF a 
self-renewing phenotype is maintained. A teratoma formation assay could be used to 
establish whether myr-p110clonesare still able to generate teratomas containing 
derivatives of all three germ layers. Forced over-expression of Nanog for instance 
was also reported to lead to LIF independent self-renewal, and these transgenic cells 
were still able to generate teratoma (Chambers et al., 2003). In contrast, LIF 
independent ES cells resulting from ectopic expression of Pramel7 did avert 
teratoma formation, indicating the absolute requirement for Pramel7 silencing 
(Casanova et al., 2011). Furthermore, it would be of interest to test whether myr-
p110 LIF independent clones are able to self-renew also in serum-free condition, 
or if additional serum stimulation is required for maintaining the phenotype. 
Over-expression of Zscan4c was found in a microarray screen to strongly upregulate 
Pramel7 transcription (Nishiyama et al., 2009), and Pramel7 in turn can inhibit Erk 
activity by promoting Erk dephosphorylation (Casanova et al., 2011). Myr-p110 
LIF independent clones exhibited drastic elevated levels of Zscan4, and, therefore, it 
is likely that Pramel7 levels may also be elevated. Together with the reported GSK-3 
inhibition by activated p110 (Popkie et al., 2010) this is proposed to lead to the 
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stable ground state of pluripotency (Silva and Smith, 2008; Wray et al., 2010), and 
might be the explanation for observed LIF independency. 
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6.1 General discussion and future directions 
Embryonic stem (ES) cells are of enormous interest as they hold great potential to be 
used in regenerative medicine to treat diseases for which no curative medical 
treatments are currently available. This potential lies in their unique abilities to self-
renew, a symmetrical cell division generating identical daughter cells without losing 
pluripotency and the ability to differentiate into any kind of cell. Some core elements 
of the molecular network governing self-renewal have already been discovered, but 
it is still a long way to fully understand all the signalling and regulatory elements 
that control these unique and very complex processes. Furthermore, the link between 
proliferation and pluripotency is far from being understood, but it is necessary to 
completely understand the whole self-renewal process in order to harness the full 
potential of ES cells. 
The contribution of PI3Ks is known to be important for keeping ES cells in a self-
renewing state (Niwa et al., 2009; Paling et al., 2004). However, precisely where 
PI3K-dependent signalling is placed in the regulatory network of self-renewal is still 
emerging and not yet completely understood. The LIF signalling pathway was found 
to integrate signals via two parallel pathways to the core circuit, one of which is the 
PI3K pathway, stimulating important pluripotency regulators like Tbx-3 and Nanog 
(Niwa et al., 2009; Storm et al., 2007; Storm et al., 2009). Of particular importance 
is determining the functional contribution of genes regulated by PI3K-dependent 
signalling and how they are involved in controlling ES cell identity. The aim of this 
study was to identify genes downstream of PI3K involved in regulating mES cell 
self-renewal and to characterize their molecular mechanisms of action. Furthermore, 
signalling pathways and the influence of specific PI3K isoforms involved in 
regulating expression of our genes of interest were a focus of this study. 
In a microarray screen performed prior to the start of this study by M. Storm and 
partners of the FunGenEs consortium (www.fungenes.org), identified 646 significant 
(ANOVA, p<0.05) probe set changes following inhibition of PI3Ks in mES cells. 
Subsequent hierarchical clustering of these 646 probe sets and final k-means 
clustering into k=12 groups helped to differentiate expression changes between the 
different conditions. Loss-of-function experiments were set up to characterize the 
role of selected candidate genes, identified by the microarray screen, in mES cell 
self-renewal. In a previous loss-of-function strategy similar to ours it was possible to 
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identify four genes with previously unrecognized roles in mES cell self-renewal 
(Ivanova et al., 2006). 
In this study, Zscan4 was found to be a mediator of mES cell self-renewal, affecting 
stem cell fate when knocked-down by siRNA-based approaches. A significant 
change to a more differentiated phenotype upon transient Zscan4 knock-down was 
detected based on assessment of colony morphology, loss of alkaline phosphatase 
activity and expression of pluripotency marker genes. Zscan4 is a novel family of 
zinc finger proteins, of which Zscan4c is the predominantly transcribed member in 
mES cells (Falco et al., 2007). Recent Ensembl database comparisons revealed a 
change in the composition of the Zscan4 family members reported by Falco et al. 
(Falco et al., 2007). The most apparent changes were that the Zscan4b and e 
paralogous genes are now, with 505aa, almost full-length coding (506aa), and the 
previous pseudogene two (ps2) is now also reported to encode full-length protein of 
506 amino acids. The earlier reported pseudogenes ps1 and ps3 could no longer be 
retrieved from the Ensembl database, but are still present in the NCBI database. As 
the Zscan4 family is a very novel gene family future changes might still occur with 
progression of our understanding. Structural prediction data suggests that Zscan4c 
contains a SCAN domain, which is a leucine-rich motif of approximately 60aa that 
often mediates protein-protein interaction (Edelstein and Collins, 2005; Falco et al., 
2007). In addition, Zscan4c contains 4 zinc finger motifs (Falco et al. 2007), which 
are associated with DNA binding and control of transcriptional targets. Therefore, it 
is quite likely that Zscan4c might act as a transcription factor, a possibility that was 
further strengthened by the finding that over-expression of Zscan4c leads to 
approximately 500 significant up- and downregulated gene changes in ES cells 
(Nishiyama et al., 2009). 
Zscan4 RNA and protein are both present in undifferentiated mES cells. When ES 
cells were induced to differentiate by the embryoid body formation assay or LIF 
withdrawal, Zscan4 expression was shown to drop rapidly. Interestingly, Zscan4 
expression appeared to be as, or even more sensitive to, differentiation than Nanog 
expression, an early marker of differentiation when compared to, for instance, Oct4 
(Brill et al., 2009). Many molecular changes are triggered by the differentiation of 
ES cells and some major disparities between ES cells and differentiated cells lie in 
the cell cycle. Cell cycle regulation is unique in ES cells and the molecular 
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mechanisms regulating proliferation are still largely undiscovered. Murine ES cells 
grow rapidly in culture in the presence of LIF, due to their short cell cycle (11-16h). 
A reduced duration of G1 phase is the main cause of this characteristic (Burdon et 
al., 2002). In contrast to somatic cells, which exhibit periodically peaking cyclin E-
CDK2 activity at the G1 to S transition in cell cycle, mES cells have constitutive 
cyclin E-CDK2 activity. The constant E-CDK2 activity of self-renewing mES cells 
bypasses the restriction point and, therefore, omits the early G1 phase (White et al., 
2005). Recent findings have linked Nanog regulation to the cell cycle dependent 
histone H3 lysine 27 (H3K27) methyltransferase Ezh2, opening up the possibility 
that cell cycle-dependent epigenetic mechanisms can influence ES cell self-renewal 
(Villasante et al., 2011). Although the precise mechanisms still remain largely 
unknown, posttranslational modification of chromatin regulators during the G2/M 
phase are critical for the control of cell fate during self-renewal and development, 
remaining under investigation for several decades (reviewed in (Budirahardja and 
Gonczy, 2009; Sharif et al., 2011)). With the described mosaic expression of Zscan4 
and the precise control of its expression at the 2-cell stage of embryonic 
development, cell-cycle mechanisms could also contribute to regulation of Zscan4 
(Falco et al., 2007; Zalzman et al., 2010). Furthermore, when transiently knocked-
down at the 2-cell stage, transition to the 4-cell stage was delayed for approximately 
24 hours (Falco et al., 2007). Strikingly, blastocyst development was also impaired, 
suggesting a more complex action of Zscan4. 
In a recent report, retinoids were found to transiently upregulate Zscan4 expression, 
with a peak at 48 hours after addition (Ko and Zalzman, 2011). Four different 
retinoids were tested, all-trans retinoic acid (atRA), 9-cis RA, 13-cis RA, and 
Vitamin A. Zscan4 positive cells peaked for all for retinoids at 48 hours, and a 
secondary increase was observed only for 13-cis RA, and Vitamin A within seven 
days, with Vitamin A resulting in the largest Zscan4 increase. It was proposed that 
this might partially relate to effects of these retinoids on proliferation, atRA and 9-cis 
RA almost completely stopped proliferation, 13-cis reduced proliferation 
moderately, whereas Vitamin A did not negatively affect proliferation. Retinoids are 
generally associated with differentiation processes (Mark et al., 2006), therefore, it is 
surprising that they are able to transiently increase Zscan4 expression, a gene 
marking self-renewal of ES cells. Interestingly, Vitamin A, which resulted in the 
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strongest increase of Zscan4 expression, was reported to enhance mES cell self-
renewal through stimulating the PI3K/Akt pathway and upregulation of Nanog 
(Chen and Khillan, 2008; Chen and Khillan, 2010; Chen et al., 2007). This finding 
fits well with our discovery that Zscan4 is regulated downstream of PI3Ks (Storm et 
al., 2009). Furthermore, evidence presented in this thesis suggests regulation of 
Zscan4 via the p110 PI3K catalytic isoform, shown by the use of the 
pharmacological inhibitors PIK-75 and Compound 15e as well as over-expression of 
a myristoylated p110 isoform, which led to increased expression of Zscan4 family 
members.  
It is of interest that Zscan4c was also recently reported to be involved in regulating 
telomere length and genomic stability (Zalzman et al., 2010). Telomere elongation 
occurred in mES cells with high levels of Zscan4c, or upon induced over-expression 
of Zscan4c, leading to rapid telomere extension, most probably by a telomere 
recombination mechanism. This might be due to the proposed function of Zscan4 as 
a transcription factor, and consequent upregulation of meiosis-specific homologous 
recombination genes, but possibly also through direct mechanisms, as Zscan4c was 
found to be in close proximity to telomeres (Zalzman et al., 2010). Spo11 catalyses 
meiosis-specific DNA double-strand breaks (Keeney et al., 1997) and was one of the 
reported upregulated genes (Zalzman et al., 2010), but it is curious that in their 
earlier performed microarray screen over-expression of Zscan4c did not upregulate 
transcription of Spo11 (Nishiyama et al., 2009). In the microarray screen over-
expression of Zscan4c rather resulted in downregulation of Spo11, but where the 
differences arise from is unclear. Despite this discrepancy, Spo11, as well as Dmc1, 
a RecA homologue recombinase required for meiotic recombination (Reinholdt and 
Schimenti, 2005), were co-localised with Zscan4 foci at the telomeres. Homologous 
recombination during meiotic recombination requires the introduction of DNA 
double strand breaks (DSBs), which are enclosed in -H2AX foci (Mahadevaiah et 
al., 2001), and -H2AX foci were co-localised to a high degree (>90%) with Zscan4 
foci on telomeres (Zalzman et al., 2010). Interestingly, -H2AX foci were observed 
by immunostaining from G1-S phase to G2 phase of the cell cycle, but during the 
metaphase -H2AX foci were absent, indicating the repair of DSBs. Furthermore, no 
Spo11, -H2AX, or DMC1 foci were detected in Zscan4 negative cells (Zalzman et 
al., 2010). Zscan4 foci were also found to co-localise with telomere repeat binding 
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factor 1 (TRF1) (Zalzman et al., 2010), which has a protective function for telomeres 
(Blasco et al., 1995; de Lange, 2005) and is also reported to be involved in telomere 
regulation (Munoz et al., 2009; van Steensel and de Lange, 1997). Levels of TRF1 
were described to correlate with that of different pluripotency markers, and a link of 
chromosome stability with pluripotency was proposed (Varela et al., 2011). 
Interestingly, ES cells expanded in vitro were found to have acquired longer 
telomeres than their in vivo counterparts, cells of the inner cell mass of the blastocyst 
(Varela et al., 2011). During the process of ES cell establishment a loss of 
heterochromatic marks was described, which might facilitate the elongation of 
telomeres (Varela et al., 2011). It is possible that Zscan4 may play a role in some of 
the described functions of telomere elongation, during early stages of ES cell 
establishment and/or during prolonged culture of ES cells. It is also worth 
mentioning that iPS cells regained the ability to express Zscan4 (Zalzman et al., 
2010), but whether that is a direct and essential process during reprogramming, or a 
secondary cause during expansion of iPS clones remains to be investigated.  
Creation of murine ES cell lines with an inducible eGFP-Zscan4c fusion protein was 
used for identifying potential protein binding partners by a combined 
immunoprecipitation - mass spectrometry strategy. Identification of binding partners 
can help to unravel potential molecular mechanisms of action of proteins of interest. 
Four potential binding partners were identified in this study, lysine specific histone 
demethylase 1 A (LSD1), C-terminal binding protein2 (Ctbp2), histidine triad 
nucleotide-binding protein 1 (HINT1) and 40S ribosomal protein S7 (Rps7). 
Interestingly, most of these proteins are associated with functions related to 
transcriptional regulation and DNA damage responses, functions that Zscan4 has 
also been reported to be involved with (as discussed above). LSD1 is able to 
maintain global DNA methylation and can demethylate non-histone substrates like 
p53, DNA (cytosine-5)-methyltransferase and E2F1 (Huang et al., 2007; Kontaki 
and Talianidis, 2010; Wang et al., 2009). Furthermore, LSD1 has been shown to 
regulate processes for gene activation through demethylation of H3K9me1/me2 
(Metzger et al., 2005; Wissmann et al., 2007) and was recently reported to play an 
important role in human embryonic stem cell self-renewal by maintaining the proper 
balance between H3K4me2/me3 and H3K27me3 at target developmental genes 
(Adamo et al., 2011). Mouse ES cells in which LSD1 was conditionally knocked-out 
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appeared to be pluripotent, but exhibited severe growth and differentiation defects 
with an increase in apoptosis (Wang et al., 2009). LSD1 could contribute to establish 
the right epigenetic environment to allow full function of Zscan4 and its partners, for 
instance a loss of heterochromatic marks at telomeres occurring before telomere 
elongation (Varela et al., 2011). 
Ctbp2 was also found to associate with Zscan4c, probably by binding to the known 
Ctbp PXDLS binding motif (Boyd et al., 1993; Quinlan et al., 2006), which is 
present in all Zscan4 members. Ctbp1 and Ctbp2, collectively referred as Ctbp, 
function as transcriptional co-repressors, and they are reported to act in protein 
complexes which can be comprised of LSD1 and other zinc finger proteins 
(Balasubramanian et al., 2003; Wang et al., 2007a). This fits well with our finding 
that Zscan4c, a zinc finger protein, and LSD1 were isolated in the same screen. 
Furthermore, Ctbp might be involved in adding complexity to the regulation 
possibilities of the multi-functional role of Zscan4, as there are different layers of 
Ctbp regulation mechanisms reported. The activity of Ctbp is dependent on 
intracellular NADH, which binds to Ctbp‟s dehydrogenase/NADH binding domain 
(Mani-Telang et al., 2007; Zhang et al., 2002). Ctbp was proposed to act as a redox 
sensor for regulating transcription as a consequence of the cellular metabolic 
environment (Fjeld et al., 2003; Zhang et al., 2006a). Also the cell cycle is involved 
in regulating Ctbp, as phosphorylation of Ctbp occurs in a cell cycle-dependent 
manner and its phosphorylation pattern suggests regulation by a cell cycle-regulated 
kinase (Boyd et al., 1993).  Phosphorylation of Ctbp might also take place at a DNA-
PK consensus phosphorylation site, and Ctbp could, therefore, be the substrate of 
DNA-PK or related kinases (Chinnadurai, 2002; Schaeper et al., 1998; Vo et al., 
2001). Furthermore, UV light triggers proteasomal degradation of Ctbp through 
activation mechanisms leading to its ubiquitination (Zhang et al., 2005).  
These features of Ctbp proteins are interesting as another potential Zscan4c 
interacting protein, HINT1, participates in ionizing radiation-induced DNA damage 
responses involved in regulation of -H2AX foci (Li et al., 2008a). MEFs deficient 
in HINT1 were shown to be more genetically unstable than their wild-type 
counterparts, exhibiting various types of chromosomal abnormalities (Li et al., 
2008a). Zscan4c function has been implicated in regulation of genomic stability and 
cells high in Zscan4c were shown to have features associated with a higher genomic 
Chapter 6: General discussion and future directions 
 
213 
 
stability (Zalzman et al., 2010). In addition, Zscan4 was reported to be transiently 
upregulated in response to oxidative stress and DNA-damaging agents (Ko and 
Zalzman, 2011), probably administrating protecting functions, enhancing survival of 
cells that were exposed to damaging events (Ko and Zalzman, 2011). It might be that 
Zscan4 in combination with HINT1 accomplish this protective function, but how and 
what function each of them contributes needs to be established.  
Carefully carried out, over-expression, knock-down, interaction, labelling and 
functional assays need to be performed to shed further light on these mechanisms. 
Time-lapse experiments with tagged Zscan4 and tagged interacting proteins might 
reveal their temporal and spatial expression, and from there it might be possible to 
draw conclusions on their individual functions. Furthermore, LSD1 DKO ES cells 
could be used to study if functions of Zscan4c over-expression are dependent on 
presence of LSD1. 
 
In another aspect of this study, the effects of artificial activation of Class IA PI3K 
catalytic isoforms in mES cells were investigated. A genetic activation strategy was 
applied by fusing a myristoylation target sequence to the p110, , and  isoforms, 
which promotes constitutive membrane attachment and activation (Klippel et al., 
1996). The piggyBac transposon system was used for over-expressing these 
constructs in mES cells with a CAG promoter. Myristoylation approaches for the 
activation of signalling pathways were previously used successfully in ES cells and, 
for instance, myr-Akt was found to be sufficient to liberate ES cells from the 
requirement of LIF (Watanabe et al., 2006). Furthermore, over-expression of 
activated p110 was reported to be able to rescue impaired growth and 
tumorigenicity in Eras (a Ras-like gene) knockout ES cells (Takahashi et al., 2003). 
In this study over-expression of myr-p110in OCRG9 mES cells, was found to be 
able to lead to LIF independency. For the activated p110 and  isoforms, self-
renewal in the absence of LIF was not as clear-cut, but cannot currently be ruled out. 
Possibly, activation of the beta and delta catalytic isoforms could also result in LIF 
independency, which might be triggered by elevated PIP3 levels activating 
downstream signalling pathways. To test whether myristoylation of the different 
isoforms resulted in a comparable elevation of intracellular PIP3 levels, biochemical 
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assays need to be performed, as described in other studies (Jirmanova et al., 2002; 
Klippel et al., 1996). Cells were also placed under some selective pressure by 
selecting for Oct4 positive cells with puromycin and by the selection for transgene 
expression with G418. Furthermore, LIF withdrawal might have caused additional 
cellular stress which might have triggered expression of stress response genes 
contributing to the observed phenotype. For instance, Zscan4 levels were reported to 
be elevated when ES cells were exposed to oxidative stress (Ko and Zalzman, 2011). 
Differences in the behaviour and expression of pluripotency marker genes have been 
observed between LIF independent clones, especially one clone (clone 6) exhibited 
higher levels of Nanog expression in absence of LIF, accompanied by an increased 
self-renewing phenotype, in comparison to other observed clones. Where this 
difference arises from is not clear yet, and needs to be further addressed. It might 
that the transgene integrated in very close proximity to the endogenous Nanog gene, 
driving its expression by the strong CAG promoter (Niwa et al., 1991). Also some 
culture adaptation might have occurred during selection and, for instance, epigenetic 
changes could have led to the permanent activation of pluripotency genes. It would 
be necessary to further characterise these clones to solve this puzzle, and localisation 
of transgene integration sites might help to understand the described differences. 
Immunostaining for p110 and measuring of PIP3 levels could also help to determine 
differences in activity or expression levels between clones. 
A model for the possible working mechanisms of activated PI3K-dependent 
signalling was proposed. This model is based on the pluripotency „ground state‟ 
theory, which in brief describes that inhibition of GSK-3 and Erk activity is 
sufficient to keep ES cells in a basal proliferative state with only minimal required 
external stimuli (Wray et al., 2010; Ying et al., 2008). However, additional 
stimulation with LIF has beneficial effects on clonogenicity, which in fact was also 
observed in the system used for the studies presented in this thesis. In this model 
myr-p110is proposed to stimulate Zscan4, either directly or indirectly through Akt, 
which leads to upregulation of Zscan4 expression, which in turn stimulates 
transcription of Pramel7, reported to be able to reduce Erk activity (Casanova et al., 
2011; Nishiyama et al., 2009). On the other hand, myr-p110 over-expression can 
result in GSK-3 inactivation by stimulating Akt activity (Popkie et al., 2010). 
Therefore, myr-p110 over-expression is able to block activity of both, GSK-3 and 
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Erk, establishing the „ground state‟ of pluripotency. This working model is not yet 
thoroughly tested and a number of experiments would be still necessary to add 
further weight to it. For instance, upregulation of Pramel7 was not tested, and also 
phosphorylation levels of Erk need to be checked by immunoblotting. Also, Akt 
phosphorylation needs to be checked on both phosphorylation sites, T308 and S473, 
to ensure its correct activation. Furthermore, GSK-3 phosphorylation needs to be 
also confirmed by immunoblotting and kinase assays, to ensure its inactivated status. 
It would also be of interest to determine whether activated p110ES cells, with 
higher levels of Zscan4, show a higher rate of telomeric recombination events, and 
as such would place PI3K signalling as an important player in regulation of 
telomeres in ES cells. In summary, more work is required to completely assess the 
detailed effects of activated PI3Ks signalling in ESCs.  
 
 
6.2 Concluding remarks 
Zscan4 is a novel ES cell master regulator important for maintaining ES cell identity, 
genomic stability, and telomere length. This study has provided further insights into 
Zscan4 regulation, by placing it downstream of the PI3K signalling pathway, in 
particular of the p110 catalytic isoform. Furthermore, Zscan4 function was linked 
to self-renewal, which might be a direct effect of Zscan4 activity or an indirect effect 
caused by a loss of genomic stability. The identification of potential binding partners 
might help to contribute to the further understanding of the multi-functional 
mechanisms of Zscan4. Many questions remain unanswered. How Zscan4 is 
precisely regulated, whether it is an essential part in ES cell or iPS cell generation, 
how it elongates telomeres, how it is linked with pluripotency or the cell cycle, and 
whether it might be involved in immortalisation or contribute to cancers, will be 
some of the challenges that have to be addressed in future studies. 
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